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ii. Abstract
Cyclic nucleotide regulated ion channels are membrane pores that permeate ions
in the presence of the cyclic nucleotides adenosine 3’, 5’-cyclic monophosphate (cAMP)
or guanosine 3’, 5’-cyclic monophosphate (cGMP). These channels play essential roles in
vision and olfaction, as well as in cardiac and neuronal pacemaking. Heterologous
expression of these eukaryotic membrane proteins, necessary for structural studies, is
usually difficult. Such difficulty is commonly overcome by studying their prokaryotic
homologues.
MlotiK1 is a bacterial cyclic nucleotide regulated potassium channel from
Mezorhizobium loti. This homotetramer contains a transmembrane region and a
cytoplasmic cyclic nucleotide binding (CNB) domain. The present thesis addresses recent
research on this potassium channel, especially concerning its ligand selectivity
determinants and global conformational change.
The molecular determinants of ligand selectivity were explored through a
comprehensive set of point mutations in the CNB domain binding pocket. By combining
three specific point mutations, ligand selectivity was inverted. While the wild-type CNB
domain is known to favour binding of cAMP over cGMP, the triple mutant favours binding
of cGMP over cAMP. Such inversion in ligand selectivity is reflected in the channel
activation by cyclic nucleotides. The crystal structure of the triple mutant CNB domain
showed that the change in selectivity is related to the establishment of an extensive water-
mediated hydrogen bond network in the binding pocket. In contrast to the apolar wild-type
binding pocket, this hydrophilic binding pocket is more flexible, allowing the
accommodation of a variable number of water molecules that mediate cGMP binding
through an hydrogen bond network.
The conformational change induced by cAMP in the full-length channel was
visualized by atomic force microscopy, using a mutant with decreased ligand affinity. Such
mutant was shown to be functionally active. The conformational change was found to be
reversible and dependent on cAMP concentration. In the presence of cAMP, the CNB
domains were organized in a four-fold arrangement, while in its absence they became
highly unorganized and could not be visualized individually.
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iii. Sumário
Os canais iónicos regulados por nucleótidos cíclicos são proteínas membranares
que permeiam iões na presença dos nucleótidos cíclicos 3’, 5’-monofostato cíclico de
adenosina (cAMP) ou 3’, 5’-monofosfato cíclico de guanosina (cGMP). Estes canais
desempenham funções essenciais na visão e no olfacto, bem como no estabelecimento
dos ritmos cardíaco e neuronal. A expressão heteróloga destas proteínas membranares
eucarióticas, necessária para estudos estruturais, é frequentemente difícil. Esta
dificuldade é geralmente superada através do estudo dos seus homólogos procarióticos.
O MlotiK1 é um canal de potássio regulado por nucleótidos cíclicos, proveniente
da bactéria Mezorhizobium loti. Este homotetrâmero contém uma região transmembranar
e um domínio de ligação a nucleótidos cíclicos citoplasmático. A presente tese aborda
investigação recente neste canal de potássio, com ênfase nos determinantes moleculares
de selectividade para o ligando e na sua alteração conformacional global.
Os determinantes moleculares de selectividade para o ligando foram explorados a
partir de um conjunto abrangente de mutações pontuais no domínio de ligação. A
selectividade para o ligando foi invertida através da combinação de três mutações
específicas. Enquanto o domínio de ligação original favorece a ligação de cAMP
relativamente a cGMP, o mutante triplo obtido favorece a ligação de cGMP sobre cAMP.
Esta inversão de selectividade reflecte-se na activação do canal por nucleótidos cíclicos.
A estrutura cristalina do domínio de ligação do mutante triplo revelou que a inversão de
selectividade está relacionada com a formação de uma extensa rede de ligações de
hidrogénio mediadas por moléculas de água no local de ligação. Em contraste com o
local de ligação original, apolar, o local de ligação do mutante triplo é hidrofílico e mais
fexível, permitindo acomodar um número variável de moléculas de água. Estas moléculas
mediam a ligação de cGMP através de uma rede de ligações de hidrogénio.
A alteração conformacional induzida por cAMP no canal foi visualizada utilizando
microscopia de força atómica e um mutante com baixa afinidade para cAMP. O referido
mutante é funcionalmente activo. A alteração conformacional é reversível e dependente
da concentração de cAMP. Na presença de cAMP, os domínios de ligação distribuem-se
num arranjo tetragonal, ficando altamente desorganizados na sua ausência, não podendo
ser visualizados individualmente.
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11. Introduction
21.1. Cyclic nucleotides
The cyclic nucleotides adenosine 3’, 5’-cyclic monophosphate (cAMP) and
guanosine 3’,5’-cyclic monophosphate (cGMP) are universal signalling molecules, found
in all organisms. They are involved in many physiological processes, including vision,
olfaction, sugar metabolism and neuronal function.
1.1.1. Identification of cAMP and cGMP
cAMP was first identified as a “heat stable factor” produced in membrane fractions
of dog or cat liver homogenates, upon addition of the hormones epinephrine or glucagon.
Adenosine 5’-triphosphate (ATP) and magnesium were required and the “heat stable
factor” could not be produced in the corresponding soluble fractions under the same
conditions. When added to the supernatant, the “heat stable factor” induced glycogen
breakdown by stimulating the liver phosphorylase activity (Berthet et al., 1957). The factor
was later purified and identified as an adenine ribonucleotide (Sutherland and Rall, 1958).
Its structure was determined (Lipkin, 1959) and it was named “adenosine 3’,5’-phosphoric
acid”, cyclic 3,5-AMP (cAMP). cAMP was shown to be quantitatively synthesized from
ATP and produced not only in the liver, but also in the heart, skeletal muscle and brain
(Rall and Sutherland, 1958). The enzyme catalyzing this reaction requires magnesium
and was named adenyl cyclase. Its distribution, preparation and properties were
described (Sutherland et al., 1962) and pyrophosphate was shown to be another reaction
product (Rall and Sutherland, 1962). Importantly, the discovery of cAMP led to the
introduction of the concept of secondary messenger. The hormone (primary messenger)
activated the membrane-bound adenyl cyclase, increasing the production of cAMP
(secondary messenger) from ATP.
cGMP was first isolated from rat urine (Ashman et al., 1963) and animal tissue
(Goldberg et al., 1969) (Ishikawa et al., 1969). Unlike cAMP, cGMP biosynthesis could not
be initiated by epinephrine or glucagon, showing that it should result from another
metabolic pathway (Hardman and Sutherland, 1969). It was shown that cGMP was
produced from guanosine 5’-triphosphate (GTP) by a guanyl cyclase (White and Aurbach,
1969), which is largely soluble, has a preference for manganese instead of magnesium
and is inhibited by several nucleotides, including ATP (Ishikawa et al., 1969).
31.1.2. Cyclic nucleotide synthesis, degradation and effectors
cAMP and cGMP are produced by adenyl and guanyl cyclases, respectively, and
degraded by cyclic nucleotide phosphodiesterases (PDEs) (Rehmann et al., 2007).
Physiological responses elicited by cyclic nucleotides are mostly mediated by cAMP-
dependent protein kinases (PKA) (Walsh et al., 1968) (Kuo and Greengard, 1969a) (Kuo
and Greengard, 1969b) (Miyamoto et al., 1969) and cGMP-dependent protein kinases
(PKG) (Kuo and Greengard, 1970). These two homologous protein families are
recognized as the main effectors of cAMP and cGMP-mediated responses (Lincoln and
Corbin, 1977).
Other effectors are the bacterial Catabolite gene Activator Protein (CAP) (Emmer
et al., 1970), which promotes gene transcription in the presence of cAMP (Zubay et al.,
1970), ion channels, which are mostly studied in vision (Cook et al., 1987; Kaupp et al.,
1989) and olfaction (Nakamura and Gold, 1987), a microbial cAMP receptor expressed on
the surface of the eukaryotic microorganism Dictyostelium discoideum (slime mold) (Klein
et al., 1988) and a protein family with Guanine nucleotide Exchange Factor (GEF) activity
called Exchange Protein directly Activated by cAMP (Epac) (de Rooij et al., 1998;
Kawasaki et al., 1998).
1.1.3. Generating cyclic nucleotides: adenyl cyclases and guanyl cyclases
In mammals, there are at least ten groups of adenyl cyclases (also known as
adenylyl cyclases or adenylate cyclases), divided into one soluble and nine membrane-
bound subgroups (Taussig and Gilman, 1995). The membrane bound adenyl cyclases are
homologous, containing two catalytic domains that form the catalytic site and are attached
to two membrane-embedded domains (Hanoune and Defer, 2001). The whole unit
converts ATP into cAMP. Adenyl cyclase activity is controlled by a membrane-bound G-
protein-coupled receptor (GPCR) and a heterotrimeric G protein (formed by α, β and γ
subunits). Adenyl cyclase activity can be triggered by several molecules, including
hormones and neurotransmiters, which bind to their specific GPCR. Upon activation by
the GPCR, the guanosine 5'-diphosphate (GDP) in the G-protein α subunit is exchanged
by guanosine 5'-triphosphate (GTP). The β and γ subunits are dissociated form it and
regulate downstream processes (Taussig and Gilman, 1995), including activation of
adenyl cyclase. During this process, the extracellular signal is amplified: one activated
GPCR can activate several adenyl cyclases and each adenyl cyclase can synthesize
many cAMP molecules. Besides G proteins, adenyl cyclases are regulated by protein
4kinases, forskolin (a plant diterpene) and the calcium-binding protein calmodulin
(Hanoune and Defer, 2001). Several human diseases are related to defective or
excessive cAMP biosynthesis (Sutherland, 1972) (Costache et al., 2013).
There are two groups of guanyl cyclases (also known as guanylyl cyclases or
guanylate cyclases): membrane-associated and soluble. Both have one catalytic domain
per subunit (Tesmer, 2008). Membrane-associated guanyl cyclases are homodimers
containing an extracellular binding domain, whose best known ligands are natriuretic
peptides (peptide hormones), a transmembrane region with one or more segments and an
intracellular catalytic domain (Wedel and Garbers, 2001) (Rehmann et al., 2007). Soluble
guanyl cyclases are heterodimers formed by a α and a β subunit, existing two and three
kinds of α and a β subunits, respectively (Friebe and Koesling, 2003). They contain a
heme group and are activated by nitric oxide (Rehmann et al., 2007). Like adenyl
cyclases, guanyl cyclases also amplify the extracellular signal during its transduction
process.
1.1.4. Degrading cyclic nucleotides: Cyclic nucleotide phosphodiesterases
The intracellular concentrations of cAMP and cGMP are regulated mainly by the
activities of adenyl/guanyl cyclase and cyclic nucleotide phosphodiesterases (PDEs).
PDEs catalyze the conversion of cAMP or cGMP to AMP or GMP, respectively (Beavo et
al., 1994). PDEs form a diverse protein family of dimers and multimeric complexes. Their
function is achieved by a conserved catalytic domain usually located at the C-terminus.
PDEs can be unspecific or specific for cAMP or cGMP (Manganiello et al., 1995). In some
PDEs, a N-terminal GAF domain has been identified, whose function is cyclic nucleotide
binding (Zoraghi et al., 2004). There are GAF domains specific for cAMP and for cGMP
(Gross-Langenhoff et al., 2006). In cGMP-specific GAF domains, ligand binding is
favoured through a conserved aspartate. GAF domains are not restricted to PDEs
(Aravind and Ponting, 1997) and can bind other small molecules besides cyclic
nucleotides (Zoraghi et al., 2004).
1.1.5. Proteins containing CNB domains
“The great variety of actions that involve adenosine 3',5'-monophosphate (cyclic
AMP), including mediation of the effects of many hormones in vertebrates as well as
stimulation of enzyme synthesis in bacteria, raises the question as to the mechanism by
5which this low molecular weight compound achieves its diversity of effects” (Kuo and
Greengard, 1969b).
When the sequences of CAP, PKA and PKG were determined, a common
structural motif was found: the cyclic nucleotide-binding (CNB) domain (Shabb and
Corbin, 1992). CNB domains are recognized as the main common link among proteins
regulated by cyclic nucleotides. The first structure of a CNB domain was obtained when E.
coli CAP was crystallized in complex with cAMP (McKay and Steitz, 1981; McKay et al.,
1982).
1.1.5.1. Protein kinases activated by cAMP or cGMP
PKAs are divided into several groups (Canaves and Taylor, 2002), which may
have different subcellular locations (Theurkauf and Vallee, 1982). Eukaryotic PKAs are
heterotetramers composed of two identical regulatory (where cAMP binds) and two
identical catalytic subunits, existing four types of each one (Johnson et al., 2001). Each
regulatory subunit has two tandem CNB domains (Titani et al., 1984; Diller et al., 2001).
The regulatory subunits dimerize through a narrow region and a catalytic subunit is
attached to each one of the regulatory subunits (Zhao et al., 1998). In the absence of
cAMP, PKA is inhibited through high-affinity binding of the regulatory subunits to the
catalytic subunits (Hofmann, 1980). In the presence of cAMP, two ligand molecules bind
cooperatively to each regulatory subunit, disrupting the interaction with catalytic subunits
and activating the kinase (Johnson et al., 2001) (Anand et al., 2002). cAMP-binding and
interaction with a catalytic subunit are achieved through separate regions (Corbin et al.,
1978; Herberg et al., 1994). PKA effects are mostly related to stimulation of glycolysis and
glycogen breakdown in muscle and liver (Nelson, 2005).
There are at least two types of PKG: PKG1, found mostly in vascular smooth
muscle cells, endothelium and platelets and PKG2, found mostly in the intestine, kidneys
and brain (Vaandrager and de Jonge, 1996). PKG1 enzymes are homodimers, where
each monomer contains one regulatory domain with two CNB domains, plus a C-terminal
catalytic domain with kinase activity (Francis et al., 2010), which forms interactions within
each monomer (Wolfe et al., 1989). The regulatory domain also forms the dimerization
interface. In the absence of cGMP, the enzyme is inhibited by internal contacts, as in PKA
(Francis et al., 2010). PKG1 mediates the vasodilation effect of nitric oxide and is, as a
consequence, involved in vascular smooth muscle relaxation. Other effects include
decrease in endothelial permeability, inhibition of platelet aggregation (Vaandrager and de
6Jonge, 1996) and activation of potassium channels regulated by calcium and voltage
(Alioua et al., 1998).
1.1.5.2. Ion channels
Ion channels regulated by cyclic nucleotides are best studied in the vision and in
the olfaction mechanisms. Cyclic nucleotide gated (CNG) channels are usually
heterotetramers, containing one C-terminal CNB domain per monomer. Their specificity
for cAMP or cGMP varies (Kaupp and Seifert, 2002). Both visual and olfactory ion
channels are specific for cations and permeate calcium (mostly) and also sodium and
potassium (Menini, 1995). Unlike other ligand-gated ion channels, they do not desensitize
in the continued presence of ligand (Kaupp and Seifert, 2002). They are also regulated by
calcium/calmodulin (Trudeau and Zagotta, 2003), pH and phosphorylation (Kaupp and
Seifert, 2002).
Light is sensed through closure of cGMP-gated ion channels and consequent
termination of neurotransmitter release into neighbouring cells. In the dark, these
channels are open. Rod cells in the retina have large amounts of the GPCR rhodopsin,
which contains constitutively bound retinal, a photosensitive derivative of vitamin A. Light
is sensed through isomerization of retinal, activating rhodopsin. Activated rhodopsin will
relay the light signal through the G-protein transducin, exchanging its GDP to GTP and
activating it. The α-subunit of activated transducin will activate a PDE, resulting in a
decrease in cGMP concentration and consequent closure of cGMP-gated calcium
channels, decreasing their current and the release of neurotransmitter. Conversely, the
decrease in intracellular calcium concentration stimulates guanyl cyclase activity,
enhancing cGMP synthesis by a feedback mechanism (Hille, 1992) (Matulef and Zagotta,
2003). A similar mechanism exists in cones, the cells in the retina responsible for colour
vision; however, they are less sensitive and adapt to a wider range of light intensities,
possibly because of differences in calcium homeostasis. Mutations in genes encoding
these channels can lead to blindness or loss of colour discrimination (Kaupp and Seifert,
2002).
Binding of an odorant to its GPCR in an olfactory neuron stimulates adenyl
cyclase, increasing the intracellular concentration of cAMP. cAMP will open calcium
channels and the consequent increase in intracellular calcium concentration will open
calcium-gated chloride channels. The current generated will stimulate neurotransmitter
release into neighbouring cells, resulting in odour perception (Hille, 1992); (Craven and
Zagotta, 2006). The ability to discriminate among many odours is due to the existence of a
7vast array of odorant receptors. Mice lacking functional cAMP-sensitive olfactory channels
exhibited no detectable response to odorants (Kaupp and Seifert, 2002).
1.1.5.3. Guanine nucleotide exchange factor, Epac
Epac is a monomer and contains a regulatory region with a CNB domain, plus a C-
terminal catalytic region that mediates GEF activity. GEF activity consists in the transfer of
GTP to the GTPase proteins Rap1 and Rap2, which cycle between GDP-bound (inactive)
and GTP-bound (active) forms (Gloerich and Bos, 2010). In the absence of cAMP, Epac is
inactive, since access of the catalytic domain to Rap is blocked by interactions with the
regulatory regions in Epac (Rehmann et al., 2006). cAMP binding causes the CNB domain
to swing away from its blocking position, allowing access to Rap proteins (Rehmann et al.,
2008).
In mammalian cells, there are two isoforms of Epac: Epac1 and Epac2 (Gloerich
and Bos, 2010). Epac2 contains an additional CNB domain at the N-terminus whose
binding affinity is lower (de Rooij et al., 2000). This additional CNB domain has a non-
canonical sequence and different phosphate-binding cassete (PBC) architecture
(Rehmann et al., 2003). Its function may not be cAMP-binding. Repac, the other member
of the family, lacks a CNB domain and is a constitutive activator of Rap proteins (de Rooij
et al., 2000). Both Epac1 and Epac2 are abundant in the central nervous system and have
neuronal functions (Gloerich and Bos, 2010). Epac1 is also abundant in blood vessels,
kidney or adipose tissue and is involved in cardiac function, vascular permeability and
inflammation (Fukuhara et al., 2005; Gloerich and Bos, 2010). Epac2 is also found in the
adrenal gland and pancreas and is involved in insulin secretion (Shibasaki et al., 2007;
Gloerich and Bos, 2010).
1.2. Potassium channels
Potassium channels are most likely the fundamental controllers of the cellular
electrical homeostasis (Torres et al., 2007). Their diversity is of great importance to
understand the variety of electrical responses of cells when subjected to stimuli.
81.2.1. The beginning of ion channel research
The ion channel research field has its foundations in the study of electrical activity
of squid giant axons. The unusually large dimensions of these cells allowed measuring
their electrical properties by using microelectrodes. Such electrical properties were found
to be dependent on ion channels.
1.2.1.1. Electrical measurements in squid giant axons
Squid giant axons were prepared by removing fibers and branches under an
optical microscope, after washing with sea water. Prepared axons usually had 6 to 8
centimetres in length and a uniform diameter between 530 and 580 µm. Recordings were
done in elongated chambers with circulating sea water. Axons whose electrical properties
stabilized within one hour were used in the following 6 to 8 hours, as their electrical
properties were constant during such period (Cole and Curtis, 1939).
This system was used for measuring the electrical currents that resulted of
applying voltage to giant axons. Such currents resulted mainly of changes in sodium and
potassium permeabilities. Upon stimuli, the conductance changed differently and
reversibly for each ion. Based on these recordings, an empirical kinetic model was
presented to describe sodium and potassium permeability changes upon stimuli, in squid
giant axons (Hodgkin and Huxley, 1952b, a, c). Such model became an explanation for
their electrical excitability.
1.2.1.2. Early structural insights
Electrical recordings using inhibitory compounds in squid giant axons (Armstrong,
1971) or frog nerve fibers (Armstrong and Hille, 1972) suggested that potassium
permeation should be achieved by permeation pores. Such pores should have two distinct
regions: a cavity wide enough to accommodate an ion or an inhibitor molecule and a
narrower inner region that could accommodate only the ion.
Perfusion of squid giant axons with proteases indicated that sodium and potassium
permeation should be carried out by distinct channels and that those should be proteins
(Armstrong et al., 1973). Other inhibition results were consistent with a potassium channel
structure with multiple ion binding sites, crossed by ions in a single file (Adelman and
French, 1978), as previously predicted (Hodgkin and Keynes, 1955). Moreover, potassium
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two ions at a time (Hille and Schwarz, 1978) and their narrowest region should be a circle
of oxygen atoms forming a 3 Å wide pore (Hille, 1973).
1.2.2. The potassium channel selectivity filter
Each potassium channel sequence contains a highly conserved segment called
potassium channel signature sequence, which forms the narrow region responsible for
selective potassium permeation, known as the selectivity filter (MacKinnon, 2003).
Mutations in this segment can severely affect ion discrimination (Heginbotham et al.,
1994).
Potassium ions permeate through these channels down their concentration
gradient at rates that can be close to 106 ions per second, corresponding to the
translocation of one ion every 0.1 millisseconds (Hille, 1992).
1.2.3. Important models of potassium channels: Shaker and KcsA
The Shaker potassium channel (Pongs et al., 1988) cloned from Drosophila
melanogaster, the fruit fly, was found to be a tetramer (MacKinnon, 1991). Its external
entryway was described as a shallow conical vestibule formed by loops, with the
selectivity filter in the apex (Ranganathan et al., 1996). The channel function is affected by
pore blockers, which can be trapped inside its cavity by the channel gate (Holmgren et al.,
1997). This mechanism is called “gating” and is associated with changes in volume and
accessibility in the cavity (Liu et al., 1997).
The KcsA channel from Streptomyces lividans, a filamentous soil bacterium, was
shown to be selective for potassium and predicted to have two transmembrane helices
per subunit (Schrempf et al., 1995). Purified KcsA is a remarkably stable tetramer in
solution (Heginbotham et al., 1997) and was the first ion channel whose structure was
determined by X-ray crstallography (Doyle et al., 1998). The structure showed a
tetrameric assembly, where each subunit contains two long α-helices that cross the
membrane and surround a shorter α-helix. The pore is located at the center of the four
subunits (Fig. 1.1 A). The selectivity filter is formed by a loop located between the shorter
and the C-terminal α-helices (Fig. 1.1 B). The selectivity filter contains four identical
potassium binding sites, where each potassium ion is coordinated by eight oxygen atoms
from main chain carbonyl groups and from side-chain hydroxyl groups (Fig. 1.1 C).
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Although crystal structures show one ion bound to each of the four potassium binding
sites, in fact, only two of those sites are occupied by ions at the same time (Zhou and
MacKinnon, 2003). Each pair of ions is separated by one water molecule, alternating
rapidly between two configurations, which are potassium-water-potassium-water and
water-potassium-water-potassium. When a potassium ion enters in one side of the line, it
displaces another potassium ion in the other side, resulting in potassium translocation
(Morais-Cabral et al., 2001).
Figure 1.1: Crystal structure of the KcsA potassium channel in ribbon
representation. Potassium ions and water molecules are represented as purple and red
spheres, respectively. (A) Extracellular view, neighboring subunits are represented in
different colors. (B) Side view, only two subunits are shown for clarity and the selectivity
filter is indicated by oval. (c) Zoom over selectivity filter, where polar contacts between
potassium ions and water molecules or carbonyl groups from the selectivity filter are
indicated by black dashed lines. Protein data bank (PDB) code: 1K4C (Zhou et al., 2001).
1.2.4. Rapid and selective potassium permeation
The pore structure present in KcsA is conserved in eukaryotic potassium channels
(MacKinnon et al., 1998). Evolutionary optimization of the potassium channel selectivity
filter resulted in very high rates of potassium permeation and very high selectivity
(MacKinnon, 2003). The very high permeation rate is explained by the weak binding of the
ions to the selectivity filter. It has been postulated that such binding is weak for two
reasons: 1) repulsion between two consecutive ions separated by one water molecule; 2)
the presence of two potassium ions changes the conformation of the selectivity filter,
causing an energetic penalty that reduces the total binding energy (MacKinnon, 2003).
Potassium permeation is facilitated also because the cavity and pore allow the ions to
remain hydrated inside the membrane and stabilized by the negative charges at the end
A B C
11
of α-helices (Roux and MacKinnon, 1999). It has also been postulated that high ion
selectivity is achieved because the selectivity filter has several “tailor-made” binding sites
that perfectly mimic the hydration shell of potassium (MacKinnon, 2003). The presence of
potassium should impose a large energy barrier to other ions, as lithium or sodium, to bind
to the selectivity filter (Thompson et al., 2009). Potassium, or another permeable cation, is
required for structural stability of the selectivity filter and overall stability of the tetramer
(Krishnan et al., 2005). Its removal causes pore dilation, loss of ion selectivity and
ultimately loss of function (Loboda et al., 2001). Potassium channel diversity is due to the
different mechanisms for gating (opening and closing of the pore) and regulation, which
can be voltage or a ligand (MacKinnon, 2003).
The main families of potassium channels will be discussed below. The members of
these families are homo or heterotetramers.
1.2.5. Voltage-gated potassium channels
When the membrane electrical field is altered, voltage-gated potassium channels
detect the alteration. They become activated, letting potassium ions cross the membrane
and restoring the electrical field to its resting state. In these channels, each monomer has
six transmembrane segments divided into two domains (Fig. 1.2): the first four helices
form the voltage sensor domain and the last two helices form the pore domain, identical to
the one seen in KcsA (Fig. 1.1). Gating is directly controlled by the transmembrane
electrical field, which is sensed in real time by a voltage sensor, located in the voltage
sensor domain. The fourth helix in each voltage-sensor domain is an essential element in
voltage sensing. It contains four to eight positively charged residues, mostly arginines,
every third position (Tombola et al., 2006). The Shaker channel is a voltage-gated
potassium channel and a useful model to explore the voltage sensing mechanism. During
voltage sensing, positive charges in the fourth helix accessible on one side of the
membrane change their accessibility to the other side by translation and most likely also
rotation of the fourth helix (Yellen, 2002; Tombola et al., 2006).
In the structures of Shaker channels (Long et al., 2005; Long et al., 2007), the
fourth helix adopts a 310 helix conformation over seven to ten residues. 310 helices are
formed when main chain hydrogen bonds are established between residues separated by
two other residues, while in -helices the separation is of three residues. Therefore, 310
helices are more tightly wound and less stable than canonical -helices. These helices
are relatively rare and most are short (usually with three or four residues). Longer 310
helices are even rarer, since they have specific packing requirements, rarely seen over
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long extensions (Vieira-Pires and Morais-Cabral, 2010). As mentioned above, voltage
sensing should involve translation and most likely, also rotation of the fourth helix across
the membrane. A 310 helix conformation would place the positively charged residues all in
the same side and the switch to a -helical conformation would provide the rotation
mentioned above. Such transition is possible and has been reversibly observed in isolated
peptides upon changes in solvent polarity (Karle et al., 1994; Bellanda et al., 2007).
Therefore, it has been proposed that voltage sensing might involve transition between the
two conformations in part of the fourth helix (Vieira-Pires and Morais-Cabral, 2010). It is
still unclear how voltage sensing is coupled to channel gating; however, several studies
indicate that the linker between both transmembrane domains and the C-terminal portion
of the C-terminal helix is involved (Tombola et al., 2006).
Figure 1.2: Crystal structure of the Shaker potassium channel in a ribbon
representation (extracellular view). Each subunit is represented in a different color. The
pore is indicated by a potassium ion represented by a sphere. The pore domain and the
voltage sensor domain are indicated. PDB code: 2R9R (Long et al., 2007).
1.2.6. Ligand-gated potassium channels
There are two main families of potassium channels regulated by ligands: inward
rectifier and calcium-gated, which will be described below.
Pore domain Voltage sensor domain
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1.2.6.1. Inward rectifier potassium channels
Inward rectifier potassium channels conduct potassium more efficiently towards
the intracellular side (inward) than in the opposite direction (outward), due to pore blocking
in the intracellular side by magnesium or polyamines (Hibino et al., 2010). Such blocking
is mediated by their regulatory cytoplasmic domain formed by the N- and C-termini from
each subunit, which provides a favorable environment for binding of polyamines (Nishida
and MacKinnon, 2002). These channels lack a voltage sensor domain. They contain only
the pore domain (Tao et al., 2009) and the overall structure is similar to KcsA. Their
activity is regulated by a vast array of ligands, mostly ions, phospholipids or proteins, like
GPCRs. Their functions include controlling the resting membrane voltage of cells, insulin
release and neurotransmitter action (Hibino et al., 2010).
1.2.6.2. Calcium-activated potassium channels
This family is subdivided into large conductance (maxi-K or BK) and small
conductance (SK) channels (McCoy and Nimigean, 2012). While both are activated by
intracellular calcium, BK channels are also activated by voltage (Rothberg, 2012)
(Adelman et al., 2012). Both types have six transmembrane helices, but BK channels
have an additional N-terminal helix, which is part of the voltage sensor and also involved
in oligomerization (Rothberg, 2012).
In SK channels, calcium regulation is mediated by calmodulin, which binds to the
C-terminus of each subunit (Adelman et al., 2012). In BK channels, calcium is sensed by
a cytoplasmic C-terminal regulator of conductance of potassium (RCK) domain (Rothberg,
2012), which has a regulatory function in various potassium channels and transporters
(Roosild et al., 2009). BK channels are essential to control action potentials and
neurotransmitter release, as well as in the control of smooth muscle contraction, triggered
by calcium release from the endoplasmic reticulum (Rothberg, 2012). SK channels are
expressed in the central nervous system and their activity has rapid effects in excitability
and synaptic transmission, as well as in long term changes that affect memory and
learning (Adelman et al., 2012).
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1.3. Channels activated by cyclic nucleotides
Cyclic nucleotide activated ion channels are divided into two main families: cyclic
nucleotide-gated (CNG) and hyperpolarization-activated cyclic nucleotide-modulated
(HCN) channels. Both are homo or heterotetrameric, containing six putative α-helices and
a cytoplasmic C-terminal CNB domain (Craven and Zagotta, 2006). Despite CNG, HCN
channels are also regulated by voltage (Kaupp and Seifert, 2001). CNG channels are non-
selective cation channels, permeating mostly sodium and calcium (Kaupp and Seifert,
2002). On the contrary, HCN channels are about 4-fold more permeant to potassium than
sodium. The CNG and HCN families are believed to be similar in structure and
mechanism; however, they play different physiological roles (Craven and Zagotta, 2006).
1.3.1. CNG channels
Although CNG channels are best studied in vertebrate photoreceptors and
olfactory neurons, they are not restricted to these tissues. Another important function of
CNG channels is mobility and chemoattraction in sperm cells. They are also found in
heart, kidney, pancreas, adrenal gland and colon (Kaupp and Seifert, 2002; Matulef and
Zagotta, 2003). Their importance in the central nervous system is being increasingly
recognized, since they are probably involved in several processes, including neuronal
excitability, neurotransmission and pain perception (Podda and Grassi, 2013). CNG
channels have also been studied in plants (Zelman et al., 2012).
In CNG channels, the four N-terminal helices form a domain with homology to the
voltage sensor domain of voltage-gated channels; however, these channels are not
sensitive to voltage. It has been proposed that although the fourth helix contains some of
the positive charges required for voltage sensing, some of the necessary counter charges
are missing (Bellanda et al., 2007). Consistently with this hypothesis, the fourth helix of a
CNG channel (voltage insensitive) was shown to work as a voltage sensor, by transferring
it to a voltage-gated channel (Tang and Papazian, 1997). In CNG channels, this helix
might also be “locked” in a fixed conformation by hydrophylic residues of its upstream loop
(Kaupp and Seifert, 2002). It was proposed that the CNG channels pore opens through a
translation and possible rotation of the intracellular ends of the C-terminal helices,
increasing its internal diameter (Flynn and Zagotta, 2001).
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1.3.2. HCN channels
In mammals, HCN channels are expressed in the heart and nervous system,
where they regulate heart rate and neuronal excitability. Due to such function, they are
also called pacemaker channels (Kaupp and Seifert, 2001). Strikingly, and unlike other
voltage gated channels, which are activated by membrane depolarization, membrane
hyperpolarization activates HCN channels. Nevertheless, the voltage sensing mechanism
in HCN channels is probably similar to those of voltage-gated channels (Bell et al., 2004).
HCN channel activation is also regulated by cyclic nucleotides, especially cAMP.
Rhythmic contraction of the cardiac muscle results of a cycle of membrane
depolarization and hyperpolarization mediated by at least four different types of ion
channels, including HCN channels (Kaupp and Seifert, 2001). Some neurotransmitters
accelerate the heartbeat rate through an increase in cAMP concentration, favouring
activation of HCN channels (Craven and Zagotta, 2006). In neurons, these channels work
through a similar, but faster mechanism, and therefore the neuronal action potentials are
faster (Craven and Zagotta, 2006). In the nervous system, they control neuronal
excitability, synaptic transmission, among other functions (Benarroch, 2013). They are
associated with learning and memory and misregulation may be involved in chronic pain
and epilepsy (Lewis and Chetkovich, 2011). HCN channels have been explored as
potential drug targets (Postea and Biel, 2011).
1.3.3. MlotiK1, a bacterial cyclic nucleotide-regulated potassium channel
The physiological and medical relevance of both CNG and HCN ion channels are
important reasons for their study. Functionally, they have been well characterized through
electrical recordings. However, structural studies require expression and purification of
significantly large amounts of protein. For these eukaryotic membrane proteins, this is
frequently not feasible and their prokaryotic homologues, such as MlotiK1, have been a
valuable alternative. MlotiK1 is a cyclic nucleotide regulated potassium channel from
Mesorhizobium loti, a symbiotic bacterium involved in nitrogen fixation (Kaneko et al.,
2000). Both the full-length channel and its isolated CNB domain can be expressed and
purified with good yield and purity. Protein folding is facilitated in the presence of a cyclic
nucleotide, since ligand depletion during purification causes extensive protein aggregation
(Nimigean et al., 2004).
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1.3.3.1. Structural data
MlotiK1 is a homotetramer and its sequence predicts a transmembrane topology
containing six α-helices and a cytoplasmic C-terminal CNB domain. Electron microscopy
(EM) of single particles in the bound state shows that the CNB domains are organized
with a four-fold symmetry, without any obvious interactions between them (Chiu et al.,
2007). The structure of its transmembrane region has been determined at 3.1 Å by X-ray
crystallography (Clayton et al., 2008), showing an arrangement similar to those of voltage-
gated potassium channels. In each subunit, the four N-terminal α-helices form a voltage
sensor-like domain and the two C-terminal α-helices form the pore domain (Fig. 1.3 A). In
the voltage sensor-like domain, the fourth helix contains an unusually long 310 helix, with
eleven residues (Clayton et al., 2008). This helix does not have positively charged
residues at the necessary positions for voltage sensing (Clayton et al., 2008) and
therefore, it is unlikely to sense the transmembrane electrical field. Although it has
structural homology to voltage-sensor domains, its role, if any, is unclear. Electron
crystallography suggests that, in the membrane, the position of the voltage sensor-like
domain relative to the pore domain is highly variable, adopting multiple orientations
(Clayton et al., 2009). The pore domain has the typical structure found in potassium
channels; however, it contains two bulky residues, F203 and Y215, which partially occlude
the pore (Fig. 1.3 B) (Clayton et al., 2008). Although the crystals were grown in the
presence of cAMP, the structure shows a closed state. The CNB domains were highly
disorded and could not be resolved.
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Figure 1.3: Crystal structure of the MlotiK1 potassium channel transmembrane
region, in a ribbon representation. (A) Extracellular view, where each subunit is
represented in a different color. The pore is indicated by a potassium ion represented by a
sphere. (B) Side-view, only two subunits are shown for clarity. In the pore domain, the
selectivity filter is indicated by four potassium ions (represented by spheres) and F203
and Y215 are represented in stick. PDB code: 3BEH (Clayton et al., 2008).
There are several crystal structures of the isolated CNB domain: four structures in
complex with cAMP, two structures in complex with cGMP and six apo structures (Clayton
et al., 2004; Altieri et al., 2008). There are also nuclear magnetic resonance (NMR)
structures: one in complex with cAMP (Schunke et al., 2009) and an apo structure
(Schunke et al., 2011). Both show that the isolated CNB domain is a monomer in solution.
The structure of MlotiK1 CNB domain in complex with cAMP consists of an antiparalel -
roll and five helices, comprising a helical linker to the transmbrane region and four -
helices, A, B, C and P (Fig. 1.4 A). Superposition of bound and unbound structures
of the CNB domain shows that the β-roll is essentially unchaged in both states, except in
the β4-β5 hairpin loop. The linker that connects the CNB domain to the transmembrane
region and the other helices are in different positions. Importantly, C helix covers the
binding pocket as a lid in the bound state and is deviated in the unbound state (Fig. 1.4
B). The different positions of C helix in different crystal structures of the unbound state
suggest that this helix is highly mobile in the absence of ligand (Clayton et al., 2004; Altieri
et al., 2008); however NMR data indicates that the CNB domain is rigid in the unbound
state (Schunke et al., 2011).
A B Pore domain
Voltage sensor-like domain
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Figure 1.4: Crystal structures of MlotiK1 CNB domain in ribbon representations,
with bound cAMP represented in stick. (A) Structure in complex with cAMP colored in red
or blue (for αB and αP helices). (B) Superposition of cAMP-bound (red) and unbound
(light red) structures through the β-roll. PDB codes: 1VP6 (bound) and 1U12 (unbound)
(Clayton et al., 2004).
1.3.3.2. Functional data
MlotiK1 has remarkably slow permeation kinetics (Clayton et al., 2004); (Silverman
and Heginbotham, 2007), partly due to the occlusion of the pore by the bulky residues
F203 and Y215 (Clayton et al., 2008). It has not been possible to study MlotiK1 function
through electrical recordings, most likely because of its slow permeation kinetics.
Alternatively, a radioactive flux assay (Nimigean, 2006) has been used to functionally
characterize this potassium channel. MlotiK1 is selective for potassium over sodium or
lithium, but accurate estimates of the selectivity ratios could not be determined (Nimigean
et al., 2004). MlotiK1 mediated potassium transport is enhanced by a cyclic nucleotide,
but not totally dependent of it (Silverman and Heginbotham, 2007). The maximum
stimulatory effect of cAMP is only about 2-fold (Clayton et al., 2004; Silverman and
Heginbotham, 2007). The channel can also be activated by cGMP, but the necessary
concentration for half of maximum activity is approximately 10-fold higher than for cAMP
(Nimigean et al., 2004; Altieri et al., 2008). The determinants that define this 10-fold
selectivity for cAMP versus cGMP are not completely known; however, CNB domain
structures in complex with cAMP or cGMP provide some insights. Due to the different
conformation of the ligand in the binding pocket, V288 makes van der Waals interactions
with cAMP, but not with cGMP (Altieri et al., 2008). The same structures show that a
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residue in the PBC, S308, establishes hydrogen bonds with cGMP, but not with cAMP.
Mutating S308 to a valine decreases the affinity for cGMP by 3-fold, without significant
effect in cAMP (Nimigean and Pagel, 2007). In CNG channels, an aspartate in αC helix
was proposed to be important for the discrimination between cAMP and cGMP (Varnum et
al., 1995). In MlotiK1, the equivalent residue is an alanine, which is not resolved in the
crystal structures (Clayton et al., 2004; Altieri et al., 2008) and is disordered in the NMR
structures (Schunke et al., 2009; Schunke et al., 2011). Mutating it to an aspartate
increases affinity for cGMP by 3-fold, without detectable effect in cAMP (Nimigean and
Pagel, 2007).
Cyclic nucleotide binding in MlotiK1 is not cooperative (Cukkemane et al., 2007)
and is well coupled to channel opening (Nimigean and Pagel, 2007). Upon cAMP binding,
the MlotiK1 CNB domain conformational change occurs through an induced-fit mechanism
(Peuker et al., 2013) that affects virtually all residues in the CNB domain (Schunke et al.,
2007; Schunke et al., 2010; Cukkemane et al., 2012). In the C helix, the R348 residue
establishes important interactions with the ligand (Clayton et al., 2004; Altieri et al., 2008;
Schunke et al., 2009). Mutating it to an alanine significantly decreases binding affinity
(Cukkemane et al., 2007).
MlotiK1 cannot be included either into the CNG or HCN families. It is selective for
potassium, like HCN channels; however, it is most likely not voltage-gated. It should
therefore be simply considered as separate family of prokaryotic potassium channels
regulated by cyclic nucleotides (Nimigean et al., 2004).
1.3.3.3. State of the art and objectives
In contrast to the well characterized conformational change occurring in the CNB
domain upon ligand binding/unbinding, the structural data available for MlotiK1 has shown
its transmembrane region only in the closed state. It would be of interest to gain insights
into the structural differences between the the open and closed states. Additionally, the
molecular mechanism that determines ligand selectivity in CNB domains is still poorly
understood and the MlotiK1 CNB domain is a good model to investigate it.
The main objectives of the present project are:
- To define the molecular determinants of ligand selectivity in MlotiK1 CNB
domain.
- To visualize the cAMP-induced conformational change in the full length
channel.
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2. Inverting ligand selectivity in MlotiK1 (Paper I)
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In the present section, a study on the molecular determinants of ligand selectivity
in the MlotiK1 channel is described.
2.1. Introduction
The function of cyclic nucleotide dependent effectors is partly determined by the
ligand selectivity properties of the CNB domain. These properties have not been
completely characterized. One of the difficulties in the study of ligand selectivity is to
distinguish the effects related to binding of nucleotide from the effects that are related to
efficiency of ligand in fuctional activation. In this study, this difficulty has been overcome
by studying the isolated CNB domain. The amino acids of the CNB domain binding pocket
that specifically affect binding of either cAMP or cGMP are critical for ligand selectivity.
Using site-directed mutagenesis and a fluorescence-based binding assay, we have
screened a comprehensive set of point mutations in the binding pocket residues known to
interact with the nucleotide base. From the single mutants tested, we generated a triple
mutant, which displayed inverted ligand selectivity, so that the mutant has higher affinity
for cGMP than for cAMP. This triple mutant was structurally and functionally
characterized.
The binding pocket of CNB domains consists of a shallow cavity formed by side
chains from several structural motifs, which are the β4-β5 hairpin, the αP helix, the PBC
region and a lid, which in MlotiK1 is formed by αC helix (Fig. 2.1 A). Inspection of crystal
structures of the MlotiK1 CNB domain binding pocket in complex with cAMP or cGMP
shows the residues that interact with the ligand base. V282 and T284 in the β4-β5 hairpin,
R348 in the lid of the αC helix, M299 in αP helix and F296 and S308 in the PBC.
Comparing the structures in complex with cAMP and in complex with cGMP, the most
obvious difference is in another residue in the β4-β5 hairpin: V288, which establishes van
der Waals interactions with cAMP (Fig. 2.1 B), but not with cGMP (Fig. 2.1 C), making it a
promising candidate in our search for determinants of ligand selectivity. Nevertheless, the
other residues in the binding pocket were also explored, except F296, since it is highly
conserved and therefore is probably not involved in ligand discrimination.
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Figure 2.1: Cyclic nucleotide binding to the MlotiK1 CNB domain. (A) The CNB
domain structural elements (in red and green) that form the ligand binding pocket are
indicated. cGMP is shown as stick. (B) and (C) Residues interacting directly with ligand
bases in the MlotiK1 CNB domain crystal structures bound to (B) cAMP (PDB code:
1VP6) and (C) cGMP (PDB code: 3CL1). Dotted circle indicates that V288 is not one of
the residues interacting with cGMP.
2.2. Materials and methods
2.2.1. Expression and purification of ligand-free MlotiK1 CNB domain
mutants
MlotiK1 CNB domain mutants were expressed and purified as described previously
(Clayton et al., 2004). Phosphate-buffered saline (PBS) buffer containing 2 mM
dithiothreitol (DTT) (purification buffer) was used throughout purification. Size-exclusion
chromatography was performed in a Superdex 75 column (GE Healthcare). For
preparation of apo-domain, freshly purified protein was incubated overnight with cAMP
agarose beads (Sigma-Aldrich), and bound protein was extensively washed with
purification buffer. cAMP-free protein was eluted by unfolding with purification buffer that
included 3 M guanidinium chloride (unfolding buffer). cAMP removal was monitored by
determining the OD260/OD280 ratio, as described previously (Peuker et al., 2013). Typical
values varied between 0.65 and 0.90 for nucleotide-free CNB domain. Protein was first
diluted to 0.3 mg/ml with unfolding buffer and then diluted threefold into refolding buffer
(100 mM NaCl, 10 mM sodium phosphate, pH 7.0, 5 mM glutathione [reduced], 0.5 mM
glutathione [oxidized], 0.5 mM L-arginine and 10 mM EDTA) (Cukkemane et al., 2007) to
a final concentration of 0.1 mg/ml protein and 1 M guanidinium chloride. This solution was
A B C
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gently stirred at 4°C for 3 h, and then the protein was concentrated to ~0.3 mg/ml. The
refolded protein was further dialyzed against refolding buffer to lower guanidinium chloride
concentration to ~50 mM. Dialyzed protein was concentrated and loaded onto a Superdex
75 size-exclusion column to remove misfolded protein (Peuker et al., 2013) (folded protein
elutes at 12.0–12.5 ml, and misfolded protein elutes at 16.0–17.0 ml). Finally, refolded
apo-protein was dialyzed against 10 mM HEPES buffer, pH 7.5, and 100 mM NaCl before
binding assays.
2.2.2. Cyclic nucleotide–binding assays
Dissociation constants (KD) were determined at room temperature in 10 mM
HEPES pH 7.5, and 100 mM NaCl, with a fluorescence assay that uses the fluorescent
nucleotide analogue 8-NBD cAMP (Biolog) (Cukkemane et al., 2007; Altieri et al., 2008).
Cyclic nucleotides (cAMP and cGMP [both from Sigma-Aldrich]), were purchased as acids
or as sodium salts. For each mutant, the KD of the fluorescent analogue was determined
by titrating 50 nM 8-NBD cAMP with increasing protein concentrations and collecting
fluorescence emission spectra (excitation at 471 nm) in a spectrofluorometer (Fluoromax-
4; Horiba Scientific). For each protein concentration tested, emission at 536 nm was
normalized as described previously (Altieri et al., 2008), and data were fitted with the
following equation:
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where y is the normalized fluorescence intensity, K is the dissociation constant of
8-NBD cAMP, P is protein concentration, and L is 8-NBD cAMP concentration. For
determination of the dissociation equilibrium constants of cAMP or cGMP, the above
assay was repeated in the presence of a competing fixed concentration of cAMP or cGMP
in each sample. For determination of the competing concentration, the protein
concentration that resulted in 70–80 % of the maximum signal was selected and titrated
with increased ligand concentrations. The ligand concentration that decreased the signal
to 40–50 % was then chosen for the competition assay. Data were fitted with the following
equation:
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where y is the fluorescence intensity, K1 is the dissociation constant of 8-NBD
cAMP, K2 is the dissociation constant of cAMP or cGMP, L1 is the 8-NBD cAMP
concentration, P is total protein concentration, L2 is total concentration of cAMP or cGMP,
G is signal gain, and y0 is signal offset. For mutants displaying 8-NBD cAMP dissociation
constants higher than 5 μM, a modified assay was used (Altieri et al., 2008). The
concentrations of the protein and 8-NBD cAMP were fixed at approximately the KD value
and two times the KD value, respectively, and titrated with increasing cAMP or cGMP
concentrations. Data were fitted with the previous equation but with a varying cyclic
nucleotide concentration.
The effect of point mutations on ligand binding was screened using the isolated
CNB domain. The approach was a binding assay that uses the fluorescent cAMP
derivative 8-NBD cAMP (Biolog). It is well known the the local environment has important
effects on fluorescent molecules (Lakowicz, 2006). The intrinsic fluorescence of 8-NBD
cAMP is enhanced upon protein binding (Kraemer et al., 2001). For determination of the
dissociation constant (KD) values of each CNB domain mutant for cAMP and cGMP, the
first step was a protein titration at a fixed concentration of 8-NBD cAMP, usually 50 nM.
Affinity for 8-NBD cAMP varied among the mutants screened, resulting on different ranges
of protein concentrations required for saturation. If saturation occurs at relatively low (1-2
micromolar) protein concentrations, the mutant has high affinity for the cAMP analog (Fig.
2.2 A). If saturation requires higher protein concentration (tens of micromolar), the mutant
has low affinity for the analogue (Fig. 2.2 B). We used different approaches for each of
these two groups, as described below.
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Figure 2.2: Titrations of MlotiK1 CNB domain with 50 nM 8-NBD cAMP (A) T284S
and (B) R348A mutants. Determined KDs were 212 ± 22 nM and 7673 ± 818 nM for T284S
and R348A, respectively.
2.2.2.1. High affinity mutants
For high affinity mutants, KDs for cAMP and cGMP were determined by repetition
of the protein titration with 8-NBD cAMP in the presence of a fixed concentration of cAMP
or cGMP. Using the T284S mutant as an example, the procedure used was the following.
To determine the concentration of cAMP or cGMP to add to the protein titration curve,
first, the fluorescence titration curve is analyzed to identify the protein concentration that
resulted in approximately 70-80 % of the maximum signal (indicated by arrow in Fig. 2.3
A). Second, the protein concentration is fixed at that value and mixed with the fluorescent
analogue. Incresing concentrations of cAMP or cGMP are added (Fig. 2.3 B), so that
fluorescence decreases. The ligand concentration that results in a decrease of the signal
to 40-50 % (indicated by arrows in Fig. 2.3 B) is chosen for the assay. The final titration
involves adding increasing amounts of protein to a mix of fluorescent cyclic nucleotide
analogue with cyclic nucleotide at the concentration determined in the previous step. The
competition effect is evident when the binding curves in the absence and presence of
cAMP or cGMP are superposed, as saturation is reached at higher concentrations of
protein in the presence of non-fluorescent ligand (Fig. 2.3 C). The KD for 8-NBD cAMP is
determined (Fig. 2.3 D) and its value is used to calculate the KDs for cAMP (Fig. 2.3 E)
and cGMP (Fig. 2.3 F), taking into account ligand concentrations.
High affinity,
low KD
Low affinity,
high KD
A B
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Figure 2.3: Determination of the KD for cAMP and cGMP in MlotiK1 CNB domain
T284S. (A) Initial protein titration with 50 nM 8-NBD cAMP. The protein concentration
used in (B) was determined and is indicated by arrow. (B) Competition between 50 nM 8-
NBD cAMP and different concentrations of cAMP or cGMP for binding to 400 nM MlotiK1
CNB domain T284S. Concentrations of cAMP and cGMP chosen for the final tritration are
indicated. (C) Superposition of the protein titration curves in the absence and in the
presence of 1 µM cAMP and 5 µM cGMP. (D) Final titration curve for determination of the
KD for 8-NBD cAMP, 212 ± 22 nM. (E) and (F) are the final titration curves for
determination of the KDs for cAMP (E) and cGMP (F), 464 ± 58 nM and 2984 ± 379 nM,
respectively. These were performed in the presence of the indicated concentrations of
non-fluorescent ligand.
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2.2.2.2. Low affinity mutants
For low affinity mutants, the procedure described above could not be used reliably,
due to the high protein concentrations required to reach saturation. The alternative
approach used was fixing protein concentration and increasing the concentrations of
cAMP or cGMP. The procedure is exemplified for R348A. The KD for 8-NBD cAMP is
determined from a triplicate binding curve (Fig. 2.4 A), as described above. Then, protein
and 8-NBD cAMP concentrations are fixed at one and two-fold of the KD determined,
respectively and the concentrations of cAMP (Fig. 2.4 B) or cGMP (Fig. 2.4 C) are varied.
From each curve, KD for cAMP or cGMP is determined taking into account the KD for 8-
NBD cAMP and ligand concentrations.
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Figure 2.4: Determination of the KDs for cAMP and cGMP in the R348A CNB
domain mutant. (A) Triplicate protein titration with 50 nM 8-NBD cAMP, for determination
of the 8-NBD cAMP KD, 7.7 ± 0.5 µM. Triplicate titration of (B) cAMP or (C) cGMP at 10
µM R348A and 20 µM 8-NBD cAMP. KD values of 24.8 ± 3.2 µM and 38.8 ± 2.4 µM were
determined for cAMP and cGMP, respectively.
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2.2.3. Expression and purification of full-length MlotiK1 channel
Full-length MlotiK1 T284S/V288S/A352D was expressed, purified, and
reconstituted as described previously for the wild-type channel (Clayton et al., 2004;
Nimigean et al., 2004). In brief, MlotiK1 expressed in C41 (DE3) cells was extracted at
4°C for 30 min with PBS buffer, pH 7.4, containing 50 mM n-decyl-β-D-maltopyranoside
(DM; Anatrace), 200 μM cAMP, 5 mM β-mercaptethanol. During purification and until gel
filtration, the same buffer was used, but cAMP was excluded and the DM concentration
decreased to 5 mM, unless stated otherwise. Detergent-extracted proteins were incubated
with nickel beads and first washed with 50 mM imidazole to remove nonspecifically bound
proteins, followed by a 200-ml wash in 2 mM DM. This ensured that cAMP bound to the
triple mutant channel, which has micromolar affinity for cAMP, would dissociate from the
protein. MlotiK1 was eluted in 500 mM imidazole and further purified by gel filtration on a
Superdex 200 column (GE Healthcare) equilibrated in 20 mM Tris-HCl, pH 7.5, 150 mM
KCl, 5 mM DM, and 3 mM DTT. Protein was immediately reconstituted in the presence of
different ligand concentrations.
2.2.4. Liposome reconstitution and radioactive uptake assay
Proteoliposome preparation followed previously described procedures (Clayton et
al., 2004; Nimigean et al., 2004; Altieri et al., 2008). In brief, 7.5 μg MlotiK1 protein was
mixed with 1.5 mg Escherichia coli polar lipids (Avanti Polar Lipids, Inc.) in 10 mM
HEPES, 5 mM N-methyl-β-D-glucamine (NMG), pH 7.6, and 150 mM KCl for a total
volume of 150 μl. The detergent was removed by hydrophobic adsorption using Bio-Beads
SM-2 (Bio-Rad Laboratories). Samples were gently stirred for 1 h at room temperature at
a Bio-Beads/detergent (wt/wt) ratio of 10-15. This step was repeated twice and followed
by an overnight incubation at 4°C with at a Bio-Beads/detergent (wt/wt) ratio of 20-30.
Proteoliposomes were not frozen at any stage. A potassium concentration gradient was
established by exchanging the external buffer to 10 mM HEPES, 5 mM NMG, pH 7.6, 20
μM KCl, and 150 mM sorbitol (sorbitol buffer) in the presence of the appropriate cAMP or
cGMP concentrations, using spin columns. Uptake assays (Nimigean, 2006) were started
by mixing one third of the final reaction volume of buffer-exchanged proteoliposomes with
two thirds of sorbitol buffer containing 5 cps/μl 86Rb+ (PerkinElmer) and the appropriate
ligand concentration. Uptake was monitored after 90 min in 100-μl aliquots and
normalized as described previously (Nimigean, 2006). Normalized uptake by MlotiK1
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reconstituted into liposomes was plotted as a function of ligand concentration and fitted
with the following Hill equation:
n
n
xk
xy  2/1
,
where y is the normalized uptake, x is the ligand concentration and n is the Hill
coefficient. The K1/2 of activation was determined.
2.2.5. Purification and crystallization of T284S/V288S/A352D mutant CNB
domain
Expression and purification of T284S/V288S/A352D CNB domain was performed
as described previously for the wild-type domain (Clayton et al., 2004). For nucleotide
removal, the protein bound to GST beads was washed with 200 ml buffer (PBS buffer
containing 3 mM DTT) before incubation with thrombin. Size-exclusion chromatography
was performed on a Superdex 75 column equilibrated in 10 mM Tris, pH 7.0, 100 mM
NaCl, and 4 mM DTT. Crystals of T284S/V288S/A352D mutant domain were grown using
the vapor diffusion method in 24-well hanging-drop trays with a 500-μl reservoir solution of
0.15 M sodium citrate, pH 5.6, 0.9 M ammonium sulfate, and 100 mM lithium sulfate.
Protein at 10 mg/ml was combined with cGMP (final concentration of 1.5 mM) and mixed
with the reservoir solution at a 1:1 ratio for a final drop volume of 4 μl. Crystals appeared
within 10 d at 25°C. Crystals were cryoprotected in well solution supplemented with 25 %
glycerol and 1.5 mM cGMP before flash cooling in liquid nitrogen. Diffraction data were
collected at 100 K at the beamline 14-4 of the European Synchrotron Radiation Facility
(ESRF) and processed with XDS (Kabsch et al., 2010) and SCALA (Evans et al., 2006).
Mutant CNB domain crystals grew in space group P212121 with two molecules in the
asymmetric unit. The structure of the mutant CNB domain–cGMP complex was solved by
molecular replacement with Phaser (McCoy et al., 2007) using chain A of the cGMP-
bound structure (Protein Data Bank accession no. 3CL1) (Altieri et al., 2008) as the
search model. Model building and refinement were performed with Coot (Emsley et al.,
2010) and Phenix (Afonine et al., 2012), respectively. Ligand restraints were generated
using Phenix. Figures were generated using PyMOL software (Schrödinger, LLC).
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2.2.6. Molecular dynamics (MD) simulations
Two models were defined as corresponding to the CNB domain of wild-type
MlotiK1 and of the T284S/V288S/A352D mutant, respectively. The atomic coordinates of
the wild-type domain were taken from the Protein Data Bank (accession number 3CL1)
(Altieri et al., 2008). Residues 350–354 are missing in 3CL1, whereas their structure was
solved in the mutant. Because these residues are close to the nucleotide-binding site, we
decided to include them in both models. The initial structure of residues 350–354 in the
wild-type domain was defined as an elongation of the αC helix. The final models included
residues 320–354 for the wild-type CNB domain and residues 314–355 for the
T284S/V288/A352 mutant domain. N and C terminals were acetylated and amidated. The
default protonation state was assumed for all the ionizable residues, and histidine
residues were protonated at the epsilon position. All of the water molecules that are
present in the crystallographic structures were retained. The systems were solvated by
~6,000 water molecules, and the necessary number of chloride ions was added to
guarantee electrical neutrality. The atomic models were first equilibrated in the NVT
ensemble (600 ps), with harmonic restraints applied to all of the heavy atoms of the
protein, of cGMP, and of the crystallographic water molecules. The harmonic restraints
were gradually removed in the course of 10-ns equilibration trajectories in the NPT
ensemble. Production trajectories of 100 ns followed. MD trajectories were simulated
using NAMD version 2.9 (Phillips et al., 2005), with the CHARMM27 force field with CMAP
corrections (MacKerell et al., 1998), and the TIP3P model for water molecules (Jorgensen
et al., 1983). Pressure was kept at 1 atm by the Nosé–Hoover Langevin piston method
(Martyna et al., 1994; Feller et al., 1995), with a damping time constant of 50 fs and a
period of 100 fs. Temperature was kept at 300 K by coupling the system to a Langevin
thermostat, with a damping coefficient of 5 ps-1 (Feller et al., 1995). Electrostatic
interactions were treated by the particle mesh Ewald algorithm, with a grid spacing below
1 Å (Essmann et al., 1995). Van der Waals interactions were truncated at 12 Å and
smoothed at 10 Å. Hydrogen atoms were restrained by the SETTLE algorithm (Miyamoto
et al., 1992). A time step of 2 fs was adopted to integrate the equations of motion.
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2.2.7. Energy calculations
The energy of binding, ∆G, is defined as:
cGMPproteincomplex GGGG  ,
where Gcomplex, Gprotein, and GcGMP are the energies of the complex, the isolated
protein, and the nucleic acid, respectively. These energies were estimated with the MM-
PBSA approach, using the single-trajectory paradigm; i.e., the structures of complex,
protein, and nucleic acid were taken from the same MD trajectory. As a general rule, the
single-trajectory paradigm provides accurate energy estimates only if the ligands and the
protein do not change structure upon binding. However, in this study, we are interested
only in energetic differences between the wild-type and the triple mutant, and not in the
absolute value of the binding energies. Therefore, a less stringent condition applies to
MM-PBSA calculations with the single-trajectory paradigm. Even if the structure of the
protein or of the ligand changes upon binding, the estimated difference in binding energy
between the wild type and the mutant is still accurate, provided that these structural
changes have similar energetic effects in the two systems. The free energy (G) of each
species was calculated as:
PBCOULSAVDW GEGEG  ,
where EVDW is the van der Waals energy, ECOUL is the coulombic energy, and GPB
and GSA are polar and apolar contributions to the solvation energy. The apolar contribution
to the binding energy is given by the sum of EVDW and GSA, whereas the sum of ECOUL and
GPB defines the polar component of the binding energy. Solvation energies were
calculated with the APBS software (Baker et al., 2001). The probe radius for the definition
of the molecular surfaces was 1.4 Å. The relative dielectric constants were 80 and 2,
respectively, for solvent and solutes. The apolar solvation energy was assumed
proportional to the solvent-accessible surface area, with proportionality constant equal to
0.0072 kcal mol-1Å-2. Binding energies were calculated as average values over the 100 ns
MD trajectories. The time series of the various energy terms was tested for the presence
of correlation with the Ljung–Box lack of correlation statistical test with a confidence level
of 95%, as described in Furini et al. (2013). A sampling period for the MD trajectories
equal to 1 ns guaranteed lack of correlation among samples in the time series of all the
energy terms. This lack of correlation is necessary for defining a safe (over) estimation of
the standard error affecting the calculated binding energies.
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2.3. Results
2.3.1. Single mutants
Using the assays described in section 2.2.2, the KD values for cAMP and cGMP
were determined for the set of single-point mutants listed in Table 2.1. As a control, we
also determined the KD values for the wild-type protein, obtaining 148 ± 22 nM and 1731 ±
264 for cAMP and cGMP, respectively. The CNB domain is 12-fold selective for cAMP
(Table 2.1).
In the β4-β5 hairpin, we mutated three positions: V282, T284 and V288. Increasing
the length of the V282 side chain, by mutating to a leucine decreased affinity for both
ligands with no change in their selectivity. In T284, the mutation to serine resulted in a
selectivity decrease relative to wild-type protein, 6-fold preference for cAMP (Table 2.1).
The structural analysis of the wild-type domain bound to cGMP or cAMP (see above)
suggested that V288 is the residue responsible for determining ligand selectivity (Altieri et
al., 2008). Four mutations were generated at this position: alanine, leucine, isoleucine and
serine. The first three mutants displayed decreased ligand selectivity, to about 6-fold.
Interestingly, the mutation V288S decreased cAMP affinity by 8-fold with insignificant
effect on cGMP, so that the domain is almost non-selective (Table 2.1).
In the αP helix, M299 was also mutated to cysteine and glutamine. In the first case,
selectivity was slightly decreased and in the second, it increased slightly (Table 2.1).
The C-terminus contains a residue, A352, in a position shown to affect ligand
selectivity in CNG channels (Varnum et al., 1995). In MlotiK1, it is not defined in the
crystal structures (Clayton et al., 2004; Altieri et al., 2008) and is disordered in the NMR
structures (Schunke et al., 2009; Schunke et al., 2011). Mutating this alanine to aspartate
increased the affinity for cGMP 3-fold, with an insignificant effect on cAMP (Nimigean and
Pagel, 2007). We generated two mutants at this position: A352S, which decreased
selectivity to 4-fold and A352D, which decreased selectivity to 3-fold. In both cases,
affinity for cGMP increased, with no effect (A352S) or a slight decrease (A352D) in cAMP
binding affinity (Table 2.1).
In αC helix, R348 was mutated to five residues with different properties, but all had
identical effects. They all severely decreased affinity and lowered selectivity to
approximately 1-2-fold (Table 2.1). This shows that, at this position, the specific properties
of arginine are essential for binding and discrimination between cAMP and cGMP.
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Table 2.1: cAMP and cGMP dissociation constants (KD) for the wild-type and single
mutant CNB domain mutants.
Structural motif Mutant cAMP KD (nM) cGMP KD (nM) KDs ratio N
WT 148 ± 22 1731 ± 264 11.7 6
β4-β5 hairpin
V282L 1008 ± 53 8951 ± 743 8.9 3
T284N 342 ± 41 6556 ± 633 19.2 3
T284Q 731 ± 90 6952 ± 1312 9.5 3
T284S 464 ± 58 2984 ± 379 6.4 6
V288A 393 ± 50 2544 ± 355 6.5 3
V288L 201 ± 19 996 ± 163 5.2 3
V288I 138 ± 39 797 ± 118 5.8 6
V288S 1205 ± 160 2105 ± 128 1.7 4
αP helix
M299C 501 ± 99 2942 ± 357 5.9 3
M299Q 734 ± 134 11649 ± 2621 15.9 3
C-terminus
A352S 174 ± 23 727 ± 160 4.2 3
A352D 256 ± 29 850 ± 121 3.3 6
αC helix
R348A 24822 ± 3182 * 38781 ± 2449 * 1.6 3
R348N 19142 ± 507 * 32106 ± 3844 * 1.7 3
R348Q 25097 ± 2216 * 46062 ± 5609 * 1.8 3
R348K 16446 ± 842 * 23547 ± 982 * 1.4 3
R348Y 24174 ± 2214 * 33172 ± 4771 * 1.4 3
KDs were determined as described for high affinity mutants, except those marked
with a *, which were determined by the approach used for low affinity mutants. KD ratio is
calculated from cGMP KD/cAMP KD; n, number of repetitions.
2.3.2. Double mutants
Overall, our mutant screening analysis (Table 2.1) shows that, although some of
the single mutants tested greatly reduce the CNB domain’s selectivity for cAMP over
cGMP, none of these mutations could invert selectivity. We decided therefore to combine
mutations and to analyse their effect on the ligand binding properties. We first combined
V288S, which caused a reduction in cAMP affinity by more than 8-fold, with A352S, which
shows increased affinity for cGMP. This double mutant displays reasonably high affinity
for both nucleotides (KD cAMP: 690 ± 72 nM; KD cGMP: 749 ±75 nM) but it still does not
35
show a preference for cGMP (Table 2.2). We then combined V288S with A352D, a single
mutant that also showed increased affinity for cGMP. Strikingly, the double mutant
V288S/A352D displayed a preference for cGMP over cAMP (~0.6x for cAMP) with KD
cAMP: 547 ± 111 nM and KD cGMP: 351 ± 95 nM (Table 2.2).
Table 2.2: KD values relative to cAMP and cGMP for CNB domain double mutants.
Mutant cAMP KD (nM) cGMP KD (nM) KDs ratio N
V288S/A352S 691 ± 72 749 ± 75 1.1 3
V288S/A352D 547 ± 111 351 ± 95 0.64 3
KDs were determined as described for high-affinity mutants. KD ratio is calculated
from cGMP KD/cAMP KD; n, number of repetitions.
2.3.3. A triple mutant with inverted ligand selectivity
2.3.3.1. Binding properties
To increase cGMP selectivity further, we combined the V288S/A352D double
mutant with a mutation in another part of the ligand binding pocket. Although T284S
decreases cGMP affinity slightly, it decreases cAMP affinity even more. As expected, the
triple mutant T284S/V288S/A352D increases the preference for cGMP even further by
decreasing cAMP affinity (KD cAMP: 2190 ± 347 nM), while not affecting cGMP affinity (KD
cGMP: 336 ±126 nM) (Table 2.3). This results in a 6.5x preference for cGMP (0.15x for
cAMP, for comparison with previous values). Binding affinities for inosine 3’, 5’-cyclic
monophosphate (cIMP) and cytidine 3’, 5’-cyclic monophosphate (cCMP) were also
determined for wild-type and T284S/V288S/A352D (Table 2.3). For each ligand, the
variation in the KDs was within 2-fold, showing that the combination of the three mutations
affects specifically the binding of cAMP and cGMP.
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Table 2.3: Comparison of the KD values of cAMP, cGMP, cIMP and cCMP for the
wild-type and triple mutant CNB domain.
Mutant cAMP KD
(nM) (n=6)
cGMP KD
(nM) (n=6)
KDs ratio cIMP KD
(µM) (n=3)
cCMP KD
(µM) (n=3)
WT
T284S/V288S/A352D
148 ± 22 1731 ± 264 11.7 11.4 ± 1.8 78.6 ± 9.4
2190 ± 347 336 ± 126 0.15 20.0 ± 1.3 * 34.3 ± 4.9 *
KDs were determined as described for high affinity mutants, except those marked
with a *, which were determined by the approach used for low affinity mutants. KD ratio is
calculated from cGMP KD/cAMP KD; n, number of repetitions.
2.3.3.2. Activity of MlotiK1 T284S/V288S/A353D in the full-length channel
Full-length MlotiK1 is studied through a radioactive uptake assay (Nimigean,
2006). In this assay, we used 86Rb+, which also permeates through potassium channels.
The experimental setup is the following. Freshly purified potassium channel is
reconstituted in liposomes in the presence of a high potassium ion concentration. Before
the experiments, a potassium gradient is formed by passing the liposomes through a
desalting resin equilibrated in a buffer solution where the potassium concentration is
7500-fold lower and replaced with sorbitol. The concentration gradient will drive potassium
efflux out of the liposomes through the potassium channel. Potassium efflux creates an
electrical gradient across the membrane, due to the excess of positive charges outside
the liposomes. 86Rb+ is then added and the electrical gradient will drive its uptake into the
liposomes through the reconstituted potassium channel. Uptake is stopped by loading
aliquots of liposomes to a cation exchange column that removes external 86Rb+.
Radioactivity inside the liposomes is then quantified in a scintillation counter and reflects
the activity of the channel. However, reconstitution efficiency or liposome density may
vary between experiments. Therefore, it is necessary to normalize the data for the total
liposome volume accessible to the channels, by adding the potassium ionophore
valinomycin, which renders all liposomes permeable to 86Rb+ (Nimigean, 2006).
Using the 86Rb+ uptake assay described above, activation of the triple mutant by
the two ligands was compared. K1/2 of activation of 0.58 ± 0.13 and 7.4 ± 3.3 µM were
obtained for cGMP and cAMP, respectively (Fig. 2.5). These values contrast with the
corresponding K1/2 values of 0.92 ± 0.11 µM and 0.11 ± 0.02 µM for cGMP and cAMP in
the wild-type (Altieri et al., 2008). This shows that the alterations in cAMP and cGMP
affinities for the CNB domain are also reflected in channel function.
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Figure 2.5: Functional analysis of MlotiK1 T284S/V288S/A352D using a 86Rb+
uptake assay. Normalized uptake by channel reconstituted in liposomes as a function of
ligand concentration (cGMP: circles, cAMP: squares) was fitted with a Hill equation
(cGMP, K1/2 = 0.6 ± 0.1 μM, Hill coefficient (n) = 1.3; cAMP: K1/2 = 7.4 ± 3.3 μM, n = 0.84).
2.3.3.3. Crystal structure of MlotiK1 CNB domain T284S/V288S/A352D
To understand the molecular details behind the inversion of ligand selectivity, the
X-ray crystal structure of the mutant CNB domain in complex with cGMP was determined
by Dr. Fátima Fonseca, from our group. The assymetric unit contains two protein
molecules that are identical except in the N-terminal linker, which occupies different
positions. Superposing this structure with the wild-type structure in complex with cGMP
reveals several differences. First, the αC helix extends to residues 354 or 355 (depending
on the molecule considered); while in the previous structures the helix is disordered after
residue 349. Second, the β4-β5 hairpin adopts a diferent conformation, collapsing towards
the binding pocket (Fig. 2.6).
Figure 2.6: Superposition of triple mutant (green) and wild-type (red) CNB domain
structures in complex with cGMP. Ligands are represented in stick and some structural
elements of the binding pocket are indicated.
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2.3.3.4. The binding pocket
The structure shows that D352 forms hydrogen bonds with the N1 and N2 groups
of cGMP, explaining the gain in affinity for cGMP (Fig. 2.7 A). This is consistent with a
crystal structure of the a mutant CNB domain from the HCN2 channel, which also shows
an aspartate in an identical position forming identical hydrogen bonds with the nucleotide
(Flynn et al., 2007). Interestingly, the two other substitutions, S288 and S284, have no
direct or only long distance contacts with the ligand. Instead, they participate with water
molecules in a hydrogen bond network that “bridges” the ligand to the S284, N286 and
S288 residues of the β4-β5 hairpin. This network is formed by four water molecules (A to
D) (Fig. 2.7 A), three of which were already present in the wild-type structure (Fig. 2.7 B).
Comparison of the binding pockets of MlotiK1 T284S/V288S/A352D and MlotiK1
wild-type clearly shows that in the wild type the water-mediated hydrogen bond network is
much less extensive. It is formed only between the O6 and N7 atoms of the ligand and
water molecules A, B and C (Fig. 2.7 B). The cGMP-selective binding pocket is therefore
more hydrophilic than the cAMP-selective binding pocket.
cGMP-selective cAMP-selective
Figure 2.7: Comparison of the binding pockets of MlotiK1 (A) T284S/V288S/A352D
mutant and (B) Wild-type. cGMP and important residues in the binding pocket are
represented in stick. Water molecules are represented by red spheres. The network of
water-mediated hydrogen bonds is represented as black dashed lines.
2.3.4. Molecular dynamics simulations
To further explore the triple mutant crystal structure, our collaborator Dr. Simone
Furini, from Siena University, Italy, performed molecular dynamics (MD) simulations. Both
A B
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the wild-type and triple mutant structures in complex with cGMP were used in this
analysis. Results showed an interesting difference between both. While the wild-type
structure remained essentially unaltered during the simulation time, in the triple mutant
structure, the β4-β5 hairpin was shown to be mobile, alternating between three main
conformations (Fig. 2.8). Such conformations are a closed one (Fig. 2.8 A), in which the
β4-β5 hairpin moves towards the ligand base and residues S288, N286 and S284
establish direct interactions with the ligand, without obvious participation of water
molecules. The second conformation, semiclosed, is quite similar to the crystal structure
(Fig. 2.8 B). In the third conformation, open, the β4-β5 hairpin is clearly shifted away from
the ligand base and the water content is higher, resulting in a larger water-mediated
hydrogen bond network (Fig. 2.8 C). Importantly, the structural variability observed during
the simulation is restricted to the β4-β5 hairpin, as the positions of the ligand and the αC
helix are essentially unaltered (Fig. 2.8 D). These results suggest that due to crystal
packing restrictions, the second conformation was selected among the three sampled by
the domain during crystal formation. The MD simulations provide therefore a more
complete picture of the dynamic structure of the triple mutant CNB domain in solution.
Figure 2.8: MD simulation conformations. View of the superposed ligand binding
pockets from the triple mutant crystal structure (yellow stick) and from MD simulation
snapshot models (cyan) in the (A) closed, (B) semiclosed and (C) open conformations.
Structures are shown as Cα traces, with ligands in yellow (crystal structure) or cyan (MD
simulation models). Only waters that mediate protein-ligand interactions are shown (as
blue spheres). Dashed lines connect some of the atoms within hydrogen bond distance.
D) Superposition of crystal structure and MD simulation snapshot structures in the
difference conformations. View of the ligand binding pocket with cGMP and R348 shown
as stick.
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2.4. Discussion
Prior to this work, our understanding of the determinants of ligand selectivity in
CNB domains was based on studies where a single point mutant inverted selectivity. It
was clear also that these single point mutations were not sufficient to explain the
selectivity in the majority of CNB domains. In this work, a large set of MlotiK1 CNB domain
point mutants was tested for binding to cAMP and cGMP and their binding affinities were
compared. As a control to use for comparison with the point mutants tested, binding
affinities were also determined in wild-type MlotiK1 CNB domain. The domain is 12-fold
selective for cAMP. None of the single mutants tested could invert ligand selectivity. The
single mutants T284S, V288S and A352D were selective for cAMP; however they were
less selective than the wild-type, with selectivity ratios of 6, 2 and 3, respectively.
Inversion of ligand selectivity in MlotiK1 CNB domain was achieved through the combined
effect of the three mutations T284S, V288S and A352D.
The crystal structure of T284S/V288S/A352D CNB domain showed a more
hydrophilic binding pocket, with an extensive network of hydrogen bonds. D352 forms
direct hydrogen bonds with the ligand base. The other two mutated residues, S284 and
S288, also form hydrogen bonds with the ligand; however, those are mediated by four
water molecules. These water molecules form “bridges” between polar groups of the
cGMP base and polar groups of the residues S284, N286 and S288. MD simulations
performed with this structure revealed three conformations of the binding pocket. The
different conformations show the β4-β5 hairpin in different positions and a variable
number of water molecules in the binding pocket. Taken together, the conformations show
that the triple mutant, cGMP-selective binding pocket has increased flexibility in
comparison to the wild-type. Such flexibility is determined by the increased mobility of the
β4-β5 hairpin.
The crystal structure and the MD simulation results indicate two novel aspects that
contribute to the increased affinity for cGMP in the triple mutant. One is the polar
environment of the binding pocket, which results in polar interactions (direct or water-
mediated) with the ligand base. This finding is supported by computational simulations
that showed that dehydration should have a higher energetic penalty for cGMP than for
cAMP (Zhou and Siegelbaum, 2007). The other aspect is the increased structural
variability in the mutant, which suggests that higher entropy associated to the cGMP-
bound state in the mutant also contributes to its higher affinity for the ligand. This
unexpected factor contributes greatly for understanding the difficulty of predicting ligand
selectivity in CNB domains by sequence analysis. Factors such as stabilization of water
41
molecules and flexibility of the binding pocket are not directly extracted from simple
analysis of the amino acid sequence of the protein.
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3. Visualizing the conformational change by atomic
force microscopy (Paper II)
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The present section describes a collaborative study of the conformational change
induced by cAMP in full-length MlotiK1.
3.1. Introduction
The structures of the isolated CNB domain have revealed the different
conformations of the bound and unbound states of the domain (Clayton et al., 2004; Altieri
et al., 2008). How the CNB domain conformation changes in the full-length channel is still
unknown. Atomic force microscopy (AFM) is a highly versatile technique for visualization
of molecular surfaces and for studying conformational changes in membrane proteins.
The use of AFM to study the conformational change in full-length MlotiK1 reconstituted
into two-dimensional (2D) crystals is described in the present section. Before discussion
of the results obtained, a brief introduction about AFM and 2D crystals will be presented.
3.1.1. The atomic force microscope (AFM) precursor: the scanning tunneling
microscope (STM)
AFM evolved from STM (Binning, 1982). STM uses a sharp metallic tip to obtain
structural information about the surface of a sample attached to a support. The principle is
the following: an electric current can be generated between two electrodes of opposite
charges if they are connected by a conductive material. However, when the distance
between the electrodes is in the nanometer range, electrons can “jump” from one
electrode to the other without any conductive material on the way. This phenomenon is
called tunnel current. The intensity of such current decreases as the distance between the
electrodes increases. STM is based on this phenomenon and the electrodes are the tip
and the sample. The sample is scanned by the tip and the distance between them is kept
constant in the nanometer range, to generate constant tunnel current (Binning, 1982) As
the sample is usually not atomically flat, the tip position has to be permanently adjusted.
Such adjustments can be converted into a surface profile of the sample. The technique
was first tested on gold and CaIrSn4 surfaces, allowing visualizing individual atoms for the
first time (Binning, 1982). However, this technique has an important limitation: only
conducting materials can be studied. Few years after its invention, STM was improved to
overcome this limitation, and AFM was developed (Binnig et al., 1986). In both
techniques, if the sample is static, the tip position is accurately adjusted. In STM it is to
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keep tunnel current constant; in AFM it is to keep constant the force exerted by the tip
over the sample surface, as there is physical contact between both (Binnig et al., 1986).
3.1.2. Operating principle of an AFM microscope
“About three decades ago few would have believed that a single atom could be
visualized simply by touching it” (Frederix et al., 2009).
Prior to analysis, sample is adsorbed onto a chemically inert hydrophilic and flat
surface by changing pH and/or ionic strength. The most appropriate materials are mica,
molybdenium dissulfide, graphite, gold or platinum. They should be freshly cleaved before
use, to ensure that they are completely clean (Frederix et al., 2009).
Essential components of any AFM microscope are a sharp tip mounted on the
edge of a flexible cantilever, a laser and a laser detector that records laser deflection (Fig.
3.1). The tip contours the sample surface, applying a constant force over it in the
piconewton (pN) range. The sample topography determines the amplitude of the
cantilever oscillations. A laser beam is deflected by hitting a reflective surface on the
cantilever backside. The laser deflection profile is therefore correlated to the sample
topography. The microscope is also equipped with a piezoelectric scanner. Piezoelectric
materials contract and expand very slightly depending on the voltage applied. The
piezoelectric scanner, which can be attached to the sample support or to the cantilever,
allows the tip position to be controlled very accurately in all three dimensions (Whited and
Park, 2014).
Figure 3.1: Schematic representation of the essential components of an AFM
microscope (adapted from (Whited and Park, 2014).
Cantilever
Laser
detector
Laser source
Piezoelectric scanner
Sample
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The most important characteristics of a cantilever are its chemical composition and
spring constant, which is a measure of its stiffness. The best cantilevers should be short
and have low spring constants (Safenkova et al., 2012).
The instrument must be isolated from sound and vibrations (Fotiadis, 2012). There
are two modes of imaging: contact mode and tapping mode. In contact mode, the tip is
dragged over the sample surface and cantilever deflection is monitored. In tapping mode,
the cantilever is oscillated so the tip touches the sample intermittently. In both modes, the
amplitude of the cantilever oscillations is related to the sample height. Tapping mode is
more adequate to avoid damage in fragile or loosely attached samples (Whited and Park,
2014).
An ideal sample for high-resolution AFM is a fairly flat surface containing shallow
cavities. Deep and/or narrow clefts decrease the resolution limit, as they are difficult to
penetrate and contour by the tip. Resolution is primarily determined by the tip dimensions.
Lateral resolution is determined by the tip apex and vertical resolution by thermal
fluctuations of the cantilever (Frederix et al., 2009). After being in contact with the sample,
the tip gets contaminated with it, so it has to be replaced frequently.
Under AFM, samples are analyzed in their native aqueous environment. Standard
deviations show not only the reproducibility of the height measurements but also the
flexible regions of the molecules in the sample (Stahlberg et al., 2001).
3.1.3. The versatility of AFM
AFM is considered as the instrument of choice for studying native membranes
structure, as well as conformational changes and dynamics of membrane proteins (Muller,
2008; Fotiadis, 2012). The AFM signal-to-noise ratio is superior to that of any optical
microscopic technique (Muller, 2008) and this instrument is the only that allows imaging
biological structures at nanometer resolution in a hydrated environment (Frederix et al.,
2009).
Conventional AFM typically requires more than one minute for complete
acquisition of an image (Picco, 2007) (Fotiadis, 2012). For visualization of rapid biological
processes, high-speed AFM was developed. One of the solutions found was the
simultaneous use of multiple cantilevers to generate composite images (Picco, 2007). The
most common one is based on high-speed scanners and small cantilevers of high
resonant frequency and low spring constant in tapping mode (Viani et al., 1999). Such
approach allows very high scanning speeds and acquisition of a new image every 80
milisseconds (Ando et al., 2001).
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The capabilities of AFM extend far beyond just making images. AFM is also used
for studying intermolecular interactions and single-molecule force spectroscopy. The tip
can be used to break chemical bonds, mechanically unfold proteins or dissociate
complexes. The forces measured provide insights concerning the nature of the molecular
interactions disrupted (Muller, 2008). In mechanical unfolding, the tip is pressed over an
immobilized protein to form a chemical bond. Then, the tip is retracted and the protein is
stretched, beginning to unfold. The graph of force produced by the cantilever as function
of the retraction distance is known as the force spectrum. In these spectra, each peak
represents the force required for unfolding a particular region of the protein, providing
insights about the relative stability and conformational variability of each region. If a ligand
has a stabilizing effect on the protein, force spectra obtained with and without the ligand
can provide insights about the protein regions stabilized by a ligand (Whited and Park,
2014).
Despite other approaches, which characterize the binding properties in average,
AFM is able, not only to visualize individual molecules, but also to measure individual
intermolecular interactions (Whited and Park, 2014). This is particularly useful when the
binding equilibrium under study is complex, with multiple binding or formation of
complexes with variable composition. Some of the successful applications of AFM for
studying molecular interactions were in the context of antigen-antibody, enzyme-inhibitor,
nucleic acid-nucleic acid, or nucleic acid-protein interactions (Safenkova et al., 2012).
Recent developments are showing that the AFM microscope can still be improved,
as well as sample preparation methods. Such improvements will increase even further its
potential.
3.1.4. Some achievements brought by AFM: from photosynthesis to
medicine
Shortly after its invention, the AFM microscope was shown to visualize molecules
in solution (Drake et al., 1989). The first biological process visualized by AFM was
thrombin-catalysed polymerization of fibrinogen into fibrin, which is involved in blood
clotting. From 9 to 33 minutes after addition of thrombin, the gradual assembly of a fibre,
followed by its increase in thickness could be clearly seen (Drake et al., 1989). Hepatic
gap junctions, which are intercellular pores in the plasma membrane involved in cell-to-
cell communication, were the first native structure to be disassembled and measured by
AFM (Hoh et al., 1991). The opening and closing of gap junctions in both sides was
shown by AFM to be stimulated by changes in pH (Muller et al., 2002; Yu et al., 2007).
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The GPCR rhodopsin, involved in vision, is densely packed in vivo. AFM allowed
visualization of the packed dimeric arrangement of these light receptors in native mouse
rod membranes, providing clues about the mechanism of light transduction in vertebrates
(Fotiadis et al., 2003).
Surfaces of membranes, obtained directly from cells or prepared in the lab, can be
studied by AFM, as any nanometer scale structure that can be adsorbed onto an
appropriate surface. Large molecules or supramolecular structures can be studied as well.
AFM has revealed much about organization, complexes and biological processes of
native membranes (Frederix et al., 2009). A remarkable example is the contribution to
understand the structure, functional assembly, interactions and light adaptation of the
photosynthetic machinery in purple bacteria (Liu and Scheuring, 2013)).
AFM can also monitor physical properties of individual living cells in real time and
follow their dynamics after stimuli. AFM has medical applications and renal physiology is
an exemplary case. The effect of antihypertensive compounds in kidney cells can be
studied by measuring forces between a cell and the tip. It is possible to follow changes in
mechanical properties, surface adhesion and stiffness of the cells before and after
treatment (Jeong and Lee, 2012).
3.1.5. Two-dimensional crystals: a platform for AFM (and electron
crystallography)
A membrane protein two-dimensional (2D) crystal is a planar assembly of a
densely packed membrane protein arranged in a two dimensional lattice. The protein
molecules are immersed in a phospholipid bilayer. These assemblies should be large,
well-ordered and single-layered. For preparation of 2D crystals, freshly purified membrane
protein is mixed with phospholipids (dissolved in detergent) at high protein to lipid ratios.
Such high ratios prevent closure of phospholipid assemblies into vesicles, keeping them
as planar bilayers and favouring formation of protein-protein contacts in the lattice. The
crystals are formed by removal of the detergent, which can be done by different methods:
dialysis, adsorption onto polystyrene particles (such as “BioBeads”) or dilution of the
mixture (to dilute detergent below the critical micelle concentration) (Levy et al., 2001;
Stahlberg et al., 2001).
2D membrane protein crystals can be studied not only by AFM, but also by
electron crystallography. Importantly, the membrane protein is in its native lipid state. AFM
allows imaging of the protein surface and its dynamics, providing insights concerning
conformational changes and mechanism. Electron crystallography provides 3D or 2D
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electron density maps. If 2D crystals of the same protein are analyzed by the two
techniques, atomic structure and surface dynamics can be explored (Stahlberg et al.,
2001).
3.2. Materials and methods
3.2.1. Protein expression and purification
Protein expression and purification were based on the procedure described
previously (Clayton, 2009). Full-length wild type MlotiK1 was expressed in E. coli C41
(DE3) cells after induction (at OD600, ~1.0) for 5 h with 0.3 μg/mL anhydrotetracycline
(Fluka). Cells were lysed in PBS buffer, and membranes containing MlotiK1 were
harvested by ultracentrifugation (257,000 g, 90 min). MlotiK1 was extracted from
membranes with PBS buffer containing 25 mM n-decyl-β-D-maltopyranoside (DM), 5 mM
β-mercaptoethanol, 200 μM cAMP. The histidine-tagged MlotiK1 was bound to Ni-NTA
agarose beads (Qiagen) and eluted with 500 mM imidazole. The histidine tag was cleaved
off with thrombin (HIT) and MlotiK1 was twice purified in a Superdex 200 (Amersham
Pharmacia Biotech) size-exclusion chromatography column equilibrated in 20 mM Tris-
HCl (pH 7.5), 150 mM KCl, 200 μM cAMP, 3 mM DTT, and 5 mM lauryldimethylamine-N-
oxide (LDAO). The same procedure was used for the MlotiK1 R348A mutant, where the
cAMP concentration was kept at 400 μM throughout purification (if not stated otherwise).
3.2.2. Reconstituting densely packed MlotiK1 membranes
MlotiK1 was reconstituted into lipid membranes forming densely packed
assemblies using E. coli polar lipid extract (Avanti) as described previously (Clayton et al.,
2009). Lipids were dissolved in 20 mM Tris-HCl (pH 7.5), 150 mM KCl, 200 μM cAMP, 3
mM DTT, 5 mM LDAO, and 60 mM n-octyl-β-D-glucopyranoside. Samples were prepared
by mixing protein and lipids at the lipid/protein ratios (mg/mg) of 1.5, 1.6, 1.7, or 1.8 (final
volume was 109–111 μL). Mixtures were incubated at 30 °C for 1 h with agitation.
Membranes were formed by dialyzing the samples against 2 L of a solution composed by
20 mM Tris-HCl (pH 7.5), 50 mM KCl, 200 μM cAMP for the wild type channel and 600 μM
cAMP for the mutant, 2 mM DTT, and 0.02 % sodium azide using Slide-A-Lyzer MINI
Dialysis units (Thermo Scientific) with a 10 KDa cutoff. Dialysis was continued for 2–3 d at
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31 °C. To prepare MlotiK1 channels without cyclic nucleotide, the membranes were
formed in the presence of cAMP as described above, but then the dialysis buffer was
changed for a dialysis solution without cAMP, and the dialysis was extended for 2 d at 31
°C. After this time, the temperature was changed to 20 °C, and the dialysis was continued
for additional 7 d during which the cAMP-free dialysis solution was changed once. The
expected nucleotide concentration after these dialysis steps was <300 pM for mutant and
<100 pM for wt MlotiK1. These concentrations are well below the cAMP affinities of the
channel (KD (wild type), ~80 nM; KD (mutant), ~18 μM). Fresh DTT was added every 2 d.
Reconstituted membranes were stored at 4 °C until AFM analysis.
3.2.3. Radioactive flux assay
The 86Rb+ uptake assay was performed as described previously (Clayton et al.,
2004; Nimigean, 2006). Briefly, MlotiK1 was reconstituted in proteoliposomes in the
presence of high concentration of K+. K+ was removed from the external solution, 86Rb+
was added, and after incubating for 90 min, the radioactivity associated with the
proteoliposomes was measured. Normalized radioactivity levels of liposomes where
MlotiK1 was reconstituted was plotted as a function of ligand concentration and fitted with
the following Hill equation:
n
n
xk
xy  2/1
,
where y is the normalized uptake, x is the ligand concentration and n is the Hill
coefficient. The K1/2 of activation was determined. The data presented here display
decreased baseline noise by comparison with our previous study (Clayton et al., 2004).
We attribute this to decreased contamination by other proteins, achieved by incremental
improvements of multiple purification steps.
3.2.4. Atomic force microscopy
The AFM (Nanocope IIe; Veeco) was equipped with a fluid cell and oxide
sharpened Si3N4 cantilevers (OMCL TR400PSA; Olympus) having nominal spring
constants of ~0.09 N/m. Reconstituted MlotiK1 membranes were adsorbed onto freshly
cleaved mica (Muller et al., 1997) in 200 mM KCl, 20 mM Tris-HCl (pH 7.5), and at cAMP
concentrations indicated. After an adsorption time of ~30 min, the sample was gently
rinsed with the imaging buffer to remove nonadsorbed membranes. Imaging buffer
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solutions were either 50 mM KCl; 200, 600, or 900 μM cAMP; and 20 mM Tris-HCl (pH
7.5); or 50 mM KCl and 20 mM Tris-HCl (pH 7.5). All buffer solutions were freshly made
using nano-pure water (18.2 MΩ/cm) and pro analysi (>98.5%) purity-grade reagents from
Sigma and Merck. Upon buffer exchange, the AFM setup was thermally equilibrated for
~30 min. When changing cAMP-containing buffer for cAMP-free buffer, the sample was
incubated for >3 h before imaging. High-resolution contact-mode AFM topographs were
recorded at room temperature and at imaging forces of ~50 pN that do not to perturb the
native membrane protein structure (Muller and Engel, 2007; Muller, et al., 1997). Imaging
forces were manually adjusted to compensate for thermal drift (Muller and Engel, 2007).
Proportional and integral gains were adjusted manually to minimize the error (deflection)
signal and to maximize the height signal. When approaching a lateral resolution of ~2 nm,
the scanning speed of the AFM stylus was between 500 and 1500 nm/s. To prove the
reproducibility of the experimental findings, we repeated every experimental condition for
wild type and mutant MlotiK1 in at least 12 independent experiments. In every experiment,
we recorded between 20 and 60 AFM topographs of MlotiK1 membranes and channels.
For every experimental condition, the statistical height analysis of MlotiK1 membranes
was determined from membranes imaged in at least 12 independent experiments. All
experiments conducted were consistent and showed that the height changes observed
upon cAMP-binding and cAMP-unbinding of mutant MlotiK1 channels were fully
reproducible.
3.2.5. Image processing and averaging
AFM topographs (512 × 512 pixels) were selected by the structural details of the
reproducibly imaged MlotiK1 surface and when showing identical structural features in the
simultaneously monitored trace and retrace scanning directions. Correlation averaging
was performed using the SEMPER image processing system (Saxton et al., 1979; Saxton
and Baumeister, 1982). Single particles were translationally and rotationally aligned to a
reference MlotiK1 and averaged. This correlation average was used as a reference for
refinement cycles. Correlation-averaged unit cells of the MlotiK1 tetramer were 4-fold
symmetrized. To assess the standard deviation (SD), σk,l, individual unit cells were aligned
angularly, as well as translationally, before single-particle averaging (Frank et al., 1988).
The SD was then calculated from the averaged topograph μk,l for each pixel (k, l) for xi
particles:
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SD maps are displayed as image in a one-to-one pixel correspondence with the
correlation-averaged topograph.
3.3. Results
3.3.1. Visualizing the bound state
The 2D crystal samples, whose preparation was described above, were studied by
our collaborators Dr. Stefania A. Mari and Dr. Daniel J. Müller at the Department of
Biosystems Science and Engineering of the Swiss Federal Institute, in Basel, Switzerland.
Samples prepared in the presence of cAMP were adsorbed onto mica plates and
analyzed by AFM at room temperature in a buffered solution. Low resolution images show
whole 2D crystals (Fig. 3.2 A). The largest ones had several tens of micrometers in length.
When samples were imaged at higher resolution, structural details became visible
(Figs. 3.2 B to 3.2 D). The crystals are formed by rows of four-fold symmetric molecules
that protrude 3.2 ± 0.5 nm above the lipid surface separated by rows of proteins with a
shallow protein surface, protruding only 1.8 ± 0.5 nm (Fig. 3.2 B). Since MlotiK1 packs into
2D crystals in an alternate up and down orientation (Chiu et al., 2007; Clayton et al.,
2009), the “tall” standing four-fold symmetric surfaces correspond to the cytoplasmic
surface of the channel and the low lying surface corresponds to the extracellular surface
of the channel (Fig. 3.2 B). The four-fold arrangement on the cytoplasmic surface are the
CNB domains in the bound state, with a vestibule at the centre. The total height of MlotiK1
membranes measured above the mica surface was 10.2 ± 0.8 nm. The CNB domains
protrude 3.2 ± 0.5 nm above the lipid surface and their total diameter is between 8 and 10
nm. These dimensions are consistent with previous structural data of MlotiK1 CNB
domain (Clayton et al., 2004; Chiu et al., 2007). The vestibule has an inner diameter of
approximately 1.5 ± 0.5 nm and a depth near 1.4 ± 0.3 nm.
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Figure 3.2: A densely packed lipid membrane containing wild-type MlotiK1 in the
presence of cAMP. (A) Overview at low resolution. The brown background represents the
surface of the mica plate where the sample was adsorbed. The sample is represented in
yellow due to its height above the surface. “LM” refers to “lipid membrane”, a phospholipid
bilayer without protein, whose height is lower in comparison to a membrane containing
MlotiK1 and is therefore represented in light-brown. Below the image there is a height
profile represented by a green line and respective standard deviation in black. The height
profile was taken along the white dashed line. (B) High-resolution topograph of a crystal
identical to the one shown in (A). In (B), each collored tetramer corresponds to a MlotiK1
channel imaged from the cytoplasmic side. Individual protrusions correspond to individual
CNB domains. Two channels with the extracellular side facing the viewer are highligted
with dashed circles. (C) and (D) average and standard deviation, respectively, of MlotiK1
channels with the cytoplasmic side facing the viewer.
3.3.2. R348A, a mutant with lower affinity for cAMP
After characterizing the bound state, we studied the unbound state. To do so,
cAMP was excluded from the sample buffer by extensive dialysis. In contrast with
previously electron crystallography studies (Clayton et al., 2009), extensive dialysis did
not result in structural changes that could be visualized by AFM. We attributed this to the
high affinity binding of cAMP (Cukkemane et al., 2007) and to the densely packed MlotiK1
molecules in the 2D crystals. We hypothesize that such fact increased the association rate
of the ligand to the binding pocket, complicating its removal.
We overcame this problem by employing a point mutant with decreased affinity for
cAMP. R348A was our choice, as its KD for cAMP is approximately 200-fold higher
(Cukkemane et al., 2007) and has a good purification yield. The choice of a lower affinity
A B C
D
54
mutant raised the question of whether the mutatant was functionally active. Using the
radioactive flux assay described in the previous section, Stephen Altieri (at Yale
University, New Haven, CT, USA) could show that the R348A mutant is still active in the
presence of cAMP. Its K1/2 of activation of 10.0 ± 4.4 µM is 100-fold higher in relation to
the wild-type and its maximum activity under saturating cAMP concentration is lower, in
comparison to the wild-type channel (Fig. 3.3).
After this study was completed, a recent report showed that the cAMP association
rate is identical both in the wild-type and in R348A; however, the dissociation rate is over
than 500-fold higher in the mutant (Peuker et al., 2013). This provides an explanation for
the difficulty in removing cAMP from wild-type MlotiK1 in comparison to R348A.
Figure 3.3: Functional analysis of MlotiK1 R348A using a 86Rb+ uptake assay.
Normalized uptake by channel reconstituted in liposomes as a function of cAMP
concentration was fitted (solid curve) with a Hill equation, yielding a K1/2 of activation of
10.0 ± 4.4 μM and a Hill coefficient (n) = 1.1 ± 0.6. The dashed curve illustrates the fitted
curve for an identical analysis of wild-type MlotiK1, which has a K1/2 of activation of 100
nM and n = 1.3. The inset shows normalized radioactivity values for wild-type and mutant
MlotiK1 at saturating cAMP concentrations (100 μM for wt; 1 mM for R348A) or in the
absence of cAMP (R348A, 0 mM). The wild-type data were taken from Clayton et al.
2004.
3.3.3. Visualizing the unbound state
The R348A mutant was assembled into 2D crystals in the presence of cAMP and
imaged in the presence of 900 µM of ligand (a saturating concentration). Within the
resolution attained, its topography was indistinguishable of that of the wild-type under the
same conditons, with a total height of 10.2 ± 0.8 nm (Figs. 3.4 A to 3.4 C). This is
55
consistent with the fact that this mutant is functionally active. When cAMP was removed
from the imaging solution and re-imaged after three hours, the membranes increased their
heights in approximately 1.7 nm, protruding 11.8 ± 0.8 nm. Mutant membranes prepared
in the presence of cAMP and extensively dialyzed against cAMP-depleted solution
showed an even higher height of 13.5 ± 0.7 nm. While interpreting the height
measurements, we took into consideration the fact that the total height measured varies
whether cAMP is added or removed in only one or in the two sides of the sample. The
ligand could not be added or removed to the CNB domains located on the side of the
membrane that was adsorbed onto the mica plate. The unbound state visualized in R348A
was quite different of the bound state: the CNB domains become totally unorganized, the
vestibule disappears and the height of the CNB domains increases from the original 3.2 ±
0.5 nm by approximately 1.7 nm (Figs. 3.4 D to 3.4 F). No individual CNB domains or any
sub-structure can be reproducibly identified. The height increase in the CNB domains in
the unbound state could result from the conformational change induced by cAMP release
from the binding pocket and also from a repositioning of the linker that connects the CNB
domains to the transmembrane region. The “disappearance” of the vestibule could simply
be a consequence of the increased structural variability or flexibility of the unbound state.
The standard deviation of the unbound state is also larger than that of the bound state,
consistent with its increased structural variability (Figs. 3.4 C and 3.4 F).
Bound state (+ cAMP) Unbound state (-cAMP)
Figure 3.4: AFM images of MlotiK1 R348A-packed membranes in the presence (A
to C) and in the absence (D to F) of cAMP. (A) and (D): membrane overviews; (B) and (E):
average; (C) and (F): standard deviation.
A DB
C
E
F
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3.3.4. The reversibility of the changes observed
Importantly, the observed structural changes in the CNB domains are reversible. A
sample of R348A prepared in the presence of cAMP was imaged. CNB domains were
organized in the four-fold arrangement (Fig. 3.5 A). When cAMP was excluded from the
medium, they became unorganized (Fig. 3.5 B). When a saturating cAMP concentration of
900 μM was re-added to the medium, the four-fold arrangement was recovered in 99 % of
the channels (Fig. 3.5 C). However, when the re-added concentration was 600 μM, which
is high but not saturating, the bound conformation was recovered only partially (data not
shown). After several repetitions of this experiment, it was concluded that the
conformational change observed is reversible and cAMP-dependent. It is summarized in
Fig. 3.5 D. In conclusion, cAMP binding has a clear effect in decreasing the structural
variability of MlotiK1 CNB domains.
Figure 3.5: AFM images of MlotiK1 R348A-packed membranes prepared in the
presence of cAMP (A) before, (B) after removal of cAMP and (C) after readdition of cAMP.
(D) Schematic representation of the reversible change in MlotiK1 CNB domains
arrangement induced by cAMP binding (+cAMP) and unbinding (-cAMP). Images are
single particle averages.
3.4. Discussion
Our work has contributed significantly to understand the cAMP-dependent
conformational change in MlotiK1. Using densely packed MlotiK1 membranes and AFM,
A B C
D
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we could show that gating of MlotiK1 affects the arrangement of the CNB domains in the
full-length channel. First, we imaged wild-type channel in the presence of cAMP. Under
such condition, the CNB domains were found to be positioned in a four-fold arrangement,
with a vestibule at the center. Removal of the ligand from solution did not result in any
detectable changes in the wild-type protein, indicating that the ligand was tightely bound
and extensive dialysis failed to remove it. The low affinity, functionally active R348A
mutant was used to overcome this difficulty. This mutant was first imaged in the presence
of cAMP. The CNB domins showed an identical arrangement to the wild-type channel.
Ligand was then removed from solution by dialysis and an unexpected difference was
found: the CNB domains have become totally unorganized and could not be visualized
separately. No structural details could be identified in the absence of cAMP. Additionally,
their total height of the CNB domains measured from the membrane surface increased.
This transition, from an organized bound state to an unorganized unbound state, was
found to be fully reversible and dependent on ligand concentration. Interestingly, the
increase in structural variability in the unbound state has also been seen in the crystal
structures of the isolated CNB domain (Clayton et al., 2004; Altieri et al., 2008). Using
AFM, we could, for the first time, visualize the rearrangement of the CNB domains in an
ion channel regulated by cyclic nucleotides. Such rearrangement provides insights
regarding the cyclic nucleotide gating mechanism in this family of ion channels.
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4. General discussion
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In the present project, the MlotiK1 potassium channel was used as a model to
explore the molecular features that determine ligand selectivity in CNB domains, as well
as the conformational changes that occur upon ligand binding in cyclic nucleotide-
regulated ion channels.
CNB domains are found not only in ion channels, but also in protein kinases,
guanine nucleotide exchange factors and transcription factors (Rehmann et al., 2007).
Some of these effector proteins are activated by cAMP, others by cGMP. For example,
the eukaryotic guanine nucleotide exchange factor Epac and the prokaryotic transcription
factor CAP are both activated by cAMP, CNG channels involved in vision are activated by
cGMP, whereas CNG channels involved in olfaction are unselective (Kaupp and Seifert,
2002). Function of these cyclic nucleotide effectors is therefore dependent on their ligand
selectivity. In the cell, this property confers the ability for similar proteins to be specifically
activated by different cyclic nucleotides and therefore, by different signalling pathways. It
is reasonable to assume that ligand selectivity is largely determined by molecular features
of the CNB domain. These features are only partially understood.
To explore this property, we inverted ligand selectivity in the 12-fold cAMP-
selective MlotiK1. To achieve this objective, we started by comparing crystal structures of
MlotiK1 CNB domain in complex with cAMP and cGMP. These structures suggested
residues that might affect ligand discrimination. A large set of single point mutations was
generated in order to test different properties on such residues. None of the single
mutants tested could invert ligand selectivity, but some had a mild effect in decreasing it.
The V288S mutant became only about 2-fold selective. In T284S and A352D, selectivity
was decreased to about 6 and 3-fold, respectively. These three mutations were combined
and a triple mutant was generated, which was about 7-fold selective for cGMP. Although
in an olfactory channel it was possible to invert ligand selectivity using a single mutant
(Altenhofen, 1991), in our studies, only after combining three point mutations the same
effect could be achieved.
The first studies of ligand selectivity in CNB domains were usually restricted to
mutagenesis followed by a functional assay (Altenhofen et al., 1991; Varnum et al., 1995).
In our study, this classic approach was complemented by structural and computational
analyses of the CNB domain triple mutant, using X-ray crystallography and molecular
dynamics (MD) simulations. The structural basis of the inversion in ligand selectivity was
revealed by the T284S/V288S/A352D CNB domain crystal structure. The structure
showed the molecular interactions between cGMP and the binding pocket. Whereas D352
establishes direct hydrogen bonds with the ligand, as predicted (Varnum et al., 1995), the
two other mutated residues are involved in a water-mediated hydrogen bond network with
cGMP. The combination of the three mutated residues changed the chemical character of
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the binding pocket. Whereas the wild-type binding pocket was predominately hydrophobic
(Clayton et al., 2004; Altieri et al., 2008), the triple mutant binding pocket showed an
increase in its hydrophilic environment. The fact that the S284 and S288 residues
establish interactions with the ligand that are not direct, but mediated by water molecules,
was an unexpected finding. The β4-β5 hairpin, where S284 and S288 are located, was
identified as a novel region in CNB domains involved in ligand selectivity.
Additionally and to overcome a common limitation of crystal structures, we
performed MD simulations. Protein molecules are dynamic in solution, frequently
displaying different conformations; however, during crystal growth, only one conformation
is usually selected by the crystal lattice. Therefore, the crystal structures tend to show only
one conformation in cases where multiple conformations are possible. To uncover such
putative conformations, both wild type (cAMP-selective) and triple mutant (cGMP-
selective) structures were studied by MD simulations. An additional difference was found.
In the wild-type structure (in complex with cGMP), only one conformation was obtained,
whereas in the triple mutant three different conformations were identified. Their basic
difference was restricted to the β4-β5 hairpin, which was found to be highly flexible in the
cGMP-selective structure. In our study, the crystal structure of the triple mutant CNB
domain showed one conformation and the MD simulations were able to uncover other
conformations. Together, these results have shown that the change in ligand selectivity
from cAMP-selective to cGMP-selective involves not only and increase in the hydrophilic
character of the binding pocket, but also an increase in flexibility of the β4-β5 hairpin.
Such flexibility increase could not be predicted from the protein sequence. This fact helps
to understand the difficulties in establishing general rules to define the determinants of
ligand selectivity in CNB domains.
Our conclusions are corroborated by independent studies. Structural and
functional studies in two HCN channels have shown that at least some of the residues that
are determinants of ligand selectivity in MlotiK1 have conserved roles in ligand selectivity
in CNB domains (Flynn et al., 2007; Zhou and Siegelbaum, 2007). The recent
determination of the crystal structure of a cGMP-selective CNB domain from protein
kinase G (Huang et al., 2014) is also of interest. The binding pocket is highly accessible to
the solvent and there is an arginine at the position of V288 in MlotiK1. This arginine forms
hydrogen bonds with cGMP, resembling the interactions with two water molecules found
in the MlotiK1 CNB domain triple mutant structure. These features show that this highly
cGMP-selective CNB domain also has a highly hydrophilic binding pocket. This fact
supports our finding that a more hydrated binding pocket favors cGMP binding relative to
cAMP. Of special interest is the fact that this structure does not have any residue at the
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position of A352 in MlotiK1. Therefore, an aspartate at this position, although favourable,
is not a universal requirement for cGMP-selectivity.
Besides ligand selectivity, another important aspect of cyclic nucleotide regulation
in cyclic nucleotide regulated ion channels is the conformational change induced by the
ligand. Crystal structures of the isolated CNB domain were determined in the absence and
presence of cAMP (Clayton et al., 2004), showing the structural differences between both
states in the isolated domain. How the conformational change affects the full-length
channel was still unclear. The conformational change of cytoplasmic domains has been
characterized in few potassium channels. Using spectroscopic approaches, it was shown
that the cytoplasmic domains of the inwardly rectifier potassium channel KirBac3.1 have
different positions in both states, being more separated and closer to the membrane in the
open state (Gupta et al., 2010). In addition, functional studies have shown that the
cytoplasmic RCK domain subunits of a BK calcium activated potassium channel also
display well defined conformations in both states (Krishnamoorthy et al., 2005).
To study the cAMP-induced conformational change in full-length MlotiK1, we took
advantage of the versatility of atomic force microscopy (AFM). AFM showed that in the
presence of cAMP, the CNB domains were arranged in a symmetric four-fold
arrangement, with a vestibule at the center. Using a low affinity, functionally active mutant,
R348A, we were able to visualize a change in the arrangement of the CNB domains in the
full-length channel that is ligand dependent. In the presence of cAMP, the mutant channel
showed a similar arrangement of the CNB domains, which, within the resolution attained
by AFM, is identical to the wild-type protein. In the absence of cAMP, large changes were
observed. The CNB domains became unorganized and the distance that separates from
the membrane leaflet increased. This transition between an organized bound state and an
unorganized unbound state was found to be dependent on cAMP concentration, since it
was reversible. In contrast with other potassium channels (Krishnamoorthy et al., 2005;
Gupta et al., 2010), in MlotiK1, the unbound state does not have a well-defined
conformation. We do not know if in other channels there are also unorganized
conformations that are important for gating.
The recent determination of 3D structures of full-length MlotiK1 in the absence and
presence of cAMP by electron crystallography (Kowal et al., 2014) provided information
concerning the conformational change in the transmembrane region, complementing our
study. The gating mechanism seems to involve a twist of the pore domain helices and a
tilt and shift of the voltage sensor-like domains helices. However, it is not totally clear if the
unbound state was really obtained. In both structures, the CNB domains are ordered and
the height increase upon ligand removal is lower than in our AFM study. The method used
to confirm the removal of cAMP from solution is not able to confirm the total removal of the
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ligand from the protein. Removal of cAMP from wild-type MlotiK1 is frequently a slow and
inefficient process. In our study, one week of dialysis with buffer changes failed to remove
it. We overcame this issue by using the R348A mutant. Another limitation of the study
by Kowal et al., (2014) concerns an advantage of AFM over electron crystallography. AFM
provides single-particle images (which can be averaged), revealing the behavior of
individual molecules.
The prokaryotic MlotiK1 is a model to understand cyclic nucleotide regulation in its
eukaryotic relatives. An important difference between MlotiK1 and CNG or HCN channels
is the length of the linker connecting the pore domain to the CNB domain. While in CNG
and HCN channels it contains approximately 80 amino acids, in MlotiK1 it contains only
about 20 residues (Clayton et al., 2008). This difference in length may partially affect the
gating mechanism and represents a limitation of MlotiK1 as a model to understand this
process in its eukaryotic homologues.
By exploring the molecular basis of ligand selectivity and conformational change,
we gained insights concerning two essential aspects of ligand regulation in cyclic
nucleotide activated ion channels. Since CNB domains are found also in other proteins
and are highly conserved, the molecular basis of discrimination between cAMP and cGMP
should be valid for other CNB domains, whether they belong to a protein kinase, a
transcription factor, a nucleotide exchange factor or an ion channel.
64
65
5. Concluding remarks
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In the present project, the bacterial cyclic nucleotide regulated potassium channel
MlotiK1 was studied in the context of its ligand selectivity and conformational change.
Using MlotiK1 as a model, we reached a better understanding of the molecular
determinants of ligand selectivity in CNB domains (Paper I). In addition to the regions of
CNB domains known to determine discrimination between cAMP and cGMP, an additional
region was identified: the β4-β5 hairpin. After screening a comprehensive set of point
mutations in the binding pocket of this cAMP-selective CNB domain, we generated a
cGMP-selective triple mutant domain. The crystal structure of the triple mutant CNB
domain and molecular dynamics simulations showed a hydrophilic and more flexible
binding pocket, especially in the β4-β5 hairpin. The polar character of the binding pocket
was found to be essential for ligand selectivity. A more apolar binding pocket favours
cAMP, whereas a strongly hydrophilic one favous cGMP.
Before the beginning of this project, our knowledge concerning the conformational
change was restricted to the bound and unbound structures of the isolated CNB domain.
AFM has shown that gating of the channel is correlated to large alterations in the
orientation of the CNB domains (Paper II). They are organized in a four-fold arrangement
in the bound state and unorganized in the unbound state. Importantly, the R348A mutant
used to visualize the unbound state was shown to be functional. The alterations visualized
by AFM were found to be reversible and dependent on cAMP concentration.
MlotiK1 has been an effective model channel for structural studies. This potassium
channel has helped in our understanding of the molecular determinants of ligand
selectivity in CNB domains. AFM provided insights concerning its conformational change.
Our studies have contributed to better understand the molecular details of cyclic
nucleotide regulation in a potassium channel.
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6. Apendix
This final section describes three preliminary experiments.
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6.1. Exploring the equilibrium between the bound inactive
and bound active states of the CNB domain
Ligand binding induces a conformational change in a CNB domain. Nevertheless,
the existence of two bound states with different conformations, bound active and bound
inactive, is generally accepted. In the bound inactive state, the ligand is bound, but the
protein conformation still corresponds to the unbound state; however, in the bound active
state, the domain has undergone a change in conformation. The effect of two R348 (in αC
helix) mutations in the equilibrium distribution between these two states was studied in the
MlotiK1 CNB domain. The approach used was the comparison of cysteine accessibility in
the CNB domain under different conditions. Accessibility was monitored using a cysteine-
reacting probe and reaction kinetics were quantified in the absence of ligand and in the
presence of saturating ligand concentrations. Differences in reaction kinetics are
dependent on differences in cysteine accessibility, which are related to the average
protein conformation at the experimental conditions.
6.1.1. 5,5'-dithiobis-(2-nitrobenzoic acid), DTNB
To measure the accessibity of different positions in the CNB domain we have
adapted a spectrophotometric assay that uses 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB),
also known as Ellman’s reagent (Ellman, 1959). DTNB reaction is represented in Fig. 6.1.
When DTNB reacts with a reduced thiol group, the compound is split in two. One half
remains attached to the thiol group, while the other is released into solution. The latter has
a higher absorbance at 412 nm than unreacted DTNB. Common applications of DTNB
include quantification of glutathione in blood samples (Sedlak and Lindsay, 1968) and
quantification of the number of cysteines in a protein (Riener et al., 2002). In proteins, the
kinetics of reaction depends on the accessibility of the cysteine residue.
Figure 6.1: Representation of the reaction between DTNB and a reduced thiol
group (R-SH).
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6.1.2. Estimation of the percentage of saturation
For estimating the percentage of protein containing ligand (% saturation) at the
ligand concentration used, a general protein-ligand binding equilibrium was considered. In
a protein (P) and ligand (L) binding reaction, in which a protein-ligand complex (PL) is
formed:
P + L PL
KD is given by:
PL
LP
K freefreeD 
Knowing that |L|free = |L|total - |PL| and that |P|free = |P|total - |PL|, |P|free and |L|free can
be replaced in the above equation:
  
PL
PLLPLP
K totaltotalD

Substituting the parameters KD (previously determined), |P|total (10 µM) and the
|L|total used, |PL| can be determined. A |PL| value between 9.90 and 9.99 µM will
correspond to a % saturation of 99.0-99.9 %.
6.1.3. Data fitting
The time constant of each reaction was quantified by fitting an equation to the
averaged curve, which was expressed in terms of absorbance (A) as function of time (t).
An exponential decay is expressed by:
kteAA  max
Where Amax is the maximum absorbance and k is the rate constant. Similarly, an
exponential growth that tends to Amax is given by:
 kteAA  1max
The time constant τ is the inverse of k. Additionally, t was substituted by (t-t0), since
the initial absorbance value recorded was usually not zero. Data were fit with the following
equation:



 


tot
eAA 1max
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6.1.4. Validating the assay: C263V (αB helix) and C263V C331V M299C (αC
helix)
MlotiK1 CNB domain has two cysteine residues, C263 and C331. Since C331 is
located in the αB helix (Fig. 6.2 A), then, the C263V mutant can be used to monitor the
cysteine accessibility at the αB helix. Importantly, C331 is more shielded in the bound
state than in the unbound (Figs. 6.2 A and 6.2 B). Additionally, we generated the C263V
C331V M299C mutant, which has a single cysteine, located close to the cyclic nucleotide
(Fig. 6.2 B). Closing down of the αC helix upon ligand binding should decrease
accessibility to M299C (Figs. 6.2 A and 6.2 B).
Cysteine accessibility of both mutants was probed with DTNB in the absence of
ligand and in the presence of saturating concentrations of cAMP, cGMP, cIMP and cCMP.
Time constants were determined (Table 6.1). For the two mutants described above, the
reaction was faster in the unbound state than in the presence of each of the four ligands
(Figs. 6.2 C and 6.2 D), as expected from structural data. This provides support for the
use of this assay. cAMP, cGMP and cIMP have identical effects in the accessibility of αB
and αC helices. Interestingly, the cCMP induced accessibility at αB and αC is not as
reduced as with other nucleotides.
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Figure 6.2: Accessibility alterations at C331 and M299. (A) and (B) Structures of
MlotiK1 CNB domain in the (A) unbound and (B) bound states. In both structures, C331
and M299 are prepresented in stick. In (B), cAMP is also represented in stick. (C) and (D)
DTNB reactions of (C) C263V and (D) C263V C331V M299C, for comparing
accessibilities of C331 and M299, respectively. Cysteine accessibility in both mutants was
monitored in the absence of ligand and in the presence of saturating concentrations of the
cyclic nucleotides indicated below the curves.
Table 6.1: Time constants in seconds (n=3) for MlotiK1 CNB domain mutants.
Ligand Monitoring αB
C263V
Monitoring αC
C263V C331V M299C
(no ligand) 42.0 ± 0.1 0.40 ± 0.02
cAMP 678.9 ± 0.7 37.7 ± 0.1
cGMP 629.0 ± 0.9 26.1 ± 0.1
cIMP 571.7 ± 0.6 38.5 ± 0.1
cCMP 398.8 ± 0.3 8.06 ± 0.05
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C D
B
M299 M299
C331
C331
cAMP
αC
helix
αC
helix
αB
helix
αB
helix
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6.1.5. The effect of R348 in the bound inactive and bound active distribution
The C263V mutation was combined with R348A and R348N. Accessibilities were
compared in the unbound state and in the presence of cAMP or cGMP (Fig. 6.3) and time
constants were determined (Table 6.2). In the unbound state, time constants are identical,
44.0 ± 0.5 seconds and 48.8 ± 0.2 seconds for C263V R348A and C263V R348N
respectively. In the presence of cAMP, however, results were different, with time constant
of 100.4 ± 0.2 seconds for R348A and 172.6 ± 0.5 seconds for R348N. With cGMP, time
constants were again lower for R348A than for R348N, 46.4 ± 0.2 seconds versus 92.6 ±
0.8 seconds, respectively. In identical conditions, accessibility in the presence of ligands is
higher in C263V R348A than in C263V R348N.
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Figure 6.3: (A) and (B) DTNB reactions of (A) C263V R348A and (B) C263V
R348N. In both mutants, accessibility of C263V was monitored in the absence of ligand
and in the presence of saturating concentrations of the cyclic nucleotides indicated below
the curves.
Table 6.2: Time constants in seconds (n=3) for MlotiK1 CNB domain mutants.
Ligand C263V R348A C263V R348N
(no ligand) 44.0 ± 0.5 48.8 ± 0.2
cAMP 100.4 ± 0.2 172.6 ± 0.5
cGMP 46.4 ± 0.2 92.6 ± 0.8
Considering that a binding equilibrium has three states: unbound, bound inactive
and bound active:
Unbound Bound Inactive Bound Active
A B
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The equilibrium between unbound and bound states (active and inactive) is
controlled by ligand concentration. However, the two bound states are different in terms of
conformational change. In the bound inactive state, the ligand is bound, but the protein
conformation still corresponds to the unbound state. In the bound active state, the domain
has undergone a change in conformation. Due to their different conformations, the two
bound states have different accessibilities. In the case of C263V R348A and C263V
R348N, different accessibilities may result from a different distribution between the
equilibrium positions of the bound inactive and the bound active states. Alternatively, they
may have different static conformations between both states. C263V R348A appears to
favour more the bound inactive state relative to the bound active than the C263V R348N
mutant. With this simple accessibility assay, we could get insights concerning the effect of
two R348 mutations in the equilibrium distribution between the bound inactive and bound
active states.
Table 6.3: Ligand concentrations, KD and % saturation used for each mutant.
C263V C263V C331V M299C
Conc. KD % sat. Conc. KD % sat.
cAMP 80 0.057 ± 0.011 99.9 80 0.197 ± 0.036 99.7
cGMP 310 0.347 ± 0.031 99.9 310 2.241 ± 0.200 99.3
cIMP 2100 1.60 ± 0.069 99.9 2100 17.8 ± 2.1 99.2
cCMP 1500 8.17 ± 0.74 99.5 15000 135.0 ± 14.3 99.1
Concentrations and KDs (determined from triplicate measurements) are expressed
in µM. KDs were determined by the method used for high-affinity mutants (described in
section 2).
Table 6.4: Ligand concentrations, KD and % saturation used for each mutant.
C263V R348A C263V R348N
Conc. KD % sat. Conc. KD % sat.
cAMP 1900 29.6 ± 1.6 98.5 1900 16.8 ± 1.1 99.1
cGMP 2200 8.37 ± 0.63 99.6 2200 8.29 ± 0.84 99.6
Concentrations and KDs (determined from triplicate measurements) are expressed
in µM. KDs were determined by the method used for low-affinity mutants (described in
section 2).
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6.2. A preliminary electron microscopy study of MlotiK1 in
NABB particles
Here, an initial structural study of MlotiK1 incorporated into nanoscale
apolipoprotein-bound bilayer (NABB) particles, using electron microscopy (EM) is
described. Nanodisc technology has been revolutionizing the membrane protein research
field. We incorporated MlotiK1 into NABB particles, a variant of nanodiscs, and explored
the potential of these particles for structure determination. Before the description of the
experiment, a short theoretical background concerning nanodiscs/NABB particles will be
presented.
6.2.1. Nanodisc technology
Nanodiscs (Bayburt, 2002) consist of a patch of a phospholipid bilayer surrounded
by a membrane scaffold protein (MSP). The MSP keeps the bilayer in a disc-like
arrangement, by protecting the phospholipid acyl groups from the solvent. The
phospholipid portion of each nanodisc particle can accommodate a membrane protein into
the bilayer, mimicking a biological membrane (Fig. 6.4) and can keep an integral
membrane protein soluble in a detergent-free solution, while still incorporated into a
phospholipid bilayer (Borch and Hamann, 2009).
Figure 6.4: Structural model of a nanodisc containing a membrane protein.
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5.2.1.1. Biological basis
Nanodiscs are based on nascent discoidal high-density lipoprotein (ndHDL)
particles, which are the direct precursors of high-density lipoprotein (HDL) particles. In
vertebrates, the main role of HDL particles is the reverse cholesterol transport, a process
consisting in cholesterol harvest throughout the organism and its delivery into the liver, for
further excretion. ndHDL particles are formed when two apolipoprotein A-1 (Apo A-1)
molecules enclose serum phospholipids, forming discoidal bilayer particles. These
particles then incorporate cholesterol through an ATP-dependent process, becoming
speroidal (Nelson, 2005). Their role in the prevention of artherosclerosis gives HDL
particles and apo A-1 great medical interest.
Human Apo A-1 is α-helical and has lipid-free and lipid-bound conformations.
While in the lipid-free conformation it forms two helical bundles (Fig. 6.5 A; Ajees et al.,
2006), in the lipid-bound conformation the protein adopts a horseshoe-like shape (Borhani
et al., 1997). Such shape results of the kinks inserted into the helices by its several proline
residues (Fig. 6.5 B). Changes in lipid concentration determine the turnover between the
lipid free and lipid-bound conformations (Narayanaswami and Ryan, 2000). Truncating the
N-terminal α-helix favours the lipid-bound conformation, as the lipid-bound structure was
determined with such truncation (Borhani et al., 1997). MSPs are based on Apo A-1 or
other apolipoproteins (Borch and Hamann, 2009), where the N-terminal helix was
removed.
Figure 6.5: Crystal structures of human Apo A-1. (A) Full-length protein (PDB
code: 2A01) and (B) ∆43 N-terminal truncation, where proline residues are represented by
red spheres (PDB code: 1AV1). The portion truncated in (B) is represented in red in (A).
A B
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5.2.1.3. Properties and applications of nanodiscs
The first report describes preparation of nanodiscs by mixing a MSP and
phospholipids in a detergent solution at appropriate molar ratios, followed by detergent
removal by dialysis (Bayburt, 2002). Similarly to ndHDL particles, each nanodisc particle
contains two MSP molecules wrapping around the edges of the particle, each one
covering the hydrophobic chains of a leaflet (Bayburt and Sligar, 2010). Nanodisc
diameter is between 9 and 13 nanometers and is fine-tuned by engineering the MSP to
adjust its length and optimizing the lipid content (Denisov et al., 2004).
Nanodiscs can be adsorbed or attached to a surface via a tag in the MSP (Borch
and Hamann, 2009; Bayburt and Sligar, 2010). Nanodiscs seem to be a promising tool for
NMR studies of small membrane proteins (Lyukmanova et al., 2008; Gluck et al., 2009).
By stabilizing a membrane protein into a lipid bilayer, nanodiscs keep it monodisperse and
soluble in the absence of detergent. Additionally, both sides are equally accessible. If the
membrane protein has multiple oligomeric states, a specific state can be selected
(Bayburt and Sligar, 2010).
Several membrane proteins have been incorporated into nanodiscs, including
bacteriorhodopsin (Bayburt and Sligar, 2003), the protomer of the SecYEG peptide
translocating complex (Alami et al., 2007), KcsA (Shenkarev et al., 2009), cytochrome
P450 and some GPCRs (Nath et al., 2007; Bayburt and Sligar, 2010). Nanodiscs can also
be used for delivery of hydrophobic drugs and contrast agents used in medical imaging
(Ryan, 2010).
5.2.1.4. Nanoscale apolipoprotein bound bilayer (NABB) particles
Danio rerio (zebrafish) apo A-1 was also shown to form discoidal particles identical
to nanodiscs, called nanoscale apolipoprotein bound bilayer (NABB) particles. Bovine
rhodopsin was shown to be functional when inserted into such particles (Banerjee et al.,
2008), as well as the plant light-harvesting complex II (Pandit et al., 2011). NABB particles
contain a HisTag, which can be used to immobilize the particle onto a surface containing
nickel ions (Zaitseva et al., 2010). It has also been shown that NABB particles can be
applied for delivering the KcsA channel into the lipid bilayer used in the ion channel
electrical recordings chamber (Banerjee and Nimigean, 2011).
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6.2.2. Incorporation of MlotiK1 into NABB particles
MlotiK1 was incorporated into NABB particles by mixing freshly purified MllotiK1 in
detergent with Zap1 and POPC. Detergent was removed by dialysis and the dialysed
sample was analyzed by size exclusion chromatography. The chromatogram obtained
and 15 % SDS-PAGE analysis of fractions collected are shown in Fig. 6.6. The elution
volumes of the three main peaks are indicated. Pure Zap1 elutes at 16.8 ml in the same
column (data not shown), therefore, the third peak was not analyzed by SDS-PAGE. The
major peak was eluted at 14.8 ml and SDS-PAGE analysis shows that it contains both
Zap1 and MlotiK1. Additionally, pure MlotiK1 in detergent solution is eluted at 14.8 ml in
the same column (data not shown). Since detergent was removed from the preparation,
these findings indicate that Zap1 has associated with MlotiK1, forming a larger structure
that elutes at a lower elution volume (14.8 ml) than Zap1 alone. There is also a “shoulder”
at approximately 13.2 ml, with the same protein composition as the peak at 14.8 ml, which
indicates that NABB particles have some tendency to aggregate.
Figure 6.6: Analysis of MlotiK1 incorporated into NABB particles (A) Gel filtration
chromatogram where the elution volumes are indicated above the respective peaks and
the fractions collected are numbered from 1 to 5 (B) 15 % SDS-PAGE analysis of the
fractions collected in (A).
6.2.3. EM data and structural model
“The case for cryoEM of membrane proteins and 3-D particle reconstructions using
Nanodiscs has also seen recent success” (Bayburt and Sligar, 2010).
MlotiK1 Zap1 1 2 3 4 5
8.0 ml
14.8 ml
16.8 ml
13.2 ml
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B
1                         2      3     4   5
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At the Rudolf Virchow Center, in Würzburg, Germany, samples corresponding to
the protein peak eluted at 14.8 ml (Fig. 6.6) were analyzed with EM by Christian Kraft
(technician) and the data collected were processed by Dr. Shashi Bhushan. Only two
kinds of particles were expected to be found: empty NABB particles and NABB particles
containing MlotiK1. Views of empty NABB particles will correspond to top and side views.
In contrast, NABB particles containing MlotiK1 will probably appear in either two top views
(with the extracellular or cytoplasmic channel faces facing the viewer) or in a side view. All
class averages (obtained by superposition of identical single particle images) should
correspond to different orientations of these two kinds of particles.
A pool of single particle images was obtained and some of those are shown in Fig.
6.7 A. Single particle images were automatically grouped into ten class averages (Fig. 6.7
B). Due to their low resolution, interpretation of the class averages obtained was not
obvious. Nevertheless, some assumptions could be made. Class averages #2 and #8
could represent side views of NABB particles without MlotiK1 incorporated, due to their
slightly elongated shape. Class averages displaying round shapes, such as #3, #5, #7 or
#10, might represent top views of the particle, with the membrane surface parallel to the
plane. It is not evident wheter MlotiK1 is present or if the CNB domains are facing the
viewer or not. Class averages #4 and #9 seem to represent side views of NABB particles
containing MlotiK1, due to their irregular electron density. Class averages #1 and #6 have
an irregular shape; therefore no interpretation could be done.
Class average #3 (Fig. 6.7 C) was the most interesting, since it provides more
details, allowing a more complete interpretation. Such interpretation is sketched in Fig. 6.7
D. In this class average, two of the CNB domains appear to stand out of the NABB disc
formed by the Zap1 proteins. In this class average, dimensions of the putative CNB
domains are approximately 2.4 nm and the disc region is approximately 7.8 nm long.
MlotiK1 has four-fold symmetry and its symmetry axis is located through the channel pore.
An axis was placed between the putative CNB domains, in a perpendicular orientation to
the disc region. The four-fold symmetric arrangement of MlotiK1 in the bound state (Paper
II) allowed applying a four-fold symmetry operation through the axis. Using such
operation, a structural model was generated (Fig. 6.7 E). For this preliminary model,
resolution was not calculated.
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Figure 6.7: EM sample imaging and model buiding of MlotiK1 reconstituted in
NABB particles. (A) Examples of single particle images. (B) Class averages (numbered
from 1 to 10) obtained from the total pool of single particle images. In (A) and (B), scale
bars in black were added, representing 100 Å (10.0 nm). (C) Magnification of class
average #9 (D) Interpretation of class average #9, where putative structural elements are
identified. Arrow: symmetry axis running through the channel pore; rectangle: protein
transmembrane region surrounded by the NABB particle; circles: CNB domains. (E) Model
generated from (D) represented in the same orientation.
6.2.4. Analysis of the model obtained
The small dimensions of MlotiK1 required the use of negative staining, which
limited the resolution attainable. The dimensions of the structural model obtained were
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estimated using the software UCSF Chimera (Pettersen et al., 2004). As a guideline, the
diameter of MlotiK1 transmembrane region was measured in the crystal structure,
resulting in values of 8.7 and 7.0 nm, between opposite and neighbouring subunits,
respectively (Fig. 6.8 A). In the EM electron density maps, the contour of the particles is
not well defined, affecting therefore the accuracy of measurements. In the EM model
obtained, particle diameter measured between neighbouring and opposite edges was
approximately 8.8 and 10.8 nm, respectively (Fig. 6.8 B). These values are consistent with
the maximal Stokes diameter of empty NABB particles, 10.0 to 12.5 nm, determined by
gel filtration chromatography (Banerjee et al., 2008). After rotating the structural model
into a side view (Fig. 6.8 C), its total height was also measured, 9.3 nm. By AFM, the total
height of MlotiK1 was approximately 8.9 nm in the bound state and 10.6 nm in the
unbound state (Paper II). The thickness of a nanodisc/NABB particle is approximately 4.3
nm (Frauenfeld et al., 2011). Considering this value, a rectangle of a width representing
4.3 nm was placed in the figure to indicate the expected location of Zap1 (Fig. 6.8 C). The
side view image shows two regions separated by the disc region. Their heights above and
below the membrane level were approximately 1.9 and 3.1 nm. In our AFM study, the
heights of the extracellular side and CNB domains of MlotiK1 were 1.8 and 3.2 nm,
respectively (Paper II). Based on this previous data, the extracellular side and the CNB
domains were assigned to the heights of 1.9 and 3.0 nm, respectively. One of the
complicating factors in this interpretation is that the overal dimensions of NABB particles
containing MlotiK1 (height: 9.4 nm; diameter: 8.8 or 10.8 nm) are similar, increasing
therefore the difficulty in distinguishing particles in different orientations.
Comparison of the structural model obtained with another one previously
determined at 16 Å also by EM, but in detergent solution, shows that resolution was lower
in the presence of the NABB particle than in its absence (Fig. 6.9). It is well known that
resolution is strongly determined by sample quality. In NABB particles, resolution obtained
was clearly lower than in detergent solution. Although other factors, such as the
equipment used and operators involved, were different, one may hypothesize that lower
resolution resulted also of increased structural heterogeneity due to the presence of Zap1.
This hypothesis is supported by a recent study. A chimera containing the MlotiK1 CNB
domains attached to the KcsA channel was incorporated into NABB particles and imaged
by EM. The resolution achieved, 26 Å (McCoy et al., 2014), was lower than that of MlotiK1
obtained in detergent solution, 16 Å (Chiu et al., 2007). Also of interest was the fact that
the cAMP binding affinity of the chimera increased 10-fold upon incorporation into NABB
particles (McCoy et al., 2014).
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Figure 6.8: Approximate dimensions of MlotiK1. (A) Top view of the
transmembrane region crystal structure (PDB code: 3BEH). MlotiK1 incorporated into
NABB particles in a (B) top view and (C) side view. In the side view, a rectangle indicates
the expected location of the MlotiK1 transmembrane region surrounded by the NABB
particle.
Side-view Extracellular side Cytoplasmic side
Figure 6.9: Structural models of MlotiK1 by EM in different orientations. (A) MlotiK1
incorporated in NABB particles. (B) Published structural model at 16 Å, where crystal
structures of MlotiK1 CNB domain and a voltage-gated potassium channel were
superposed (Chiu et al., 2007).
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6.3. A fluorescence-based activity assay for potassium
channels
Here, our effort in developing a new functional assay for MlotiK1 is described.
Such assay is a non-radioactive alternative to the 86Rb+ uptake assay currently used
(Nimigean, 2006). Besides the specific safety requirements in any radioactive work, the
rubidium uptake assay shows large deviations within replicates of the same condition,
requiring a large number of repetitions for a reliable quantitative result. In addition, 86Rb
has to be used within two monts after production, due to its relatively low half-lfe
(approximately 18 days). After such period, it becomes contaminated with 86Rb decay
products, which may affect the data. Due to these drawbacks, we decided to try
developing an alternative assay to use with MlotiK1 and other potassium channels that fail
to be studied by electrical recordings.
6.3.1. Potassium-binding benzofuran isophthalate (PBFI)
Potassium-binding benzofuran isophthalate (PBFI, Molecular Probes, Fig. 6.10 A)
is a fluorophore that binds potassium ions through a crown ether chemical group. Upon
potassium binding, its intrinsic fluorescence is significantly enhanced (Fig. 6.10 B). PBFI
has been used for functional studies of several potassium transport systems, including a
potassium/proton antiporter (Jezek et al., 1990) and an ATP-dependent potassium
channel (Paucek et al., 1992). It has also been used for quantification of intracellular
potassium concentration (Andersson et al., 2006). Functional studies based on
fluorescent probes have also been used for other ions, such as for sodium and calcium (Li
et al., 1992). These facts provided some hope concerning the possibility of developing a
novel functional assay for potassium channels using PBFI as a fluorescent probre.
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Figure 6.10: PBFI. (A) Chemical structure, where the potassium-binding site is
indicated. (B) Emission spectra of apo-PBFI (red) and PBFI in complex with 15 mM KCl
(blue).
6.3.1.1. Characterization of PBFI binding properties
We started by characterizing PBFI binding to potassium and to sodium, obtaining
KD values of 5.7 ± 0.3 mM and 17.1 ± 1.3 mM for potassium and sodium, respectively
(Fig. 6.11). The potassium binding curve shows that fluorescence increases rapidly
between 0 and 15 mM potassium, starting to saturate at 30 mM (Fig. 6.11 A). PBFI
fluorescence is very sensitive to potassium concentration between 0 and 15 mM,
therefore we chose to use in the assay a 0 to 15 mM potassium ion concentration gradient
between the inside and the outside of the liposomes. Since PBFI affinity for sodium is
approximately 3-fold lower (Fig. 6.11 B), we do not expect that traces of sodium ions in
solution should interfere.
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Figure 6.11: PBFI fluorescence as a function of (A) potassium or (B) sodium
concentration. KD values determined were 5.7 ± 0.3 mM and 17.1 ± 1.3 mM for potassium
and sodium, respectively.
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6.3.2. Setup of the assay
The final objective of this work was to develop an activity assay based on PBFI
fluorescence enhancement in the presence of potassium. The KcsA channel was chosen
for testing the assay, since it is stable, easy to purify and has a high permeation rate
(Heginbotham et al., 1998).
Liposomes containing 15 mM KCl were prepared in a buffer with pH 7.4 and then
destabilized with detergent, in order to enable membrane protein insertion into the
liposomes membrane. The potassium channel was added and detergent was removed by
hydrophobic adsorption. PBFI was then added and samples were freeze-thawed and
sonicated, to allow PBFI to penetrate the liposomes. The liposomes were further loaded
into a desalting column equilibrated in a buffer of pH 7.0 depleted of KCl, to remove
external PBFI and create KCl and pH gradients. Proteoliposomes were eluted in the void
volume. Osmotic pressure was kept close to zero by adding N-methyl-β-D-glucamine
(NMG) to both buffers. This compound was used to adjust total concentrations to 155 mM.
The fluorescence signal due to the [PBFI-K]+ complex remains reasonably stable
even after creating the concentration gradient, because the KcsA potassium channel is
highly selective for potassium and therefore the chemical equilibrium between K+ and
[PBFI-K]+ is not significantly disturbed. The efflux of K+, a positive charge, requires the
influx of another cation, which was chosen to be H+, to compensate for the establishment
of a difference in electrical potential. When the proteon ionophore carbonyl cyanide 3-
chlorophenyl hydrazone (CCCP) is added, liposomes become selectively permeable to
protons, allowing the influx of these positive charges, since pH is lower outside the
liposomes. This allows efflux of potassium ions though the potassium channel, causing
therefore their displacement from PBFI and a consequent fluorescence decrease. Finally,
when the potassium ionophore valinomycin is added, there is a total potassium efflux from
the liposomes and maximal fluorescence decrease (Fig. 6.12 A).
A representative result is shown in Fig. 6.12 B. Here, liposomes samples were
destabilized with 13 mM [(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate
hydrate (CHAPS) and reconstituted with KcsA at protein to lipid ratios (w/w) of 1/150 and
1/500. There are two negative controls without KcsA: one in which liposomes were
destabilized with detergent and another in which they were not. All curves were
normalized and superposed. Addition of CCCP (500 seconds after the beginning of the
measurement) did not cause any fluorescence decrease in samples containing KcsA.
When valinomycin was added (1400 seconds after the beginning of the measurement), a
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rapid decrease in fluorescence was observed in all conditions. This is consistent with a
rapid displacement of potassium from PBFI, caused by its efflux, which resulted in a rapid
decrease in its concentration inside the liposomes.
Upon addition of CCCP, fluorescence should have decreased in samples
containing KcsA, fact that was consistently not observed. The main reason behind such
lack of detectable effect could be the low sensitivity of the assay. This lack of sensitivity in
combination with the low open probability of the channel would make the signal
indistinguishable from the control conditions. The intrinsic leakiness of the liposomes,
reflected in the tendency of the baseline to lower over time, might have also contributed.
Moreover, the baseline usually showed some “bumps”, complicating even further the
assay. Additionally, reconstitution efficiency was not evaluated. Consequently, the lack of
signal could also be caused by decreased reconstitution efficiency. In the end, we could
not overcome the problems encountered and the assay was abandoned.
Figure 6.12: The fluorescence-based activity assay (A) Setup of the assay, where
a liposome is represented as a large circle containing K+ ions and the [PBFI-K]+ complex.
CCCP, which provides permeability ot H+ ions, and KcsA are represented in grey and
blue, respectively. “Internal buffer”: 20 mM HEPES-HCl pH 7.4, 120 mM NMG-HCl, 80 µM
PBFI, 15 mM KCl; “Extrernal buffer”: 20 mM HEPES-HCl pH 7.0, 135 mM NMG-HCl (B)
Time-course graph of potassium efflux in liposomes where the pH and potassium
gradients were created as described above. CCCP and valinomycin were added at 500
and 1400 seconds after the beginning of the measurement, respectively (indicated by
arrows). Data were normalized to the valinomycin-induced potassium efflux.
BA
CCCP
Vallinomycin
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6.4. Materials and methods
6.4.1. DTNB assay
MlotiK1 CNB domain C263V and C263V C331V M299C were expressed and
purified as described (Clayton et al., 2004; Altieri et al., 2008). Gel fitration
chromatography was performed in a Superdex 75 column and cAMP was removed as
described in Paper I for other CNB domain mutants. Refolded MlotiK1 CNB domain
mutants were pre-incubated overnight at 4 ºC with 1 mM tris(2-carboxyethyl)phosphine
(TCEP) and 10 mM dithiothreitol (DTT), which were later removed by desalting in a HiTrap
desalting column. DTNB (Invotrogen) reactions were carried out in 50 mM sodium
phosphate pH 7.4, 100 mM NaCl, 1 mM EDTA. The procedure was based on (Vopel et
al., 2009). 10 μM of single cysteine protein mutant were reacted with 200 μM DTNB in the
absence of any ligand or in the presence of the ligand concentrations indicated in Tables
5.3 and 5.4. KD values were determined as described in Paper I for other CNB domain
mutants. Absorbance was recorded at 412 nm over time and temperature was kept at 25
ºC. For recording fast reactions, such as C263V C331V M299C in the absence and
presence of cCMP, a stopped-flow apparatus was attached to the spectrophotometer. For
each condition, the reaction was carried out in triplicate and data were averaged.
6.4.2. Incorporation of MlotiK1 into NABB particles and EM
The MSP used was Zap1 (Banerjee et al., 2008), provided by Prof. Thomas P.
Sakmar (Rockefeller University, New York, NY, USA). Zap1 was expressed and purified
as described (Banerjee et al., 2008) with the exception that protein was expressed in
BL21 (DE3) RIL cells and a Superose 6 gel filtration column was used. 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC, Avanti) was prepared as described (Banerjee
and Nimigean, 2011). Prepared Zap1 and POPC were stored at -80 and -20 ºC,
respectively. Full-length MlotiK1 was expressed and purified according to Paper II, with
the exception that protein was loaded once onto a Superose 6 gel filtration column.
NABB particles were prepared by mixing Zap1, freshly purified MlotiK1 and POPC
at the molar ratios 2:1:25, respectively, in a total volume of 200 μl. Buffer used was 20 mM
Tris-HCl pH 7.5, 100 mM KCl, 3 mM DTT, 5 mM n-decyl-β-D-maltopyranoside (DM,
Anatrace), 200 μM cAMP. The mixture was incubated on ice for 30–40 minutes and
transferred to Slide-A-Lyzer MINI Dialysis units (Thermo Scientific) with a 10 kDa cutoff.
The detergent was removed by dialysis during three days against 200 ml DM-depleted
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buffer. Self-assembled NABB particles were loaded onto a Superose 6 gel filtration
column equilibrated in dialysis buffer. Samples were collected at different elution volumes
and analyzed by SDS-PAGE.
Sample was analyzed at the Rudolf Virchow Center, Würzburg, Germany, by
Christian Kraft and Dr. Shashi Bhushan. 3.5 µl of 10-fold diluted sample were applied to
10 nm carbon-coated grids and stained with uranyl acetate. Sample was imaged under
low-dose conditions (25 electrons/Å2) on a Tecnai T12 transmission electron microscope
operated at 120 kV and cooled with liquid nitrogen. 67,000x nominal magnification at a
defocus in the range of 1.0-1.5 μm were used. Micrographs were obtained using a 4K
CCD camera, corresponding each pixel to 2.2 Å. The data was processed with image
processing package EMAN2 (Tang et al., 2007). About 2,000 particles were used for 2D
classification and model building. Model was visualized and its dimensions were
measured using UCSF Chimera (Pettersen et al., 2004).
6.4.3. Fluorescence-based activity assay
PBFI concentration was determined by absorption at 346 nm, using the molar
extinction coefficient of 42000 M-1cm-1, provided by the manufacturer. All fluorescence
measurements were carried out in a Horiba Fluoromax-4 (Jobin Yvon) spectrofluorometer.
For binding assays, solutions containing 80 nM PBFI and increasing concentrations of
potassium or sodium were prepared. Spectra were collected with excitation at 340 nm and
emission between 390 and 650 nm. [PBFI-K]+ and [PBFI-Na]+ KDs were determined using
the procedure described in Paper I for 8-NBD cAMP binding to CNB domain mutants.
Liposomes were prepared from E. coli Polar Lipid Extract (Avanti) purchased in a
chloroform solution. Solvent was evaporated and lipids ressuspended in 15 mM KCl, 120
mM NMG, 20 mM HEPES-NMG pH 7.4 to a lipid concentration of 4 mg/ml. Phospholipid
aggregates were disrupted by sonication in a water bath, followed by freeze-thawing (four
times) and extrusion through a 400 nm filter. Extruded lipssomes were stored at 4 ºC and
used within three days.
KcsA was expressed and purified as described (Heginbotham et al., 1997).
Liposomes were aliquoted to 100 µl portions and solubilized with 13 mM CHAPS for 120
minutes. Freshly purified KcsA was added at protein to lipid ratios (w/w) of 1/500 and
1/150. CHAPS concentration corresponds to the detergent-to-lipid ratio used in the 86Rb+
uptake assay. Detergent was removed by hydrophobic adsorption using Bio-Beads (Bio-
Rad), using the procedure described in Paper I for the uptake assay. After detergent
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removal, 80 μM PBFI was added to liposome suspension, which was further freeze-
thawed four times and sonicated in water bath for 3 x 5 seconds. Liposomes were loaded
onto a 5 ml HiTrap desalting column attached to an ÄKTA purifier system, equilibrated in
135 mM NMG, 20 mM HEPES-NMG pH 7.0, to remove external PBFI and create a pH
gradient.
Kinetic measurements were performed immediately after the gradients were
formed. Temperature was set at 20 ºC and a 1.5 ml Hellma quartz cuvette with agitation
was used. Excitation and emission wavelengths were set at 340 and 494 nm, respectively,
with both slit widths at 7 nm. Shutter was controlled in the “anti-photobleaching” mode.
Integration time was 0.5 seconds. After the beginning of each measurement, 200 nM
CCCP and 90 nM valinomycin were added after 500 and 1400 seconds, respectively.
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I N T RODUC T I ON
The cyclic nucleotides cAMP and cGMP are important 
secondary messengers in several signal transduction 
pathways, including those of vision and olfaction (Zhang 
and Cote, 2005; Rehmann et al., 2007; Pifferi et al., 
2010). Action of these small molecules is, in many cases, 
dependent on binding to a cyclic nucleotide–binding 
(CNB) domain. Ligand binding induces a conforma-
tional change in the CNB domain, which is propagated 
to an effector domain leading to a functional alteration 
(Rehmann et al., 2007). Among the proteins with cyclic 
nucleotide–dependent activity, there are three families 
of cation tetrameric channels (Fig. S1): the eukaryotic 
CNG channels (Craven and Zagotta, 2006); the eukary-
otic hyperpolarization-activated CNG (HCN) channels 
(Craven and Zagotta, 2006); and the bacterial cyclic 
nucleotide–regulated channels, which include the MlotiK1 
potassium channel (Clayton et al., 2004; Nimigean 
et al., 2004). All of these channels have subunits with 
six transmembrane helices and a C-terminal cytoplas-
mic CNB domain.
The ligand-binding pocket in CNB domains (Fig. 1 A) 
has a shallow cavity, formed by residues from several 
structural motifs (the 4–5 hairpin, the P helix, and 
loop of the phosphate-binding cassette [PBC]) and a 
Correspondence to João H. Morais-Cabral: j c a b r a l @ i b m c . u p . p t 
Abbreviations used in this paper: CNB, cyclic nucleotide–binding; 
HCN, hyperpolarization-activated CNG; MD, molecular dynamics; PBC, 
phosphate-binding cassette; RMSD, root-mean-square deviation.
lid that closes over the nucleotide (Rehmann et al., 
2007). In MlotiK1, the lid is formed by the C-terminal 
C helix and includes an arginine (R348) that interacts 
directly with the nucleotide base (Clayton et al., 2004). 
Strikingly, cyclic nucleotide selectivity varies greatly 
among proteins with CNB domains, with some proteins 
strongly favoring cAMP while others favor cGMP. For 
example, the bovine rod photoreceptor and olfactory 
CNG channels are 40 times more sensitive to cGMP 
than to cAMP, as measured from the ratio of the K1/2 for 
channel activation (Altenhofen et al., 1991). In the olfac-
tory channel, mutation of a threonine at the C-terminal 
end of the PBC to alanine was sufficient to invert selec-
tivity from a 40-fold preference for cGMP to a 3.3-fold 
preference for cAMP. However, the equivalent mutation 
in the rod photoreceptor channel, although reducing 
affinity for cGMP, did not invert selectivity. However, 
mutation of an aspartate present in the C helix of the 
bovine rod CNG channel to a non-negatively charged 
residue resulted in the inversion of the efficacy of cGMP 
versus cAMP to act as agonists (Varnum et al., 1995). 
Nimigean and Pagel (2007) analyzed the effect of equiva-
lent mutations in the MlotiK1 channel. They found that 
mutations S308V, equivalent to the threonine in the PBC, 
and A352D, equivalent to the aspartate in C helix, 
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42 Ligand selectivity in the MlotiK1 channel
16.0–17.0 ml). Finally, refolded apo-protein was dialyzed against 
10 mM HEPES buffer, pH 7.5, and 100 mM NaCl before bind-
ing assays.
Cyclic nucleotide–binding assays
Dissociation constants were determined at room temperature in 
10 mM HEPES, pH 7.5, and 100 mM NaCl, with a fluorescence 
assay that uses the fluorescent nucleotide analogue 8-NBD cAMP 
(Biolog) (Cukkemane et al., 2007; Altieri et al., 2008). Cyclic 
nucleotides (cAMP and cGMP [both from Sigma-Aldrich], cIMP 
[Sigma-Aldrich], and cCMP [Biolog]) were purchased as acids or 
as sodium salts. For each mutant, the Kd of the fluorescent ana-
logue was determined by titrating 50 nM 8-NBD cAMP with in-
creasing protein concentrations and collecting fluorescence 
emission spectra (excitation at 471 nm) in a spectrofluorometer 
(Fluoromax-4; Horiba Scientific). For each protein concentration 
tested, emission at 536 nm was normalized as described previ-
ously (Altieri et al., 2008), and data were fitted with the follow-
ing equation:
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where y is the normalized fluorescence intensity, K is the dissocia-
tion constant of 8-NBD cAMP, P is protein concentration, and L is 
8-NBD cAMP concentration.
For determination of the dissociation equilibrium constants of 
cAMP or cGMP, the above assay was repeated in the presence of a 
competing fixed concentration of cAMP or cGMP in each sample. 
For determination of the competing concentration, the protein 
concentration that resulted in 70–80% of the maximum signal 
was selected and titrated with increased ligand concentrations. 
The ligand concentration that decreased the signal to 40–50% 
was then chosen for the competition assay. Data were fitted with 
the following equation:
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where y is the fluorescence intensity, K1 is the dissociation con-
stant of 8-NBD cAMP, K2 is the dissociation constant of cAMP or 
cGMP, L1 is the 8-NBD cAMP concentration, P is total protein 
concentration, L2 is total concentration of cAMP or cGMP, G is 
signal gain, and y0 is signal offset.
For mutants displaying 8-NBD cAMP dissociation constants 
higher than 5 µM, a modified assay was used (Altieri et al., 2008). 
The concentrations of the protein and 8-NBD cAMP were fixed at 
approximately the Kd value and two times the Kd value, respec-
tively, and titrated with increasing cAMP or cGMP concentrations. 
Data were fitted with the previous equation but with a varying cyclic 
nucleotide concentration.
altered the affinity for cAMP and cGMP, as predicted 
previously. However, these changes were relatively small, 
and channel ligand selectivity was not inverted. The in-
ability to define general rules that explain selectivity in 
CNB domains (Cukkemane et al., 2011) is a reflection 
of our incomplete understanding of this mechanism, 
and it probably results from several factors: the diffi-
culty of many studies to distinguish the impact of mu-
tated residues on functional selectivity versus binding 
selectivity, the lack of structural analysis to complement 
the biochemical or functional studies, and the inex-
haustive exploration of all the residues in the binding 
pocket of CNB domains.
The MlotiK1 channel is particularly amenable for de-
fining the determinants of cyclic nucleotide selectivity. 
This channel has been well characterized at a structural, 
functional, and biochemical level (Clayton et al., 2004, 
2008; Nimigean et al., 2004; Chiu et al., 2007; Cukkemane 
et al., 2007; Nimigean and Pagel, 2007; Altieri et al., 2008; 
Schünke et al., 2009, 2011; Peuker et al., 2013), and, by 
studying the isolated CNB domain, it is possible to sepa-
rate ligand binding from, at least, the final steps of the 
mechanism of channel activation. We performed an ex-
tensive mutagenesis analysis of the residues involved in 
the structural interaction with the nucleotide base and 
evaluated the impact of these mutations on the binding 
of cAMP and cGMP. Ligand-binding selectivity was in-
verted only after three different mutations were com-
bined; a structural analysis of this triple mutant reveals 
how these mutations alter the molecular details of the 
nucleotide-binding pocket.
MAT E R I A L S  AND  M E THOD S
Preparation of CNB domain without ligand
MlotiK1 CNB domain mutants were expressed and purified as de-
scribed previously (Clayton et al., 2004). PBS buffer containing 
2 mM DTT (purification buffer) was used throughout purifica-
tion. Size-exclusion chromatography was performed in a Superdex 
75 column (GE Healthcare). For preparation of apo-domain, freshly 
purified protein was incubated overnight with cAMP agarose beads 
(Sigma-Aldrich), and bound protein was extensively washed with 
purification buffer. cAMP-free protein was eluted by unfolding 
with purification buffer that included 3 M guanidinium chlo-
ride (unfolding buffer). cAMP removal was monitored by deter-
mining the OD260/OD280 ratio, as described previously (Peuker 
et al., 2013). Typical values varied between 0.65 and 0.90 for 
nucleotide-free CNB domain. Protein was first diluted to 0.3 mg/ml 
with unfolding buffer and then diluted threefold into refolding 
buffer (100 mM NaCl, 10 mM sodium phosphate, pH 7.0, 5 mM 
glutathione [reduced], 0.5 mM glutathione [oxidized], 0.5 mM 
l-arginine, and 10 mM EDTA) (Cukkemane et al., 2007) to a final 
concentration of 0.1 mg/ml protein and 1 M guanidinium chlo-
ride. This solution was gently stirred at 4°C for 3 h, and then the 
protein was concentrated to 0.3 mg/ml. The refolded protein 
was further dialyzed against refolding buffer to lower guanidin-
ium chloride concentration to 50 mM. Dialyzed protein was 
concentrated and loaded onto a Superdex 75 size-exclusion col-
umn to remove misfolded protein (Peuker et al., 2013) (folded 
protein elutes at 12.0–12.5 ml, and misfolded protein elutes at 
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two molecules in the asymmetric unit. The structure of the mu-
tant CNB domain–cGMP complex was solved by molecular re-
placement with Phaser (McCoy et al., 2007) using chain A of the 
cGMP-bound structure (Protein Data Bank accession no. 3CL1) 
(Altieri et al., 2008) as the search model. Model building and re-
finement were performed with Coot (Emsley et al., 2010) and 
Phenix (Afonine et al., 2012), respectively. Ligand restraints were 
generated using Phenix. Figures were generated using PyMOL 
software (Schrödinger, LLC).
Molecular dynamics (MD) simulations
Two models were defined as corresponding to the CNB domain 
of wild-type MlotiK1 and of the T284S/V288S/A352D mutant, re-
spectively. The atomic coordinates of the wild-type domain were 
taken from the Protein Data Bank (accession no. 3CL1) (Altieri 
et al., 2008). Residues 350–354 are missing in 3CL1, whereas their 
structure was solved in the mutant. Because these residues are 
close to the nucleotide-binding site, we decided to include them 
in both models. The initial structure of residues 350–354 in the 
wild-type domain was defined as an elongation of the C helix. 
The final models included residues 320–354 for the wild-type 
CNB domain and residues 314–355 for the T284S/V288/A352 
mutant domain. N and C terminals were acetylated and amidated. 
The default protonation state was assumed for all the ionizable 
residues, and histidine residues were protonated at the epsilon 
position. All of the water molecules that are present in the crystal-
lographic structures were retained. The systems were solvated by 
6,000 water molecules, and the necessary number of chloride 
ions was added to guarantee electrical neutrality. The atomic 
models were first equilibrated in the NVT ensemble (600 ps), 
with harmonic restraints applied to all of the heavy atoms of the 
protein, of cGMP, and of the crystallographic water molecules. 
The harmonic restraints were gradually removed in the course of 
10-ns equilibration trajectories in the NPT ensemble. Production 
trajectories of 100 ns followed.
MD trajectories were simulated using NAMD version 2.9 (Phillips 
et al., 2005), with the CHARMM27 force field with CMAP correc-
tions (MacKerell et al., 1998), and the TIP3P model for water mol-
ecules (Jorgensen et al., 1983). Pressure was kept at 1 atm by the 
Nosé–Hoover Langevin piston method (Martyna et al., 1994; Feller 
et al., 1995), with a damping time constant of 50 fs and a period of 
100 fs. Temperature was kept at 300 K by coupling the system to a 
Langevin thermostat, with a damping coefficient of 5 ps1 (Feller 
et al., 1995). Electrostatic interactions were treated by the particle 
mesh Ewald algorithm, with a grid spacing below 1 Å (Essmann 
et al., 1995). Van der Waals interactions were truncated at 12 Å 
and smoothed at 10 Å. Hydrogen atoms were restrained by the 
SETTLE algorithm (Miyamoto and Kollman, 1992). A time step of 
2 fs was adopted to integrate the equations of motion.
Energy calculations
The energy of binding, G, is defined as:
 ∆G G G Gcomplex protein cGMP= − − ,  
where Gcomplex, Gprotein, and GcGMP are the energies of the complex, 
the isolated protein, and the nucleic acid, respectively. These en-
ergies were estimated with the MM-PBSA approach, using the 
single-trajectory paradigm; i.e., the structures of complex, pro-
tein, and nucleic acid were taken from the same MD trajectory. As 
a general rule, the single-trajectory paradigm provides accurate 
energy estimates only if the ligands and the protein do not change 
structure upon binding. However, in this study, we are interested 
only in energetic differences between the wild-type and the triple 
mutant, and not in the absolute value of the binding energies. 
Therefore, a less stringent condition applies to MM-PBSA calcula-
tions with the single-trajectory paradigm. Even if the structure of 
Expression and purification of full-length MlotiK1 channel
Full-length MlotiK1 T284S/V288S/A352D was expressed, puri-
fied, and reconstituted as described previously for the wild-type 
channel (Clayton et al., 2004; Nimigean et al., 2004). In brief, 
MlotiK1 expressed in C41 (DE3) cells was extracted at 4°C for 
30 min with PBS buffer, pH 7.4, containing 50 mM n-decyl--
d-maltopyranoside (DM; Anatrace), 200 µM cAMP, 5 mM -
mercaptethanol. During purification and until gel filtration, the 
same buffer was used, but cAMP was excluded and the DM con-
centration decreased to 5 mM, unless stated otherwise. Deter-
gent-extracted proteins were incubated with nickel beads and first 
washed with 50 mM imidazole to remove nonspecifically bound 
proteins, followed by a 200-ml wash in 2 mM DM. This ensured 
that cAMP bound to the triple mutant channel, which has micro-
molar affinity for cAMP, would dissociate from the protein. MlotiK1 
was eluted in 500 mM imidazole and further purified by gel filtra-
tion on a Superdex 200 column (GE Healthcare) equilibrated in 
20 mM Tris-HCl, pH 7.5, 150 mM KCl, 5 mM DM, and 3 mM DTT. 
Protein was immediately reconstituted in the presence of differ-
ent ligand concentrations.
Liposome reconstitution and radioactive uptake assay
Proteoliposome preparation followed previously described proce-
dures (Clayton et al., 2004; Nimigean et al., 2004; Altieri et al., 
2008). In brief, 7.5 µg MlotiK1 protein was mixed with 1.5 mg 
Escherichia coli polar lipids (Avanti Polar Lipids, Inc.) in 10 mM 
HEPES, 5 mM N-methyl--d-glucamine (NMG), pH 7.6, and 
150 mM KCl for a total volume of 150 µl. The detergent was re-
moved by hydrophobic adsorption using Bio-Beads SM-2 (Bio-Rad 
Laboratories). Samples were gently stirred for 1 h at room tem-
perature at a Bio-Beads/detergent (wt/wt) ratio of 10-15. This 
step was repeated twice and followed by an overnight incubation 
at 4°C with at a Bio-Beads/detergent (wt/wt) ratio of 20-30. Pro-
teoliposomes were not frozen at any stage. A potassium concen-
tration gradient was established by exchanging the external 
buffer to 10 mM HEPES, 5 mM NMG, pH 7.6, 20 µM KCl, and 
150 mM sorbitol (sorbitol buffer) in the presence of the appropri-
ate cAMP or cGMP concentrations, using spin columns. Uptake 
assays (Nimigean, 2006) were started by mixing one third of the 
final reaction volume of buffer-exchanged proteoliposomes with 
two thirds of sorbitol buffer containing 5 cps/µl 86Rb+ (PerkinElmer) 
and the appropriate ligand concentration. Uptake was monitored 
after 90 min in 100-µl aliquots and normalized as described previ-
ously (Nimigean, 2006).
Purification and crystallization of T284S/V288S/A352D mutant 
CNB domain
Expression and purification of T284S/V288S/A352D CNB domain 
was performed as described previously for the wild-type domain 
(Clayton et al., 2004). For nucleotide removal, the protein bound 
to GST beads was washed with 200 ml buffer (PBS buffer contain-
ing 3 mM DTT) before incubation with thrombin. Size-exclusion 
chromatography was performed on a Superdex 75 column equili-
brated in 10 mM Tris, pH 7.0, 100 mM NaCl, and 4 mM DTT.
Crystals of T284S/V288S/A352D mutant domain were grown 
using the vapor diffusion method in 24-well hanging-drop trays 
with a 500-µl reservoir solution of 0.15 M sodium citrate, pH 5.6, 
0.9 M ammonium sulfate, and 100 mM lithium sulfate. Protein 
at 10 mg/ml was combined with cGMP (final concentration of 
1.5 mM) and mixed with the reservoir solution at a 1:1 ratio for 
a final drop volume of 4 µl. Crystals appeared within 10 d at 25°C. 
Crystals were cryoprotected in well solution supplemented with 
25% glycerol and 1.5 mM cGMP before flash cooling in liquid 
nitrogen. Diffraction data were collected at 100 K at the beamline 
14-4 of the European Synchrotron Radiation Facility (ESRF) and 
processed with XDS (Kabsch, 2010) and SCALA (Evans, 2006). 
Mutant CNB domain crystals grew in space group P212121 with 
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Accession numbers
The coordinates and structure factors of the mutant CNB do-
main–cGMP complex from the MlotiK1 channel were deposited 
at the Protein Data Bank under the accession number 4MUV.
Online supplemental material
Table S1 shows statistics of crystallographic data and refinement. 
Fig. S1 shows the sequence alignment of CNB domains from the 
MlotiK1, HCN2, and CNGA-1 channels, and the CNB  domain 
from the cGMP-dependent kinase I and CNB homology domains 
from the ELK and EAG1 channels. Figs. S2 and S3 illustrate two 
stereo views of the ligand-binding pocket of the triple mutant 
CNB domain from the MlotiK1 channel. Fig. S4 shows a mutant 
cycle analysis of mutations V288S and A352D. Fig. S5 shows repre-
sentations of the ligand-binding pocket in the structure of the 
cGMP-bound CNB  domain from the cGMP-dependent protein 
kinase I. The online supplemental material is available at http://
www.jgp.org/cgi/content/full/jgp.201311145/DC1.
R E S U L T S
Inverting ligand selectivity in the MlotiK1 channel
We determined the constants of dissociation of cAMP 
and cGMP for the MlotiK1 channel CNB domain (Kd: 
148 ± 22 nM, n = 6, for cAMP; 1,731 ± 264 nM, n = 6, for 
cGMP) (Fig. 1, B–D, and Table 1); these values are 
the protein or of the ligand changes upon binding, the estimated 
difference in binding energy between the wild type and the mu-
tant is still accurate, provided that these structural changes have 
similar energetic effects in the two systems.
The free energy of each species was calculated as:
 G E G E GVDW SA COUL PB= + + + ,  
where EVDW is the Van der Waals energy, ECOUL is the coulombic 
energy, and GPB and GSA are polar and apolar contributions to the 
solvation energy. The apolar contribution to the binding energy 
is given by the sum of EVDW and GSA, whereas the sum of ECOUL and 
GPB defines the polar component of the binding energy. Solvation 
energies were calculated with the APBS software (Baker et al., 
2001). The probe radius for the definition of the molecular sur-
faces was 1.4 Å. The relative dielectric constants were 80 and 2, 
respectively, for solvent and solutes. The apolar solvation energy 
was assumed proportional to the solvent-accessible surface area, 
with proportionality constant equal to 0.0072 kcal mol1 Å2. 
Binding energies were calculated as average values over the 100-ns 
MD trajectories. The time series of the various energy terms was 
tested for the presence of correlation with the Ljung–Box lack of 
correlation statistical test with a confidence level of 95%, as de-
scribed in Furini et al. (2013). A sampling period for the MD trajec-
tories equal to 1 ns guaranteed lack of correlation among samples 
in the time series of all the energy terms. This lack of correlation 
is necessary for defining a safe (over) estimation of the standard 
error affecting the calculated binding energies.
Figure 1. Cyclic nucleotide binding in the MlotiK1 CNB domain. (A) View of the CNB domain bound to cGMP. Structural elements 
(in red and green) that form the ligand-binding pocket are indicated. cGMP is shown as stick. (B–D) Fluorescence binding curves of the 
CNB domain protein titrated against 50 nM 8-NBD cAMP, (B) in the absence of competitor, and in the presence of (C) 400 nM cAMP 
or (D) 2 µM cGMP. Kd values determined were 171 ± 20 nM for 8-NBD cAMP, 148 ± 22 nM for cAMP, and 1,731 ± 264 nM for cGMP. 
Error bars indicate standard deviation of error. Experiments involve six replicates from two different protein batches. (E and F) View of 
residues interacting directly with ligand bases in the wild-type MlotiK1 CNB crystal structures bound to (E) cAMP (Protein Data Bank 
accession no. 1VP6) and (F) cGMP (Protein Data Bank accession no. 3CL1). Dotted circle indicates that V288 is one of the residues not 
interacting with cGMP.
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noted). Our measurements show that the domain is 
12 times more selective for cAMP than for cGMP, as de-
fined from the ratio of the experimentally determined 
affinities for the two ligands. This nucleotide prefer-
ence is also reflected in the nucleotide concentration 
dependence of channel activity measured using an 
larger than the values reported by others (Cukkemane 
et al., 2007), but the discrepancy does not alter the con-
clusions of our study, as we are interested in under-
standing the molecular basis of the relative preference 
of one nucleotide over the other, and we have used the 
same procedure throughout this study (exceptions are 
TA B L e  1
cAMP and cGMP Kds for the wild-type and CNB domain mutants
Structural motif Mutant cAMP Kd cGMP Kd Kd ratio n
nM nM
Wild type 148 ± 22 1,731 ± 264 11.7 6
4–5 hairpin V282L 1,008 ± 53 8,951 ± 743 8.9 3
T284N 342 ± 41 6,556 ± 633 19.2 3
T284Q 731 ± 90 6,952 ± 1312 9.5 3
T284S 464 ± 58 2,984 ± 379 6.4 6
V288A 393 ± 50 2,544 ± 355 6.5 3
V288L 201 ± 19 996 ± 163 5.2 3
V288I 138 ± 39 797 ± 118 5.8 6
V288S 1,205 ± 160 2,105 ± 128 1.7 4
P helix M299C 501 ± 99 2,942 ± 357 5.9 3
M299Q 734 ± 134 11,649 ± 2,621 15.9 3
C terminus A352S 174 ± 23 727 ± 160 4.2 3
A352D 256 ± 29 850 ± 121 3.3 6
C helix R348A 24,822 ± 3182a 38,781 ± 2,449a 1.6 3
R348N 19,142 ± 507a 32,106 ± 3,844a 1.7 3
R348Q 25,097 ± 2,216a 46,062 ± 5,609a 1.8 3
R348K 16,446 ± 842a 23,547 ± 982a 1.4 3
R348Y 24,174 ± 2,214a 33,172 ± 4,771a 1.4 3
V288S/A352S 691 ± 72 749 ± 75 1.1 3
V288S/A352D 547 ± 111 351 ± 95 0.64 3
T284S/V288S/A352D 2,190 ± 347 336 ± 126 0.15 6
Kds were determined by competition at a constant ligand concentration and with variable protein concentration; except for those marked with footnote a. 
Kd ratio is calculated from (cGMP Kd/cAMP Kd); n, number of repetitions.
aKds were determined by competition at a constant protein concentration and with variable ligand concentration.
Figure 2. Titration experiments with the MlotiK1 T284S/ 
V288S/A352D mutant. (A–C) Fluorescence binding curves 
of triple mutant CNB domain titrated against 50 nM 8-NBD 
cAMP, (A) in the absence of competitor and in the pres-
ence of (B) 4 µM cAMP or (C) 1 µM cGMP. The Kd values 
determined were 2,005 ± 160 nM for 8-NBD cAMP, 2,190 ± 
347 nM for cAMP, and 336 ± 126 nM for cGMP. (D) Func-
tional analysis of the T284S/V288S/A352D MlotiK1 po-
tassium channel using an 86Rb+ uptake assay. Normalized 
uptake by channel reconstituted in liposomes as a function 
of ligand concentration (circles, cGMP; squares, cAMP) 
was fitted with a Hill equation (cGMP: K1/2 = 0.6 ± 0.1 µM 
and Hill coefficient = 1.3; cAMP: K1/2 = 7.4 ± 3.3 µM and 
Hill coefficient = 0.84). Error bars indicate standard devia-
tion of error. Data in fluorescence binding assays involved 
six replicates from two different protein batches. Radioac-
tivity uptake assay involved three to eight replicates from 
three different protein batches.
 o
n
 July 1, 2014
jgp.rupress.org
D
ow
nloaded from
 
Published June 30, 2014
46 Ligand selectivity in the MlotiK1 channel
dependence of activity in the triple mutant channel show 
a functional preference for cGMP over cAMP (K1/2 of 
600 nM for cGMP and 7 µM for cAMP) (Fig. 2 D). 
Ligand efficacy in the wild-type and triple mutant chan-
nels was estimated by measuring the 86Rb+ flux after 
90 min in the presence of saturating concentrations of li-
gand (>100 times higher than the K1/2). The maximum 
normalized flux for the wild-type channel is 0.29 ± 0.11 
(n = 7) for cAMP and 0.18 ± 0.07 (n = 6) for cGMP. For 
the mutant, the values are 0.39 ± 0.07 (n = 6) for cAMP 
and 0.33 ± 0.05 (n = 6) for cGMP. Because of the limi-
tations inherent to the assay, these values have to be 
considered carefully, but they show that unlike for ligand 
sensitivity, the three mutations do not appear to greatly 
alter the functional efficacy of the ligands.
Structure of the triple mutant
We determined the x-ray structure of the T284S/V288S/
A352D mutant domain in complex with cGMP at 1.25 Å 
(Figs. 3, S2, and S3, and Table S1). These crystals con-
tain two protein copies in the asymmetric unit, which 
are for the most part indistinguishable.
A comparison of the triple mutant structure to the 
wild-type domain structure in complex with cGMP (Pro-
tein Data Bank accession no. 3CL1) (Altieri et al., 2008) 
reveals high overall structural similarity (Fig. 3 A), with a 
backbone root-mean-square deviation (RMSD) of 0.60 Å. 
86Rb+ flux assay; the channel has a higher sensitivity 
for cAMP (K1/2 values of 110 ± 20 nM) than for cGMP 
(920 ± 110 nM) (Altieri et al., 2008).
A comparison of the MlotiK1 CNB domain structures 
bound to cAMP and cGMP (Fig. 1, E and F) shows that 
the residues that are within 4 Å of the nucleotide bases 
and which probably determine much of the binding 
properties of the domain are: V282 and T284 in the 
4–5 hairpin; F296, M299, and S308 in different sec-
tions of the PBC; and R348 in the C helix, the lid of 
the binding pocket. The most obvious difference in the 
interactions established by cAMP and cGMP is V288. 
This residue is positioned in the 4–5 hairpin and is 
within interacting distance of the cAMP base but not of 
cGMP (Fig. 1, E and F). Confirming the importance of 
these local interactions for the ligand-binding proper-
ties of the domain, we inverted ligand selectivity in the 
MlotiK1 CNB domain through a combination of muta-
tions at three of these residues (T284S/V288S/A352D). 
This mutant domain shows a 6.5× preference for cGMP 
or, to allow a direct comparison with the wild-type value, 
a 0.15× preference for cAMP. Relative to the wild-type 
domain, these mutations decreased cAMP affinity (Kd 
cAMP: 2,190 ± 347 nM) and increased cGMP affinity 
(Kd cGMP: 336 ± 126 nM) (Fig. 2, A–C, and Table 1).
Reflecting the ligand-binding properties of the isolated 
mutant domain, the K1/2 values for the concentration 
Figure 3. Structural characterization of 
the T284S/V288S/A352D MlotiK1 CNB 
domain mutant. (A) Superposition of tri-
ple mutant (green) and wild-type (red) 
CNB domain structures in complex with 
cGMP. Ligands are represented as stick. 
Some structural elements of the binding 
pocket are indicated. (B) Detail of the li-
gand-binding pocket of the triple mutant. 
cGMP is shown in white stick, with some 
of the residues in the pocket shown in yel-
low. Water molecules bound in the ligand-
binding pocket are shown as red spheres. 
Dashed lines connect some of the atoms 
within hydrogen bond distance. The rest 
of the protein is shown in transparent 
cartoon. (C) As in B, but viewed from just 
below the 4–5 hairpin. (D) View as in B 
of the ligand-binding pocket of one of the 
asymmetric unit protein molecules pres-
ent in the cGMP-bound wild-type CNB do-
main crystals. Some of the residues in the 
hairpin and the three waters present in the 
binding pocket are shown.
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differences, the nucleotides adopt the same syn confor-
mation and are in similar positions.
A more detailed analysis of the triple mutant inter-
actions between the protein and the nucleotide base 
shows that V282, M299, S308, and R348 interact with the 
ligand in the same way as in the wild-type structure. In 
one of the asymmetric unit mutant copies, the side-chain 
methyl groups of A309 and A351 are also within 4 Å of 
the base, but this is not observed in the other copy. More 
There are, however, interesting differences in the bind-
ing pocket. First, the C helix in the mutant, where A352D 
was introduced, is five to six residues longer and the 
domain structure ends at residue 354 or 355 (Fig. 3 A), 
depending on the asymmetric unit molecule consid-
ered. Second, the 4–5 hairpin in the mutant, where 
the other two mutations were introduced, adopts a dif-
ferent conformation relative to the wild-type structure, 
closing further over the ligand (Fig. 3 A). Despite these 
Figure 4. MD simulations of the MlotiK1 CNB domain. MD trajectories were sampled with a period of 10 ps. Data for the wild-type 
CNB domain and for the T284S/V288S/A352 mutant are shown, respectively, in red and in blue. (A) RMSD of the backbone atoms 
in the 4–5 hairpin (residues 280–291). The probability histograms shown on the right side of the panel were calculated using a bin 
size of 0.05 Å. (B) RMSD of the backbone atoms of residues 252–354, corresponding to the whole CNB domain. In A and B, all of the 
MD snapshots were superimposed on the corresponding crystal structure, using the heavy atoms of cGMP as reference. (C) Number of 
water molecules closer than 4.0 Å from heavy atoms of the nucleotide base. At the beginning of the simulation, the structure contains six 
waters within 4.0 Å of the base. (D) RMSD of the heavy atoms of cGMP. All the MD snapshots were superimposed on the corresponding 
crystal structure, using the backbone atoms of residues 252–354 as reference. (E and F) Number of water molecules closer than 4.0 Å 
from heavy atoms of the nucleotide base as a function of the RMSD of the backbone atoms in the 4–5 hairpin (residues 280–291), 
(E) in the mutant and (F) wild-type domains.
 o
n
 July 1, 2014
jgp.rupress.org
D
ow
nloaded from
 
Published June 30, 2014
48 Ligand selectivity in the MlotiK1 channel
the nucleotide base, of the hydroxyl groups in V288S 
and T284S, and of the carbonyl of N286. Analysis of the 
previously determined structures of the MlotiK1 CNB 
domain reveals that in one of the asymmetric unit pro-
tein copies of the cGMP-bound wild-type domain crystal 
structure (Fig. 3 D), there are water molecules in the 
binding pocket that are equivalent to waters A, B, and 
C. However, they do not form a hydrogen bond net-
work in the ligand pocket, and they are not observed in 
the other protein copy.
Exploring the binding pocket interactions  
with MD simulations
To get a more complete view of the interactions be-
tween the ligand-binding pocket residues and the nu-
cleotide, we performed MD simulations with the triple 
mutant and the wild-type CNB domain structures bound 
to cGMP.
Interestingly, a plot of 4–5 hairpin backbone atom 
RMSD over the duration of the simulation revealed that 
the mutant structure hops repeatedly between two or 
three different conformations, corresponding to RMSDs 
of 1.1, 1.5, and 2.0–2.5 Å, whereas the wild-type struc-
ture oscillates around a more uniform average structure 
(Fig. 4 A). Further analysis reveals that, in the triple mu-
tant simulations, there is a correlation between the num-
ber of waters and the different hairpin conformations 
(Fig. 4, A, C, and E) so that higher RMSD values corre-
spond to a higher number of waters within 4 Å of the 
base. Thus, transition between the different conforma-
tions is accompanied by movement of water molecules 
interesting are the differences in the structural roles of 
the three mutations (T284S, V288S, and A352D). The 
A352D side chain extends toward the nucleotide base, 
with the carboxylic group hydrogen bonding N1 and 
N2 of the guanine (Figs. 3, B and C, and S3) and an-
choring the end of the C helix to the body of the do-
main. This interaction mirrors a similar disposition 
seen in the I336D–HCN2 CNB domain structure (Flynn 
et al., 2007). In contrast, T284S and V288S are either 
beyond the 4-Å range for Van der Waals interactions 
with the nucleotide base or at the far end of this type of 
interaction, leading us to conclude that these residues 
do not establish close interactions with the nucleotide. 
Instead, T284S and V288S are involved in a hydrogen 
bond network with four water molecules present in the 
binding pocket (Fig. 3, B and C). Waters A and B are 
positioned along the rim of the guanine ring, whereas 
waters C and D are positioned between the 4–5 hair-
pin and the nucleotide base. The B factors of the four 
waters and of the surrounding protein atoms are simi-
lar, indicating that these waters are stably bound in the 
crystal. This water network connects several residues in 
the binding pocket to each other and to the nucleotide 
base. Water A bridges V288S and N7 in the nucleotide 
base and is also within hydrogen-bonding distance of 
water B; water B also hydrogen bonds O6 in the nucleo-
tide base. Water C is within hydrogen-bonding distance 
of the carboxylic group of A352D, of the hydroxyl in 
T284S, of O6 in the nucleotide, and of the main-chain 
amino group in N286 in the 4–5 hairpin. Finally, 
water D is within hydrogen-bonding distance of O6 in 
Figure 5. MD simulation conformational states. View of 
the superposed ligand-binding pockets from the triple mu-
tant crystal structure (yellow stick) and from MD simulation 
snapshot models (cyan) in the (A) closed conformation, 
(B) semi-closed conformation, and (C) open conforma-
tion. Structures are shown as C traces, with ligands in 
yellow (crystal structure) or cyan (MD simulation models). 
Only waters that mediate protein–ligand interactions are 
shown (as blue spheres). Dashed lines connect some of the 
atoms within hydrogen bond distance. (D) Superposition 
of crystal structure and MD simulation snapshot structures 
in the different conformations. View of the ligand-binding 
pocket with cGMP and R348 shown as stick.
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shows that in the wild-type structure, there is an average 
of one hydrogen bond formed directly with protein atoms 
and one bond that is mediated by water (we did not 
consider interactions that might be mediated by more 
than one water molecule). In the triple mutant, the 
numbers are 2.5 for direct bonds and 1 for water medi-
ated. A breakdown of these hydrogen bonds among the 
binding pocket residues is shown in Table 2. The direct 
hydrogen bond formed between S308 and N7 in the 
base is present both in the wild-type and mutant protein 
and is highly stable over the length of the simulations, 
agreeing well with the demonstrated importance of this 
residue for the stability of bound cGMP (Altenhofen 
et al., 1991; Flynn et al., 2007). The hydrogen bonds 
that are present in the mutant but not in the wild-type 
simulations are caused by A352D, which forms a long-
lived interaction with the ligand through its carboxylic 
group, and V288S, which either forms a direct or a water-
mediated hydrogen bond over a good fraction of the 
simulation time. The water-mediated interaction between 
V288S and the ligand is present in the crystal structure 
of the mutant (Fig. 3, B and C) as well as in the simula-
tion semi-closed conformation (Fig. 5 B); the direct 
hydrogen bond involving this residue occurs in the sim-
ulation closed conformation, when the binding pocket 
loses water molecules and the hairpin approaches the 
nucleotide base (Fig. 5 A).
The analysis of the MD simulations suggests that there 
are two aspects that contribute favorably for the tighter 
binding of cGMP by the mutant. The detection in the 
triple mutant MD simulation of several conformations 
of the ligand-binding site, whereas in the wild-type do-
main only one conformation is observed, suggests that 
tighter binding of cGMP in the triple mutant involves a 
more favorable entropic component. In addition, sev-
eral factors indicate that the tighter cGMP binding in 
in and out of the nucleotide neighborhood. In contrast, 
a similar plot for the wild-type simulation shows a rapid 
fluctuation in the number of waters around the average 
value of five to six waters (Fig. 4 F).
Analysis of snapshot structures corresponding to the 
different conformations of the triple mutant revealed: a 
closed conformation in which the hairpin moves toward 
the base (Fig. 5 A), establishing closer interactions with 
the ligand base; a semi-closed conformation that strongly 
resembles the crystal structure (Fig. 5 B); and an open 
conformation where the hairpin moves away from the 
nucleotide base (Fig. 5 C). These conformations are as-
sociated with different numbers of water molecules in 
the binding pocket so that: the closed conformation has 
no or very few waters within hydrogen-bonding distance 
of the base; the semi-closed has approximately four wa-
ters within hydrogen-bonding distance of the base, just 
like the crystal structure; and the open conformation has 
a larger number of waters forming a network that con-
nects the ligand and the protein. Importantly, the nucleo-
tide and the C helix remain stable throughout the 
simulation and in all of these conformations (Figs. 4 D 
and 5 D), indicating that the bound state of the domain is 
not affected by these conformational changes around the 
nucleotide, and that the ligand can be stabilized either by 
direct protein contacts or water-mediated contacts.
In addition, visual inspection of the triple mutant 
crystal lattice reveals that the 4–5 hairpin is tightly 
packed against other protein molecules in the lattice. 
Therefore, it seems reasonable to conclude that during 
crystal formation there is a selection of one of the con-
formational states sampled by the ligand-binding pocket 
and that the MD simulation has uncovered the existence 
of other conformations.
The analysis of hydrogen bonds formed between the 
protein and the nucleotide base during the MD simulations 
TA B L e  2
Stability of hydrogen bonds formed between protein and ligand base during MD simulation
Wild type T284S/V288S/A352D
Residue Protein–cGMP h-bonds Water-mediated h-bonds Protein–cGMP h-bonds Water-mediated h-bonds
284 2% (OG1) 23% (OG1) — 10% (OG)
286 — 35% (ND2)  
+20% (N)  
+3% (O)
6% (ND2) 22% (O)  
+9% (N)  
+4% (ND2)
288 — — 24% (OG) 35% (OG)
297 — — — —
298 — — — —
308 95% (OG) 3% (O) 93% (OG) —
348 — 6% (NE)  
+2% (O)
— 2% (NE)
352 — — 67% (OD2)  
+61%(OD1)
7% (OD1)  
+7% (OD2)
Percentages correspond to the fraction of time in the MD trajectory when a protein residue forms a hydrogen bond (h-bond) with the guanine group. 
The name of the protein atom participating to the h-bond is given in parentheses. Two atoms are considered part of an h-bond if donor and acceptor are 
closer than 3.5 Å and the donor–hydrogen–acceptor angle is below 35°.
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its overall selectivity decreased to an approximately six 
times cAMP preference.
The increased affinity for cGMP in the A352D mutant 
fits well with the close interaction between this residue 
and the ligand seen in the crystal and in the MD simula-
tion. The almost neutral effect of T284S on cGMP bind-
ing also fits well with the structural and simulation data 
where no specific interactions are observed between 
this residue and cGMP. In contrast, the crystal structure 
and the MD simulations led us to expect that the V288S 
mutant would show tighter cGMP binding, but the af-
finity measurements in the V288S single mutant show 
no impact on cGMP binding. In addition, none of the 
single mutants alone causes the inversion in ligand se-
lectivity, strongly suggesting that inversion in ligand se-
lectivity is caused mainly by an effect that results from 
the combination of the three residue changes (T284S/
V288S/A352D). To dissect the underlying details of this 
combination of mutations, we performed a mutant cycle 
energetic coupling analysis (Carter et al., 1984; Schreiber 
and Fersht, 1995; Ranganathan et al., 1996; Yifrach et al., 
2009). More specifically, in a double mutant cycle analy-
sis of ligand binding, a coupling energy above or below 
zero indicates that there is a difference in the energetic 
interaction of two side chains between the bound and 
unbound states.
After determining the affinity of the V288S/A352D 
double mutant for cAMP and cGMP (Kd cAMP: 547 ± 
111 nM and Kd cGMP: 351 ± 95 nM [Table 1], corre-
sponding to an 0.6× preference for cAMP), we calcu-
lated the coupling energies between these two residues. 
For cAMP binding, the coupling energy is 0.78 ± 0.18 
kcal/mol, and for cGMP binding, it is 0.64 ± 0.20 
kcal/mol. We also determined the coupling energies 
for the combination of T284S with V288S/A352D: 0.14 ± 
0.19 kcal/mol for cAMP binding and 0.34 ± 0.29 
kcal/mol for cGMP binding. The V288S/A352D plus 
T284S coupling energies are small and, within their as-
sociated error, close to zero, so we consider that they 
represent independent effects. In contrast, analysis of 
the mutant cycle for V288S and A352D (Fig. S4) shows 
that the impact of V288S in the absence or presence of 
A352D is different. V288S alone has no effect (0.12 ± 
0.10 kcal/mol) in cGMP binding but has a stabilizing 
impact (0.52 ± 0.18 kcal/mol) when combined with 
A352D. This stabilization fits nicely with the type of in-
teractions observed in the crystal structure and MD 
simulations between this residue and the ligand. Addi-
tionally, it is worthwhile considering that in the triple 
mutant structure, these two residues are far from each 
other (8 Å) and, most likely, even further away in the 
unbound-state structures (Clayton et al., 2004; Altieri 
et al., 2008; Schünke et al., 2009, 2011); the coupling en-
ergies for this residue pair are therefore larger than the 
coupling energy values determined by Schreiber and 
Fersht (1995) for residue pairs separated by more than 
the triple mutant is also the result of an increase in the 
polar chemical nature of the binding pocket: (a) all of 
the mutations introduced in the triple mutant have a 
strong polar chemical character, and (b) our analysis of 
both the crystal structure and MD simulation show that 
A352D and V288S are involved in polar interactions (di-
rect or water mediated) with the nucleotide. An estima-
tion of the polar energy contribution to the total energy 
of cGMP binding in the wild-type and mutant domains 
supports this proposal. A quantitative comparison of 
the estimated binding energies with experimental data 
is not possible because of the approximations applied; 
for example, the entropic contribution to the binding 
energy is not considered. Nevertheless, these approxi-
mations are not expected to affect greatly the main result 
of our energetic analyses (Table 3), which shows that 
the polar component of the binding energy is more favor-
able for cGMP binding in the mutant (6.4 kcal/mol) 
than in the wild-type domain (2.8 kcal/mol). In con-
trast, the apolar term is less favorable in the mutant than 
in the wild-type domain.
Impact of individual mutations in the triple mutant  
CNB domain
We also analyzed the role of the individual mutated resi-
dues on the stability of the mutant complex by measuring 
the ligand-binding properties of the single-point mu-
tant domains (Table 1). The A352D single-point mutant 
has lower ligand selectivity than the wild-type domain 
(approximately three times preference for cAMP). This 
results from a decrease in cAMP affinity (Kd cAMP: 256 ± 
29 nM) and an increase in cGMP affinity (Kd cGMP: 
850 ± 121 nM). On the other hand, the V288S single-
point mutant domain is almost nonselective (1.7× pref-
erence for cAMP) because of a large decrease in cAMP 
affinity (Kd cAMP: 1,205 ± 160 nM), with no effect on 
cGMP (Kd cGMP: 2,105 ± 128 nM). Similarly, the rela-
tively neutral substitution of T284 for serine reduced 
cAMP affinity (Kd cAMP: 464 ± 58 nM) while having lit-
tle effect on cGMP (Kd cGMP: 2,984 ± 379 nM), so that 
TA B L e  3
Binding energies estimated with MM/PBSA
CNB domain Eapolar Epolar Etot
kcal/mol kcal/mol kcal/mol
Wild type 49.1 ± 0.3 2.8 ± 0.3 51.9 ± 0.4
Mutant 47.1 ± 0.4 6.4 ± 0.3 53.4 ± 0.4
G(mutant)-G(wild-type) 2.0 ± 0.7 3.6 ± 0.6 1.5 ± 0.8
Binding energies are reported as average values ± standard errors 
calculated over 100 samples (100-ns MD trajectories sampled with a period 
equal to 1 ns). The total binding energy (Etot) is the sum of an apolar term 
(Eapolar; equal to the Van der Waals energy plus the apolar contribution 
to the solvation energy) and a polar term (Epolar; equal to the coulombic 
energy plus the polar contribution to the solvation energy).
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et al., 2011) (Fig. S1). In the MlotiK1 channel, this is il-
lustrated by several observations within the CNB domain: 
the interactions established by the arginine in the nu-
cleotide-bound domain structures (Clayton et al., 2004; 
Altieri et al., 2008; Schünke et al., 2009); the greatly 
reduced cAMP affinity of the R348A mutant domain 
(Cukkemane et al., 2007; Peuker et al., 2013); and in 
the channel, by the high K1/2 for the nucleotide depen-
dence of activation in the R348A mutant channel and 
by its lower flux activity at saturating concentrations of 
ligand (Mari et al., 2011).
We first confirmed that R348A is almost nonselective 
(Kd cAMP: 25 ± 3.2 µM; Kd cGMP: 39 ± 2.5 µM) and 
then tested other side chains at this position. In particu-
lar, we wondered whether residues with long polar side 
chains could replace the arginine by retaining the inter-
actions with the nucleotide base and also the hydrogen 
bonding with residues in the binding pocket. Strikingly, 
mutations R348N, R348Q, and R348K have basically the 
same ligand-binding properties as R348A, with affinities 
for cAMP and cGMP that vary between 16 and 46 µM 
and are almost nonselective (1.4–1.8× for cAMP). Be-
cause of the low affinity for the fluorescent analogue 
displayed by all mutations of R348, we used a slightly 
different titration procedure (see Materials and meth-
ods and Table 1). We also evaluated if electronic delo-
calization in the side chain was a determining factor at 
this position by measuring ligand-binding affinities for 
the mutant R348Y; however, results are very similar to 
R348A (Kd cAMP: 24 ± 2.2 µM; Kd cGMP: 33 ± 4.8 µM). 
Collectively, these results show that R348, in the C 
helix, is a major determinant of nucleotide affinity (both 
cAMP and cGMP), as it was the only residue where mu-
tations caused Kd changes >10-fold and resulted in large 
changes in ligand selectivity. Our results mirror previ-
ous findings in other cyclic nucleotide–regulated chan-
nels (Craven and Zagotta, 2006; Flynn et al., 2007; Zhou 
and Siegelbaum, 2007; Puljung and Zagotta, 2013). Col-
lectively, these results support the general importance 
of the C helix arginine for the stabilization of the 
“bound-activated state” through closure of the C lid 
over the nucleotide and show that the physical–chemi-
cal properties of the arginine side chain are essential 
for this role.
D I S C U S S I ON
Our analysis in the MlotiK1, together with a study by 
Nimigean and Pagel (2007), confirmed the importance 
of specific binding pocket residues for cGMP binding 
(Table 1), a serine/threonine at the end of the PBC se-
quence, and an aspartate at the end of the C helix. We 
also established that apolar residues on the 4–5 hair-
pin favor cAMP binding.
In certain cyclic nucleotide–regulated proteins, the pre-
sence of one of the residues discussed above is sufficient 
7 Å (all <|0.5| kcal/mol) on the interface of the barstar–
barnase protein complex. It is possible to envisage that 
a long-distance interaction between V288S and A352D 
could result from the stabilization of the water mole-
cule network present in the binding pockets of the crys-
tal and simulation structures. However, the V288S/A352D 
coupling energies are smaller than the |1| kcal/mol ar-
bitrary barrier commonly used to define cooperative ef-
fects; therefore, we cautiously considered this residue 
combination as additive.
Exploring other residues in the binding pocket
In addition to the three mutations described above, we 
evaluated the impact of various other binding pocket 
mutations. We have summarized the results of this analy-
sis in Table 1. Overall, this mutant screening shows that, 
although some of the tested single mutants greatly re-
duce the domain’s preference for cAMP over cGMP, none 
of these single mutations (including those found to de-
termine selectivity in other cyclic nucleotide–regulated 
channels) caused a reversal of selectivity, as defined by 
the ratio of the Kds.
We have found specific effects that provide new in-
sights into the general ligand-binding properties of 
CNB domains. The lack of a clear definition of which 
residues in the binding pocket favor cAMP binding ex-
plains in part our incomplete understanding of the 
molecular determinants of cyclic nucleotide binding in 
CNB domains. It has been shown in HCN2 channels 
that residues at the C-terminal end of the C helix af-
fect cAMP binding (Zhou and Siegelbaum, 2007), but 
these do not appear to interact directly with the nucleo-
tide. We have now found that apolar residues (valine, leu-
cine, isoleucine, and alanine) at position 288 of MlotiK1, 
in the 4–5 hairpin and in the immediate neighbor-
hood of the nucleotide base, favor cAMP binding. This 
conclusion results from finding that the presence of 
the apolar amino acids at this position maintains tight 
cAMP binding and cAMP preference over cGMP (Table 1), 
whereas the introduction of a serine (V288S) caused a 
large decrease in the affinity for cAMP and made the 
mutant almost nonselective (Table 1).
In addition, we have confirmed the importance of a 
negatively charged amino acid at the end of the C helix 
(Varnum et al., 1995; Flynn et al., 2007) at position 352, 
for the increased stability of the cGMP complex (Table 1). 
Also, we showed that a serine, at this same position 
(A352S), increases cGMP affinity (Kd cGMP: 727 ± 170 nM) 
while not altering cAMP affinity (Kd cGMP: 174 ± 
23 nM).
We also looked at substitutions in R348 (Table 1), a 
residue that has an important role in the closure of the 
C helix over the ligand and therefore on the stabiliza-
tion of the bound state of CNG (Puljung and Zagotta, 
2013), HCN (Zhou and Siegelbaum, 2007), and MlotiK1 
channels (Clayton et al., 2004; Altieri et al., 2008; Mari 
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compensates for ligand dehydration or allows many of 
the solvation waters to be retained in the bound state. 
These are exactly the features that we have found in our 
analysis of the MlotiK1 triple mutant.
In this context, it is also interesting to analyze the re-
cently published structure of the cGMP-bound CNB 
 domain from the cGMP-dependent protein kinase I 
(Protein Data Bank accession no. 4KU7) (Huang et al., 
2014), a domain that is 250 times more selective for 
cGMP than cAMP (Figs. S1 and S5). Its binding pocket 
includes an arginine at a position that is equivalent to 
residue 288 in MlotiK1; importantly, it was shown that 
mutation of this residue to alanine strongly affects the 
selectivity properties of the domain. In the structure, 
the arginine hydrogen bonds N7 and O6 in the guanine 
base, resembling the interactions established between 
the waters A and B and the base in our triple mutant 
structure (Fig. S5, A and B). In addition, the ligand base 
is highly exposed to the bulk solvent (Fig. S5, C and D) 
because the C helix is very short and the tip of the 
4–5 hairpin is disordered. Collectively, this analysis 
shows that the ligand-binding pocket of this strongly 
cGMP-selective CNB domain shares some of the polar 
environment characteristics described above in the 
MlotiK1 triple mutant domain.
Our conclusion that the polar character and the struc-
tural freedom of the ligand-binding pocket in the triple 
mutant are determining factors for cGMP preference 
also explains the difficulty in establishing rules for deter-
mining the selectivity properties of a CNB domain just 
from an amino acid sequence. These prediction rules 
cannot just consider the possible direct interactions be-
tween side chains and the nucleotide chemical groups. 
They have to consider that there are multiple mecha-
nisms for establishing selectivity in a CNB domain, 
mechanisms that include more complex effects such as 
the stabilization of water molecules in the ligand-binding 
pocket or differences in the entropy of this pocket.
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for determining preference for cGMP over cAMP. How-
ever, in the MlotiK1 CNB domain, and in many other 
cyclic nucleotide–regulated proteins, this is not true 
(Cukkemane et al., 2011), and it is clear that other fac-
tors (other residues and/or structural features) also play a 
role in ligand selectivity. We inverted ligand selectivity in 
the MlotiK1 channel with a combination of mutations at 
T284S, V288S, and A352D. The x-ray structure of our tri-
ple mutant shows that A352D establishes close contacts 
with the guanine group, whereas the other two residues 
are involved with a network of four water molecules that 
connect the protein and the ligand. Surprisingly, an MD 
simulation reveals that the conformation seen in the crys-
tal is not unique; in the simulation, the crystal confor-
mation (or semi-closed conformation) appears to be in 
equilibrium with two other conformations: a closed con-
formation where the 4–5 hairpin is positioned closer to 
the nucleotide base and V288S forms direct interactions 
with the guanine group, and an open conformation where 
the hairpin has moved away from the ligand and contacts 
between the protein and the ligand involve a network of 
many waters. Importantly, all of these different conforma-
tions appear to correspond to a bound-activated state of 
the domain, as the nucleotide position and the position of 
the C helix do not vary greatly over the length of the 
simulation. In contrast, the MD simulation of the cGMP-
bound wild-type domain shows only one conformation.
The “structural freedom” of the triple mutant ligand-
binding pocket observed in the MD simulation, involv-
ing multiple conformations of the 4–5 hairpin and 
movement of solvent molecules in and out of the 
pocket, strongly suggests that the increased stability of 
the cGMP complex in this mutant is partly caused by an 
increase in the entropy of the bound state relative to 
the wild-type domain. In addition, our mutagenesis 
analysis together with the crystal structure and MD sim-
ulation also strongly indicates that there is a combined 
effect of the three mutations (T284S/V288S/A352D) 
to create a polar environment around the nucleotide 
base involving interactions of water molecules with the 
protein. This conclusion is based on several factors: the 
increased polar chemical character of all the substitu-
tions; the larger number of hydrogen bonds established 
between the protein and the ligand in the simulation 
closed and semi-closed conformations relative to the 
wild-type domain; the larger number of water molecules 
that solvate the ligand in the simulation open confor-
mation; and the calculated contribution of the polar 
energy to the total binding energy of the ligand. Impor-
tantly, the significance of the polar environment for defin-
ing cGMP preference in our mutant domain is supported 
by theoretical calculations that show that the cGMP hy-
dration energy is greater than for cAMP (Zhou and 
Siegelbaum, 2008). This theoretical finding suggests that 
preference for cGMP binding in a CNB domain can be 
generally achieved through a binding pocket that either 
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Figure S1. Sequence alignment of CNB domains from the MlotiK1 (UniProt accession no. Q98GN8), HCN2 (RefSeq accession no. 
NP_032252), and CNGA-1 channels (UniProt accession no. Q00194); CNB  domain from the cGMP-dependent kinase I (UniProt ac-
cession no. Q13976); and CNB homology domains from the ELK (RefSeq accession no. XP_001919436) and EAG1 (RefSeq accession 
no. NP_034730) channels. Secondary structure elements of MlotiK1CNB domain are shown as arrows ( strand) or rectangles ( helix). 
Residues that are discussed in the main text are shown in bold.
Figure S2. Stereo view of the 2Fo-Fc electron density map at 1.25-Å resolution covering the binding pocket of the T284S/V288S/A352D 
MlotiK1 CNB domain. cGMP and side chains of S288, D352, and S384 are represented as stick. Water molecules A–D are represented in 
red spheres. Electron density around these elements is represented by a gray mesh.
S U p p L E m E N TA L  m AT E R I A L
Pessoa et al., http://www.jgp.org/cgi/content/full/jgp.201311145/DC1
S2 Ligand selectivity in the MlotiK1 channel
Figure S3. Stereo view of the ligand-binding pocket in the triple mutant. Water molecules are represented by red spheres, and the li-
gand (in white) and some residues (in yellow) are represented as stick. Residues and atoms discussed in the main text are labeled. The 
hydrogen bond network is represented by dashed lines.
Figure S4. Mutant cycle energetic analysis. Mutant cycle of the V288S and A352D combination for cAMP (left) and cGMP binding 
(right). Corners correspond to wild-type, single, and double mutant CNB domain. Changes in ligand-binding energy (in kcal/mol) be-
tween different protein forms are indicated along the arrows connecting the corners. Coupling energy (Gc; in kcal/mol) is shown at 
the center of each panel.
 Pessoa et al. S3 of 19
Figure S5. The CNB  domain from the cGMP-dependent protein kinase I. Identical views of the ligand-binding pocket in (A) the tri-
ple mutant domain from the MlotiK1 channel and in (B) the CNB  domain from the cGMP-dependent protein kinase I (Protein Data 
Bank accession no. 4KU7). Waters and some of the residues surrounding the nucleotide are labeled and shown as spheres and sticks, re-
spectively. (C and D) Two views of the ligand-binding pocket in the CNB  domain from the cGMP-dependent protein kinase I, with the 
protein shown as a solvent-accessible surface. The figure shows that in this domain, the ligand is very exposed to the bulk solvent through 
two large water-accessible tunnels.
Table S1 
Statistics of crystallographic data and refinement
Parameter Value
Data collection
Space group P 21 21 21
Cell dimensions a, b, c (Å) a = 60.05, b = 61.57, c = 67.84
Cell angles , ,  (°) , ,  = 90.00
Resolution (Å) 42.99–1.22 (1.29–1.22)
Rmerge 0.033 (0.646)
Total reflections 260,877 (33,195)
Unique reflections 74,662 (10,447)
I/I 20.9 (1.8)
Completeness (%) 99.0 (98.5)
Multiplicity 3.5 (3.2)
Refinement:
Resolution (Å) 42.99–1.25 (1.27–1.25)
No. reflections 66,278 (3,514)
Rwork / Rfree 13.7/17.2
Number of atoms:
Protein 4,402
Ligands 74
Solvent 355
Average B factor (all atoms) (Å2) 18.0
RMSDs:
Bond lengths (Å) 0.013
Bond angles (°) 1.56
Values in parentheses refer to the highest resolution shell.
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Cyclic nucleotide-regulated ion channels are present in bacteria,
plants, vertebrates, and humans. In higher organisms, they are
closely involved in signaling networks of vision and olfaction.
Binding of cAMPor cGMP favors the activation of these ion channels.
Despite awealth of structural and studies, there is a lack of structural
data describing the gating process in a full-length cyclic nucleotide-
regulated channel.We used high-resolution atomic forcemicroscopy
(AFM) to directly observe the conformational change of the mem-
brane embedded bacterial cyclic nucleotide-regulated channel Mlo-
tiK1. In the nucleotide-bound conformation, the cytoplasmic cyclic
nucleotide-binding (CNB) domains of MlotiK1 are disposed in a
fourfold symmetric arrangement forming a pore-like vestibule. Upon
nucleotide-unbinding, the four CNB domains undergo a large rear-
rangement, stand up by ∼1.7 nm, and adopt a structurally variable
grouped conformation that closes the cytoplasmic vestibule. This
fully reversible conformational change provides insight into how
CNB domains rearrange when regulating the potassium channel.
conformational changes | cyclic nucleotide gating | membrane protein |
MloK1 | single-molecule imaging
Potassium channels are tetrameric membrane proteins that fa-cilitate the permeation of potassium ions through the mem-
brane with high speciﬁcity and high-throughput rates. These
channels are central to the electrical activity of cells in humans
and are, therefore, of fundamental importance for the function
of nervous and muscular systems. The major mode of functional
regulation in potassium channels is gating, a conformational
change that occurs on the intracellular regions of the ion pore
domain and involves an iris-like movement of the C-terminal
transmembrane helices and a widening of the intracellular pore.
Gating in potassium channels is induced by a variety of stimuli,
including membrane voltage, intracellular calcium concentration,
and cyclic nucleotide levels (1). These stimuli are sensed by a
separate domain from the ion pore domain, inducing a confor-
mational change that is then propagated to the gate of the channel.
The MlotiK1 potassium channel, from the bacterium Meso-
rhizobium loti, belongs to the family of channels that is regulated by
cyclic nucleotides and includes eukaryotic cyclic nucleotide-gated
(CNG) and hyperpolarization activated cyclic nucleotide-gated
(HCN) channels (2, 3). These channels have C-terminal cytoplas-
mic cyclic nucleotide-binding (CNB) domains and upon binding
of cAMP or cGMP, these domains undergo a conformational
change that favors the opening of the gate of the channel. The
major difference between the MlotiK1 channel and the CNG or
HCN channels is the linker that connects the gate to the CNB
domains. This helical linker (C linker) is roughly 80 residues long
in CNG and HCN channels and only ∼20 residues long in the
MlotiK1 channel.
The MlotiK1 channel has been the focus of structural and
functional studies with the aim of understanding channel regulation
by cyclic nucleotides. X-ray and NMR structures of the CNB do-
main in the cAMP-bound and -unbound conformations have been
reported (4–6). Together with other CNB domain structures (7–9),
the MlotiK1 studies have provided molecular details of ligand-
binding and deﬁned associated conformational changes. The
structure of the full-lengthMlotiK1 channel, in detergent, has been
reported at 3.1 Å resolution. This X-ray structure revealed the
membrane-buried channel regions in the closed state, whereas the
disordered CNB domains could not be observed (10). Electron
microscopy of full-length channels in the presence of cAMP, either
as 2D crystals in lipid bilayers or as single particles solubilized
in detergent, produced a 9-Å resolution projection map (11) and a
16-Å resolution 3D structural model (12), respectively. The single-
particle reconstruction shows the ligand-binding domains disposed
in a fourfold symmetric arrangement. Despite this structural
information, there is still a lack of understanding about the con-
formational changes that occur in the MlotiK1 channel upon lig-
and-binding.
Atomic force microscopy (AFM) has been established to ob-
serve the surfaces of membrane proteins at high resolution (0.5–
2 nm) in their native state (13, 14). Importantly for biological
applications, AFM requires no labeling or staining and allows
imaging of membrane proteins in the lipid membrane, in buffer
solution, and at ambient temperature (15, 16). With time-lapse
AFM, it is possible to image single-membrane proteins at work
(15, 17–19), as well as diffusing and assembling into higher com-
plexes (20, 21).
To better understand the mechanism of gating in full-length
cyclic nucleotide-regulated channels, we applied time-lapse AFM
to characterize the conformational changes induced in the Mlo-
tiK1 channel by ligand-binding and -unbinding. AFM topographs
show that upon cAMP-unbinding, the CNB domains of MlotiK1
undergo large conformational changes and move ∼1.7 nm. These
conformational changes are reversed upon rebinding of cyclic
nucleotide.
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Results
High-Resolution AFM Imaging of Bound-State MlotiK1 Channels.
Wild-type (wt) MlotiK1 channels reconstituted at high protein:
lipid ratio in polar Escherichia coli lipid membranes were adsorbed
onto freshly cleaved mica and imaged by AFM in the presence of
cAMP (Fig. S1). AFM topographs showed the 3D surface of lipid
membranes, having diameters up to several tens of micrometers
and islands of densely packedMlotiK1 channels. The height of the
lipid membranes above the mica support was 4.0 ± 0.5 nm (n =
81), whereas the height of MlotiK1 containing membranes was
10.2 ± 0.8 nm (n = 176).
At higher resolution, AFM topographs of the densely packed
protein assemblies revealed single MlotiK1 channels (Fig. 1) that
showed a fourfold symmetric arrangement protruding 3.2± 0.5 nm
(n = 100) from the lipid surface. Previous structural studies sug-
gest that only the relatively large cytoplasmic CNB domains can
protrude that far from the membrane surface (4, 11, 12). In con-
trast, the extracellular surface of MlotiK1 is expected to protrude
less. Indeed, AFM topographs showed shallow fourfold symmetric
protein surfaces that protruded only 1.8± 0.5 nm (n=48) between
the higher protruding tetrameric MlotiK1 channels (Fig. 1B and
Fig. S2). This alternate disposition of MlotiK1 channels exposing
either their cytoplasmic or extracellular surface is consistent with
the previously described “up-and-down” packing of MlotiK1
channels reconstituted into 2D crystals (11, 12). A schematic ﬁgure
(Fig. S3) shows the arrangement of the MlotiK1 channels and the
heights measured by AFM. From these observations, we conclude
that the four high protrusions of MlotiK1 represent the cytoplas-
mic cAMP-binding domains.
To gain further insights into the disposition of CNB domains, we
calculated a correlation-averaged topography of the MlotiK1 tet-
ramer (Fig. 1C). The average shows that each CNB domain is
oriented radially from the axis of the tetramer. At the center, the
tetramer shows a vestibule with an inner diameter of∼1.5± 0.5 nm
and a depth of∼1.4± 0.3 nm (n=54). The SDmap (22) shows the
structural variability of the CNB domains (Fig. 1D).
MlotiK1 Membranes Increase Thickness in the Absence of cAMP. It is
expected that changing the functional state of MoltiK1 because of
binding or unbinding of cyclic nucleotide causes the potassium
channel to undergo a conformational change. Unfortunately, we
could not use the wtMlotiK1 channel for imaging this change. The
CNB domain of the wt MlotiK1 channel shows a high binding
afﬁnity for cAMP (KD, ∼80 nM) (23). Therefore, removal of nu-
cleotide from the CNB domain by dialysis or by exchanging the
buffer is an extremely slow and inefﬁcient process (4, 6, 23). Ac-
cordingly, wt MlotiK1 membranes showed no signiﬁcant changes
in the absence of cAMP (Fig. S1 a–c). This observation was not
altered after extensive washing steps and storage of wt MlotiK1
membranes for 4 d in cAMP-free buffer solution at room tem-
perature (Fig. S4). High-resolution AFM topographs of wt Mlo-
tiK1 channels recorded in the absence of cAMP did not reveal
conformational changes (Figs. S4b and S5). wt MlotiK1 mem-
branes that were dialyzed for 9 d against cAMP-free buffer
(Materials and Methods) showed no structural changes as well
(Fig. S6a).
To study the conformational change that occurs upon ligand-
binding and -unbinding, we used the R348A mutant of MlotiK1
that has lower afﬁnity for cAMP (KD, ∼18 μM) and can be pre-
pared both in the bound and unbound states (23). We had pre-
viously reported that this mutant was not activated by cAMP (4),
but by decreasing the background noise of the radioactivity uptake
assay, we are now able to detect nucleotide-dependent channel
activity (Fig. 2 andMaterials andMethods). R348Amutant channel
has a substantially lower maximal activity than the wt channel (Fig.
2, inset), with a K1/2 of activation (10.0 ± 4.4 μM) 100-fold higher
than wt MlotiK1 (Fig. 2). These results are consistent with pre-
vious cAMP-binding studies that show the CNB domain of the
R348A mutant to bind cAMP at lower afﬁnity (23).
We ﬁrst imaged the R348A mutant in the presence of a satu-
rating concentration of 900 μM cAMP (Fig. 3 A–C). Within the
resolution achieved (1.5–2 nm), the mutant channel is indis-
tinguishable from wt MlotiK1 (Fig. 1). Additionally, these mutant
Fig. 1. High-resolution AFM topographs of the wt cyclic nucleotide-regu-
lated potassium channel MlotiK1. (A) Overview of a membrane patch of
densely packed MlotiK1 channels. (B) MlotiK1 channels imaged at higher
resolution. Each of the light colored tetramers corresponds to a channel
viewed from the cytoplasmic side. Individual protrusions correspond to in-
dividual CNB domains that protrude 3.2 ± 0.5 nm (n = 100) from the lipid
bilayer. In between the highly protruding (or light colored) channels, lower-
lying tetramers (dashed circles) exposing the extracellular surface of the
channel can be observed. These lower tetramers protrude 1.8 ± 0.5 nm (n =
48) from the lipid bilayer. A gallery of these lower-protruding MlotiK1
channels is shown in Fig. S2. Correlation average (C) and SD map (D) calcu-
lated from 54 highly protruding MlotiK1 tetramers show details of the CNB
domains. AFM topographs show full-color levels corresponding to vertical
height scale of 12 nm (A), 5 nm (B), 4 nm (C), and 0.6 nm (D). Imaging buffer
was 50 mM KCl, 200 μM cAMP, and 20 mM Tris-HCl (pH 7.5).
Fig. 2. cAMP-dependent activity of the wt and R348A mutant MlotiK1
channels. Uptake of 86Rb+ into liposomes containing R348A mutant channel
was measured in dependence of cAMP. The uptake activity was examined in
duplicate at each cAMP concentration, from a common stock of liposomes.
Raw values were ﬁrst normalized by valinomycin uptake in the same vesicles
and subsequently normalized by uptake at the maximum value (1 mM
cAMP). The experiment was conducted twice (with different puriﬁcations),
yielding four data points at each concentration. The solid curve shows a ﬁt
of the R348A data (triangles) with a Hill equation, yielding a K1/2 of acti-
vation of 10 ± 4 μM and Hill coefﬁcient of 1.1 ± 0.6. The dashed curve
illustrates the ﬁtted curve of similar experiments published on wt MlotiK1
(5), with K1/2 of 110 nM and Hill coefﬁcient of 1.3. The inset shows nor-
malized radioactivity cpm for wt and mutant MlotiK1 at saturating cAMP
concentrations (100 μM for wt; 1 mM for R348A) or in the absence of cAMP
(R348A, 0 mM). The raw data (R348A) show mean values, and bars indicate
SEs. The wt data were taken from ref. 4.
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MlotiK1 membranes showed the same height 10.1 ± 0.8 nm (n =
156) as observed for wt MlotiK1 membranes (Fig. S1D). This
agrees with the functional characterization that shows that the
mutant is active (Fig. 2). To characterize the changes induced by
cAMP release, we replaced the AFM imaging buffer for a cAMP-
free buffer and reimaged the mutant MlotiK1 membranes after an
incubation time of >3 h (Fig. S1 d and e). Mutant MlotiK1
membranes signiﬁcantly increased heights (∼1.7 nm) upon re-
moval of cAMP, protruding 11.8± 0.8 nm (n= 147) from the mica
support. This height change was reversed by the addition of
900 μM cAMP (Fig. S1f and Table S1).
We also imaged mutant MlotiK1 membranes that underwent a
long dialysis step (9 d, with several dialysis-buffer changes) against
cAMP-free buffer after protein reconstitution and before adsorp-
tion to the mica support. These membranes, imaged in cAMP-free
buffer, showed an even larger height increase relative to the bound-
state channel membranes, now protruding 13.5 ± 0.7 nm (n= 153)
from the support (Fig. S6b). The cAMP-dependent height differ-
ences of the differently prepared mutant samples (Table S1) de-
pend on the adsorption to mica. In samples already adsorbed to the
mica support, the CNB domains in contact with the mica (Fig. S3)
are hardly accessible to buffer exchange, do not loose the ligand,
and, therefore, do not undergo a conformational change. Accord-
ingly, removal of cAMP causes a ∼1.7 nm height increase per
membrane leaﬂet. Table S1 gives an overview of all heights mea-
sured for wt andmutantMlotiK1membranes, and Fig. S7 illustrates
the nucleotide-dependent height changes of themembrane leaﬂets.
Nucleotide-Binding Domains Undergo Drastic Conformational Changes.
To characterize in detail the structural changes occurring with
ligand-unbinding, we imaged the membranes containing mutant
MlotiK1 channels at higher resolution. In cAMP-free buffer, we
observed that the potassium channels protruded by 4.9 ± 0.6 nm
(n = 148) from the lipid surface (Fig. 3D and Figs. S8 and S9).
The characteristic fourfold symmetric structure of MlotiK1 ob-
served in the cAMP-bound state (Figs. 1 and 3 A and B and Fig.
S5), with four CNB domains surrounding the vestibule, was lost
and each channel showed a single protrusion (Fig. 3 D and E).
Importantly, at the single-molecule level, the protrusions do not
show any obvious structural feature. This was reﬂected in the
correlation-averaged topography (Fig. 3E). The SD map of the
cAMP-unbound CNB domains showed much higher values (Fig.
3F) than that observed in presence of cAMP (Fig. 3C). This
indicates an increased structural variability (or conformational
ﬂexibility) (22) of the CNB domains in the absence of ligand.
Possibly because of this ﬂexibility, substructural details of nucle-
otide-free MlotiK1 could not be contoured by the scanning AFM
tip. Moreover, the AFM topographs showed that some pro-
trusions appear to become more continuous between neighboring
channels as if the CNB domains in the cAMP-unbound state
could group with CNB domains from adjacent channels (Fig. 3D
and Figs. S8 and S9). This change probably reﬂects an enhanced
structural ﬂexibility of the CNB domains, which allows them to
explore a larger area and to interact with adjacent CNB domains
provided by the densely packed potassium channels.
Upon readdition of saturating cAMP concentrations of 900 μM
(Fig. 2), all CNB domains (∼99%) collapsed back onto the
membrane and adopted the cAMP-bound conformation (Fig. 3G).
To image densely packed MlotiK1 membranes that show both
bound and unbound channel conformations, we incubated mutant
MlotiK1 membranes with cAMP-free buffer. Veriﬁcation that the
CNB domains switched to their cAMP-unbound conformation was
performed by AFM imaging the height changes of MlotiK1
membranes. After this, we readded 600 μM cAMP, which did not
fully saturate the CNB domains, and imaged the mutant MlotiK1
channels at a higher resolution (Figs. S8 and S9). It was observed
that the majority, but not all, of channels collapsed back to the
cAMP-bound conformation. The AFM topographs showing the
coexistence of both cAMP-unbound and cAMP-bound con-
formations suggest that the conformational change of MlotiK1
channels is not cooperative between neighboring channels. Most
importantly, however, these topographs directly show the height
difference between the cAMP-unbound and cAMP-bound mutant
Fig. 3. High-resolution AFM topographs of the R348A mutant cyclic nu-
cleotide-regulated potassium channel MlotiK1. (A) Mutant potassium
channels imaged in the presence of cAMP. Single MlotiK1 tetramers pro-
trude 3.1 ± 0.5 nm (n = 57) from the lipid bilayer. (B and C) Correlation
average (B) and SD map (C) of 73 MlotiK1 tetramers showing details of the
CNB domains. (D) Mutant potassium channels imaged in the absence of
cAMP. The topograph shows single protrusions that correspond to individual
MlotiK1 tetramers and extend 4.9 ± 0.6 nm (n = 148) from the lipid bilayer.
(E) Single-particle average of 256 protrusions. (F) SD map of E showing the
high structural variability of the protrusions in the unbound state. (G) Mu-
tant Mlotik1 imaged after readdition of cAMP shows single tetramers that
protrude 3.2 ± 0.5 nm (n = 45) from the lipid bilayer. AFM topographs have
full-color levels corresponding to vertical height scales of 4 nm (A, B, and G),
0.6 nm (C), 6 nm (D and E) and 1.5 nm (F). Imaging buffer was 50 mM KCl,
900 μM cAMP (A and G), no cAMP (D), and 20 mM Tris-HCl (pH 7.5).
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MlotiK1 channels of ∼1.7 nm (Figs. S8 and S9) and conﬁrm the
same height difference detected upon switching the conformation
of all mutant channels of a membrane by cAMP (Fig. 3 and Tables
S1 and S2).
Table S2 summarizes the heights measured for wt and mutant
MlotiK1 channels in the presence and absence of cAMP. Every
experiment from which we calculated the average heights was re-
peated 12 times (seeMaterials and Methods). In every experiment
that involved removing cAMP from the buffer solution, we ob-
served that the mutant channels switched from the cAMP-bound
to the cAMP-unbound conformation, and upon adding cAMP to
the buffer solution, the mutant channels readopted the cAMP-
bound conformation. However, these nucleotide-dependent con-
formational changes could not be recorded for wt MlotiK1 chan-
nels. In summary, these results show that the conformational
changes observed for mutant MlotiK1 are fully reversible and
dependent on cyclic nucleotide. They further support the idea that
these changes are involved in the gating mechanism of the cyclic
nucleotide-regulated potassium channel MlotiK1.
Discussion
Using AFM, we have imaged at the single molecule level two
different conformational states of the cyclic nucleotide-regulated
potassium channel MlotiK1 in a lipid membrane. For these
experiments, we used wt MlotiK1 and the R348A point mutant
MlotiK1. Consistent with previous reports (4, 6, 23), the wt Mlo-
tiK1 channel could only be imaged in the cAMP-bound state. In
contrast, the mutant channel is activated at a higher cAMP con-
centration, allowing us to visualize both the unbound and bound
states. Importantly, the conformations of the bound state of wt and
mutant MlotiK1 were indistinguishable. In the bound state, the
cytoplasmic CNB domains are clearly discernible and organized in
a fourfold arrangement (Figs. 1 B and C and 3 A and B), matching
the symmetry of the membrane-buried regions of the channel (10).
This disposition of the CNB domains was previously observed by
electron microscopy (12). Strikingly, with AFM, it was possible to
image a vestibule at the center of the tetrameric arrangement
(Figs. 1C and 3B and Fig. S5b).
We compared the AFM topograph of the channel in the bound
state to a model generated (Fig. 4C,E, andG) withMlotiK1X-ray
structures of the transmembrane channel regions [Protein Data-
bank (PDB) code 3BEH] (10) and of the cAMP-bound domain
(PDB code 1VP6) (4). Because residues 219–224 of MlotiK1 are
present in a α-helical conformation in both crystal structures, the
four CNB domains could be docked to the transmembrane
channel region (Fig. 4 E and G). The CNB domains were then
rotated outward to minimize steric clashes with the long S2–S3
channel loops and between the four CNB domains. Superimposing
the CNB domain X-ray structure to the AFM topograph of the
cAMP-bound state (Fig. 4 A and C) conﬁrms that the four pro-
trusions contoured by AFM are the cytoplasmic CNB domains.
The model also shows the presence of a vestibule created by the
CNB domains and the helical linker (C linker) that connects the
domains to the transmembrane regions of the channel.
AFM imaging revealed that removal of cAMP from the buffer
solution caused a dramatic conformational change in the mutant
MlotiK1 channel. In the unbound state, the well-deﬁned ar-
rangement of the CNB domains is lost and a single large pro-
trusion without reproducible substructures is detected (Figs. 3D
and 4 B and D). The protrusion stands out ∼1.7 nm relative to the
CNB domains in their cAMP-bound conformation. The topo-
graphs also show that during the structural rearrangement, the
cytoplasmic vestibule has disappeared. Moreover, AFM detected
an increased structural variability of CNB domains that was not
observed for the nucleotide-bound state. This variability could
result from the ability of the four CNB domains in a singleMlotiK1
channel to adopt distinct positions from each other. Importantly,
this conformational change was reversible, and upon addition of
cAMP, the CNB domains converted back to the bound state (Fig.
3G and Figs. S8 and S9). In their rebound state, the CNB domains
adopted the same structural conformation and regained the re-
duced structural ﬂexibility observed before removal of cAMP.
Unlike for the bound state, the molecular interpretation of the
AFM topographs of the channel in the unbound state is not
straightforward, mainly because it is not possible to identify in-
dividual CNB domains. However, we can use what is known about
the structural properties of the MlotiK1 channel to try to un-
derstand the changes detected by AFM. The transition between
cAMP-bound and -unbound states involves the disappearance of
the cytoplasmic vestibule and an increase in the height of the CNB
Fig. 4. Model of the conformational change gating the cyclic nucleotide-
regulated potassium channel MlotiK1. Correlation-averaged AFM topographs
of the cAMP-bound (A) and -unbound (B) conformations of the cytoplasmic
surface of the MlotiK1 channel. Yellow lines represent height proﬁles of cross-
sections along the averaged topographs. The dashed yellow line is that of the
MlotiK1 channel in the cAMP-bound state. (C and D) Superimposition of av-
eraged topograph and structural models for the cAMP-bound (C) and -un-
bound (D) conformations. Cytoplasmic CNB domains of the MlotiK1 channel
are shown in red and yellow (see E and F); transmembrane domains are shown
in gray. (E–H) Top (E and F) and side (G and H) view of structural models.
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domains. A possible explanation for the height change between
the two states is revealed by creating a molecular model with the
MlotiK1 X-ray structures of the transmembrane channel regions
(PDB code 3BEH) (10) and of the cAMP-unbound CNB domain
(PDB code 1U12) (4). A comparison between the model created
with the cAMP-unbound CNB domains (Fig. 4 F and H) and the
one created with cAMP-bound CNB domains (Fig. 4 E and G)
shows a height difference of ∼1.6–1.9 nm, a value that compares
very well with the height change measured by AFM between the
channel bound and unbound states (Fig. 4 A and B). This com-
parison reveals that the height increase detected by AFM could
result from the conformational change that occurs in the CNB
domains upon ligand-unbinding, a change that has been well
characterized by X-ray crystallography and NMR (4–6).
An intriguing aspect detected in the transition between the
bound to the unbound state is the increase in the structural vari-
ability (or ﬂexibility) of the CNB domains. This increase was
assessed from a series of features revealed byAFM. (i) The SDmap
of the unbound-state protrusions (Fig. 3F) shows much larger val-
ues than similar maps for the bound state (Figs. 1D and 3C). This
reﬂects a larger structural variability between protrusions of in-
dividual MlotiK1 channels. (ii) The averaged single protrusion in
the unbound state lacks structural details; (iii) the CNB domains
of single MlotiK1 channels in the unbound state are no longer
distinguishable (Fig. 3D and Figs. S8 and S9a); and (iv) the pro-
trusions of some channels in the unbound state can group with
protrusions of neighboring MlotiK1 channels, indicating that the
CNBdomains are free to extend and to establish contacts with CNB
domains from adjacent channels (Fig. 3D and Figs. S8 and S9).
Structural variability had been previously associated with the
MlotiK1 CNB domains: (i) in the X-ray structure of the full-length
MlotiK1, with partial ligand occupancy (10), the linker connecting
the domains to the last transmembrane helix was clearly deﬁned,
but the CNBdomains were crystallographically disordered and not
observed; and (ii) in a comparison between different cAMP-un-
bound domain structures (5), the helices on the surface of the CNB
domain, including the C-linker helix that connects to the channel
gate, adopted different positions reﬂecting accessibility to multiple
conformational states. In contrast, different X-ray structures in the
cAMP-bound state were basically identical.
The conformational change observed for the CNB domains
upon cAMP release is associated with an apparent volume in-
crease of the cytoplasmic MlotiK1 surface. This increase is illus-
trated by the height proﬁles of the correlation averages (Fig. 4B).
Based on the AFM topographs, we estimate that the apparent
increase in volume is between 16–31 nm3, depending on whether
or not we consider that the cytoplasmic vestibule is ﬁlled with
protein. Using as rule of thumb an average volume of 0.14 nm3 for
each amino acid (24), this apparent volume increase corresponds
to 114–220 residues more in the cytoplasmic region in the unbound
state relative to the bound state. From everything we know about
potassium channels, a conformational change involving the
transfer of these many amino acids from the transmembrane re-
gion to the cytoplasm is not possible. One possible explanation is
that the apparent volume increase results from the conformational
change of CNB domains that upon cAMP-unbinding increase
height and distance from the transmembrane MlotiK1 domain,
thereby creating a dome-like structure.
In conclusion, with AFM imaging of theMlotiK1 channel in two
different functional states, we have shown that CNB domains in
their cAMP-bound conformation are close to the membrane sur-
face and adopt a well-deﬁned conformation, whereas in the
cAMP-unbound conformation, the CNB domains extend consid-
erably from the transmembrane channel. A central characteristic
of this ligand-induced conformational change is an order-to-dis-
order transition where in the bound state, CNB domains are or-
dered, and in the unbound, state the domains display a clear
increase in their structural variability.
Materials and Methods
Protein Expression and Puriﬁcation. Protein expression and puriﬁcation were
based on the procedure described previously (11). Full-length wt MlotiK1 was
expressed in E. coli C41 (DE3) cells after induction (at OD600, ∼1.0) for 5 h with
0.3 μg/mL anhydrotetracycline (Fluka). Cells were lysed in PBS buffer, and
membranes containing MlotiK1 were harvested by ultracentrifugation
(257,000× g, 90min). MlotiK1was extracted frommembranes with PBS buffer
containing 25 mM n-decyl-β-D-maltopyranoside (DM), 5 mM β-mercaptoetha-
nol, 200 μMcAMP. The histidine-taggedMlotiK1was bound toNi-NTA agarose
beads (Qiagen) and eluted with 500 mM imidazole. The histidine tag was
cleaved off with thrombin (HIT) and MlotiK1 was twice puriﬁed in a Superdex
200 (Amersham Pharmacia Biotech) size-exclusion chromatography column
equilibrated in 20mMTris-HCl (pH 7.5), 150 mMKCl, 200 μMcAMP, 3mMDTT,
and 5mM lauryldimethylamine-N-oxide (LDAO). The sameprocedurewas used
for theMlotiK1 R348Amutant, where the cAMP concentrationwas kept at 400
μM throughout puriﬁcation (if not stated otherwise).
Reconstituting Densely Packed MlotiK1 Membranes.MlotiK1was reconstituted
into lipid membranes forming densely packed assemblies using E. coli polar
lipid extract (Avanti) as described previously (11). Lipids were dissolved in
20 mM Tris-HCl (pH 7.5), 150 mM KCl, 200 μM cAMP, 3 mM DTT, 5 mM LDAO,
and 60 mM n-octyl-β-D-glucopyranoside. Samples were prepared by mixing
protein and lipids at the lipid/protein ratios (mg/mg) of 1.5, 1.6, 1.7, or 1.8 (ﬁnal
volume was 109–111 μL). Mixtures were incubated at 30 °C for 1 h with agi-
tation. Membranes were formed by dialyzing the samples against 2 L of a so-
lution composed by 20 mM Tris-HCl (pH 7.5), 50 mM KCl, 200 μM cAMP for the
wt channel and 600 μM cAMP for the mutant, 2 mM DTT, and 0.02% sodium
azide using Slide-A-Lyzer MINI Dialysis units (Thermo Scientiﬁc) with a 10 kDa
cutoff. Dialysis was continued for 2–3 d at 31 °C.
To prepare MlotiK1 channels without cyclic nucleotide, the membranes
were formed in the presence of cAMP as described above, but then the dialysis
buffer was changed for a dialysis solution without cAMP, and the dialysis was
extended for 2 d at 31 °C. After this time, the temperature was changed to
20 °C, and the dialysis was continued for additional 7 d during which the
cAMP-free dialysis solution was changed once. The expected nucleotide
concentration after these dialysis steps was <300 pM for mutant and <100 pM
for wt MlotiK1. These concentrations are well below the cAMP afﬁnities of
the channel (KD (wt), ∼80 nM; KD (mutant), ∼18 μM). Fresh DTT was added
every 2 d. Reconstituted membranes were stored at 4 °C until AFM analysis.
Radioactive Flux Assay. The 86Rb+ uptake assay was performed as described
previously (4, 25). Brieﬂy, MlotiK1 was reconstituted in proteoliposomes in
the presence of high concentration of K+. K+ was removed from the external
solution, 86Rb+ was added, and after incubating for 90 min, the radioactivity
associated with the proteoliposomes was measured. The data presented
here display decreased baseline noise by comparison with our previous study
(4). We attribute this to decreased contamination by other proteins, ach-
ieved by incremental improvements of multiple puriﬁcation steps.
AFM. The AFM (Nanocope IIe; Veeco) was equipped with a ﬂuid cell and oxide-
sharpened Si3N4 cantilevers (OMCL TR400PSA; Olympus) having nominal spring
constants of∼0.09N/m.ReconstitutedMlotiK1membraneswere adsorbedonto
freshly cleaved mica (26) in 200 mM KCl, 20 mM Tris-HCl (pH 7.5), and at cAMP
concentrations indicated. After an adsorption time of ∼30min, the sample was
gently rinsed with the imaging buffer to remove nonadsorbed membranes.
Imagingbuffer solutionswere either 50mMKCl; 200, 600, or 900 μMcAMP; and
20 mM Tris-HCl (pH 7.5); or 50 mM KCl and 20 mM Tris-HCl (pH 7.5). All buffer
solutions were freshly made using nano-pure water (18.2 MOhm/cm) and pro
analysi (>98.5%) purity-grade reagents from Sigma and Merck. Upon buffer
exchange, the AFM setup was thermally equilibrated for ∼30 min. When
changing cAMP-containing buffer for cAMP-free buffer, the sample was in-
cubated for >3 h before imaging. High-resolution contact-mode AFM topo-
graphs were recorded at room temperature and at imaging forces of ∼50 pN
that do not to perturb the nativemembrane protein structure (13, 27). Imaging
forces were manually adjusted to compensate for thermal drift (13). Pro-
portional and integral gains were adjusted manually to minimize the error
(deﬂection) signal and to maximize the height signal. When approaching a
lateral resolution of ∼2 nm, the scanning speed of the AFM stylus was between
500 and 1500 nm/s.
To prove the reproducibility of the experimental ﬁndings, we repeated
every experimental condition for wt and mutant MlotiK1 in at least 12 in-
dependent experiments. In every experiment,we recordedbetween20and60
AFMtopographsofMlotiK1membranesand channels. For everyexperimental
condition, the statistical height analysis ofMlotiK1membranes (Table S1) was
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determined from membranes imaged in at least 12 independent experi-
ments. All experiments conducted were consistent and showed that the
height changes observed upon cAMP-binding and cAMP-unbinding of mu-
tant MlotiK1 channels were fully reproducible (Tables S1 and S2).
Image Processing and Averaging. AFM topographs (512 × 512 pixels) were
selected by the structural details of the reproducibly imaged MlotiK1 surface
and when showing identical structural features in the simultaneously moni-
tored trace and retrace scanning directions. Correlation averaging was per-
formed using the SEMPER image processing system (28, 29). Single particles
were translationally and rotationally aligned to a reference MlotiK1 and av-
eraged. This correlation averagewas used as a reference for reﬁnement cycles.
Correlation-averaged unit cells of the MlotiK1 tetramer were fourfold sym-
metrized. To assess the SD, σk,l, individual unit cells were aligned angularly, as
well as translationally, before single-particle averaging (30). The SD was then
calculated from the averaged topograph μk,l for each pixel (k, l) for xi particles:
σ
2
k; l
¼ 1
N
XN
i−1

X
i
k; l
−μk;l
2
SD maps are displayed as image in a one-to-one pixel correspondence with
the correlation-averaged topograph.
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Fig. S1. Overview AFM topographs of wt and mutant R348A MlotiK1 reconstituted into membranes of E. coli polar lipid extract. Overviews of wt MlotiK1
channel (a–c) and mutant MlotiK1 channel (d–f) membranes prepared in the presence of cAMP (see Materials and Methods), and adsorbed and imaged in the
presence of 200 μM cAMP (a) and 900 μM cAMP (d) after removing cAMP (b and e), and after the readdition of 200 μM cAMP (c) or 900 μM cAMP (f). Lipid
membranes (LM) and densely packed MlotiK1 are clearly visible. Below each topograph is the height proﬁle taken along the dashed lines. Every height proﬁle
represents the superimposition of 10 height lines and shows the height average (colored line) and height variation (gray shading). In the presence of cAMP,
lipid membranes protruded 4.0 ± 0.5 nm (average ± SD; n = 81), wt MlotiK1 membrane patches protruded 10.2 ± 0.8 nm (n = 176) and mutant MlotiK1 patches
protruded 10.1 ± 0.8 nm (n = 156) from the supporting mica. Imaging the same membranes in the absence of cAMP revealed no changes for wt MlotiK1
patches (b). Extending the incubation time in cAMP-free buffer solution to 4 d did not change the appearance and height (10.3 ± 0.6 nm; n = 163) of wt
MlotiK1 membranes (compare with Fig. S4). In the absence of cAMP, mutant MlotiK1 membranes increased their height from 10.1 ± 0.8 nm (d) to 11.8 ± 0.8 nm
(n = 147) (e). For better comparison, we superimposed the average height lines recorded in presence of cAMP (green lines) and height lines recorded in absence
of cAMP (red lines) (e). Upon readding cAMP, wt MlotiK1 membranes showed no change in height (c), whereas mutant MlotiK1 membranes reduced their
height back to that measured initially in the presence of cAMP (f). For better comparison, we superimposed the average height lines recorded in presence of
readded cAMP (blue lines) and height lines recorded before depletion of cAMP (green lines) (f). Imaging buffers were 50 mM KCl and 20 mM Tris-HCl (pH 7.5)
with cAMP concentrations as indicated. All heights for wt and mutant MlotiK1 measured in the presence of cAMP, in the absence of cAMP, and upon readding
cAMP are given in Table S1. n gives the number of lipid membranes or MlotiK1 membranes measured.
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Fig. S2. Gallery of high-resolution AFM topographs of the extracellular surface of the wt MlotiK1 channel. AFM topographs revealed shallow tetrameric
surfaces (outlined by dashed circles) between the highly protruding cytoplasmic surfaces of MlotiK1 channels. Different channels are shown at slightly different
magniﬁcations. The shallow tetramers protrude 1.8 ± 0.5 nm (n = 48) from the lipid bilayer, whereas the highly protruding tetramers protrude 3.2 ± 0.5 nm (n =
100) from the lipid membrane. On average, both the shallow and the highly protruding tetramers have an outer diameter of ∼8–10 nm. AFM topographs show
a gray level range corresponding to a vertical height scale of 4.5 nm. Imaging buffer was 50 mM KCl, 200 μM cAMP, and 20 mM Tris-HCl (pH 7.5). n gives the
number of MlotiK1 tetramers measured.
Fig. S3. Measured heights of the reconstituted wt MlotiK1 membrane. Schematic drawing showing a side view of the reconstituted MlotiK1 channels in an up-
and-down orientation. Height values are average values measured from wt MlotiK1 in the presence of 50 mM KCl, 200 μM cAMP, and 20 mM Tris-HCl (pH 7.5).
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Fig. S5. High-resolution AFM topograph of wt MlotiK1 incubated for 12 h in cAMP-free buffer solution at room temperature. (a) Topograph showing single
MlotiK1 channels with clearly visible CNB domains. Correlation average of 54 MlotiK1 tetramers showing the arrangement of the four CNB domains (b) and
corresponding SD map showing the structural variability of the domains (c). As revealed from the AFM topographs, the appearance of wt MlotiK1 did not
change when removing cAMP (compare Fig. 1 and Fig. S4). In absence of cAMP, the wt MlotiK1 channels protruded 3.2 ± 0.5 nm (n = 54) from the lipid bilayer.
n gives the number of MlotiK1 channels measured. Images have full-color levels corresponding to vertical height scales of 5 nm (a), 4.5 nm (b), and 0.6 nm (c).
Imaging buffer was 50 mM KCl and 20 mM Tris-HCl (pH 7.5).
Fig. S4. AFM topographs of wt MlotiK1 membranes incubated for 4 d in cAMP-free buffer solution. (a) Overview topograph of wt MlotiK1 membranes. Lipid
membranes (LM) embedding densely packed MlotiK1 are clearly visible. The height proﬁle taken along the dashed line indicated in the topograph is shown at
the bottom. The height proﬁle represents the superimposition of 10 height lines and shows their average height (red line) and variation (gray shading). Lipid
membranes protruded 3.6 ± 0.7 nm (n = 61), and MlotiK1 channels protruded 10.3 ± 0.6 nm (n = 163) from the support and 3.3 ± 0.5 nm (n = 117) from the lipid
membrane. n gives the number of MlotiK1 membranes or channels measured. These average heights were not signiﬁcantly different from average heights of
wt MlotiK1 membranes recorded in the presence of cAMP (Fig. S1 a and c and Table S1). (b) High-resolution topograph showing wt MlotiK1 channels after
incubation for 4 d in cAMP-free buffer at room temperature. The inset shows the correlation average of 117 MlotiK1 channels. Incubation and imaging buffer
was 50 mM KCl and 20 mM Tris-HCl (pH 7.5). AFM topographs show full-color levels corresponding to vertical height scale of 20 nm (a) and 4.5 nm (b).
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Fig. S6. AFM topographs of wt and mutant R348A MlotiK1 membranes prepared, adsorbed, and imaged in cAMP-free buffer solution. (a) Overview topo-
graph of wt MlotiK1 membranes. The average height determined from 105 membranes was 10.0 ± 0.7 nm. (b) Overview topograph of a mutant MlotiK1
membrane. Lipid membranes (LM) embedding densely packed MlotiK1 are clearly visible. Lipid membranes protruded 3.9 ± 0.6 nm (n = 47) and MlotiK1
membranes protruded 13.5 ± 0.7 nm (n = 153) from the support. Below each topograph is the height proﬁle taken along the dashed line. Each height proﬁle
is a superimposition of 10 height lines and shows their average (red line) and variation (gray shading). The gray dashed line indicates a height of 10 nm. Before
adsorption to the supporting mica, the MlotiK1 membranes underwent a long dialysis step (9 d, with several dialysis-buffer changes) against cAMP-free buffer
(see Materials and Methods). After dialysis the membranes were adsorbed to the mica and imaged by AFM using cAMP-free buffer solution [50 mM KCl and
20 mM Tris-HCl (pH 7.5)]. n gives the number of membranes measured.
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Fig. S7. Heights measured for reconstituted wt and mutant R348A MlotiK1 in the presence and absence of cAMP. (a) When prepared, adsorbed, and imaged
in the presence of cAMP, wt and mutant MlotiK1 show the same heights within the errors of the AFM measurements (see Figs. S1 a and d and S3 and Table S1).
The heights of wt MlotiK1 do not change after incubation and imaging in cAMP-free buffer (Figs. S1 a–c, S4, S5, and S6a and Table S1). (b) Mutant MlotiK1
membranes prepared and adsorbed in the presence of saturating cAMP concentrations but imaged in the absence of cAMP show an increased height of
∼11.8 nm (Fig. S1e and Table S1). This height change is attributable to conformational changes of the CNB domains facing the buffer solution (Fig. 3D and Figs.
S8 and S9 and Table S1). Reincubating the cAMP-free mutant MlotiK1 (b) with cAMP reduces the membrane height to that measured for mutant and wt
MlotiK1 membranes in the presence of cAMP (Figs. 3 A and G, Figs. S1f and S8 and Table S1). (c) When prepared, adsorbed, and imaged in the absence of cAMP,
mutant MlotiK1 membranes show a height of ∼13.5 nm (Fig. S6b and Table S1). (d) Upon incubating the cAMP-free mutant MlotiK1 membranes (c) with
saturating cAMP concentrations, the membranes show a height of ∼11.8 nm.
Fig. S8. High-resolution AFM topograph of mutant R348A MlotiK1 recorded after readdition of 600 μM cAMP. After adsorption to the supporting mica,
cAMP-bound mutant MlotiK1 membranes were incubated in cAMP-free buffer solution [50 mM KCl and 20 mM Tris-HCl (pH 7.5)] for several hours. In the
absence of cAMP, the MlotiK1 tetramers undergo a conformational change and increase height (Fig. 3D). After this, the membranes were incubated with
600 μM cAMP that was insufﬁcient to saturate mutant MlotiK1. The AFM topograph shows an overview of MlotiK1 tetramers that coexist in two different
conformational states. The lower protruding MlotiK1 tetramers (compare Figs. 1 and 3A) represent the cAMP-bound conformations, whereas the higher
protrusions having the diameter of approximately one MlotiK1 tetramer (∼8–10 nm) represent the cAMP-unbound conformations. At fully saturating cAMP
concentrations, all MlotiK1 tetramers (∼95%) are in the cAMP-bound conformation (Fig. 3G). The image on the right shows selected regions of the topograph
at larger scale. These regions were taken from dashed rectangles indicated in the topograph. Below every selected region, we show a height proﬁle (noise-
ﬁltered) that has been taken along the dashed line indicated. The height difference between lower-protruding (cAMP-bound) and higher-protruding (cAMP-
unbound) MlotiK1 channels corresponds to ∼1.7 nm. The topographs show a full-color level corresponding to vertical height scale of 6 nm. The height analysis
of cAMB-bound and cAMP-unbound mutant MlotiK1 channels is shown in Table S2. Imaging was 50 mM KCl, 600 μM cAMP, and 20 mM Tris-HCl (pH 7.5).
Mari et al. www.pnas.org/cgi/content/short/1111149108 5 of 7
Fig. S9. Time-lapse AFM topographs of mutant R348A MlotiK1 recorded in the absence and presence of cAMP. (a) Mutant MlotiK1 channels recorded in
cAMP-free buffer solution. After an incubation time of ∼3 h all channels increased height by ∼1.7 nm (see Fig. 3D and Table S2). (b) The same mutant MlotiK1
channels as in a recorded ∼150 min after readdition of 600 μM cAMP. The asterisk highlights a reference area, and the dashed circles and ellipses highlight
conformational changes of the same membrane area imaged in absence and presence of cAMP. The lower-protruding MlotiK1 tetramers represent the cAMP-
bound conformations (compare Figs. 1 and 3A and Fig. S8), whereas the higher protrusions having the diameter of about one MlotiK1 tetramer represent the
cAMP-unbound conformations (compare Fig. 3D and Fig. S8). Because mutant MlotiK1 was not fully saturated at 600 μM cAMP, not all channels have re-
adopted the cAMP-bound conformation. The image on the right shows selected regions of the MlotiK1 membrane at larger scale. These regions were taken
from dashed rectangles indicated in the topograph b. Below every selected region, we show a height proﬁle (noise-ﬁltered) that has been taken along the
dashed line indicated. The height difference between lower-protruding (cAMP-bound) and higher-protruding (cAMP-unbound) MlotiK1 channels corresponds
to ∼1.7 nm. Topographs have full-color levels corresponding to a vertical height scale of 6 nm. Imaging buffer was 50 mM KCl, no cAMP (a), 600 μM cAMP (b),
and 20 mM Tris-HCl (pH 7.5).
Table S1. Heights measured for wt and mutant R348A MlotiK1 membranes protruding from the
mica support in the presence and absence of cAMP
Preparation/imaging wt MlotiK1 Mutant MlotiK1
+cAMP/+cAMP/+cAMP 10.2 ± 0.8 nm (n = 176) 10.1 ± 0.8 nm (n = 156)
+cAMP/+cAMP/−cAMP 10.3 ± 0.6 nm (n = 163)* 11.8 ± 0.8 nm (n = 147)†
−cAMP/−cAMP/−cAMP 10.0 ± 0.7 nm (n = 105)* 13.5 ± 0.7 nm (n = 153)†
−cAMP/−cAMP/+cAMP — 12.1 ± 0.8 nm (n = 39)†
Average heights and SDs measured from a number (n) of MlotiK1 membranes imaged by AFM. Sample
preparation, adsorption, and imaging conditions were as follows:
+cAMP/+cAMP/+cAMP: MlotiK1 membranes were prepared in the presence of cAMP (see Materials and
Methods), adsorbed in cAMP-containing buffer, and imaged in cAMP-containing buffer [200 μM cAMP (wt
MlotiK1) or 900 μM cAMP (mutant MlotiK1)].
+cAMP/+cAMP/−cAMP: MlotiK1 membranes were prepared in the presence of cAMP (see Materials and
Methods), adsorbed in cAMP-containing buffer [200 μM cAMP (wt MlotiK1) or 900 μM cAMP (mutant MlotiK1)],
and imaged in cAMP-free buffer.
−cAMP/−cAMP/−cAMP: MlotiK1 membranes were prepared in the absence of cAMP (see Materials and
Methods), adsorbed in cAMP-free buffer, and imaged in cAMP-free buffer.
−cAMP/−cAMP/+cAMP: MlotiK1 membranes were prepared in the absence of cAMP (see Materials and
Methods), adsorbed in cAMP-free buffer, and imaged in cAMP-containing buffer (900 μM cAMP for mutant
MlotiK1).
For every experimental condition listed, the statistical height analysis of MlotiK1 membranes was taken from
membranes imaged in at least 12 independent experiments. For each experiment between 20 and 60 AFM,
topographs of membranes have been recorded.
*Indicates that the average height is not signiﬁcantly different (Student t test) from the average height shown
at the top of the row. Adsorption buffer: 200 mM KCl, 20 mM Tris-HCl (pH 7.5), and cAMP concentrations as
indicated. Imaging buffer: 50 mM KCl, 20 mM Tris-HCl (pH 7.5), and cAMP concentrations as indicated.
†Indicates that the average height is signiﬁcantly different (Student t test) from the average height shown at
the top of the row (+cAMP/+cAMP/+cAMP).
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Table S2. Heights measured for wt and mutant R348A MlotiK1 channels protruding with their
CNB domains from the lipid bilayer
Preparation/imaging wt MlotiK1 Mutant MlotiK1
+cAMP/+cAMP/+cAMP 3.2 ± 0.5 nm (n = 100) 3.1 ± 0.5 nm (n = 57)
+cAMP/+cAMP/−cAMP 3.3 ± 0.5 nm (n = 117)* 4.9 ± 0.6 nm (n = 148)†
−cAMP/−cAMP/−cAMP 3.4 ± 0.6 nm (n = 78)* 4.9 ± 0.6 nm (n = 123)†
−cAMP/−cAMP/+cAMP — 3.2 ± 0.5 nm (n = 45)*
Average heights and SDs measured from a number (n) of MlotiK1 channels imaged by AFM. Sample prep-
aration, adsorption, and imaging conditions were as follows:
+cAMP/+cAMP/+cAMP: MlotiK1 membranes were prepared in the presence of cAMP (see Materials and
Methods), adsorbed in cAMP-containing buffer, and imaged in cAMP-containing buffer [200 μM cAMP (wt
MlotiK1) or 900 μM cAMP (mutant MlotiK1)].
+cAMP/+cAMP/−cAMP: MlotiK1 membranes were prepared in the presence of cAMP (see Materials and
Methods), adsorbed in cAMP-containing buffer [200 μM cAMP (wt MlotiK1) or 900 μM cAMP (mutant MlotiK1)],
and imaged in cAMP-free buffer.
−cAMP/−cAMP/−cAMP: MlotiK1 membranes were prepared in the absence of cAMP (see Materials and
Methods), adsorbed in cAMP-free buffer, and imaged in cAMP-free buffer.
−cAMP/−cAMP/+cAMP: MlotiK1 membranes were prepared in the absence of cAMP (see Materials and
Methods), adsorbed in cAMP-free buffer, and imaged in cAMP-containing buffer (900 μM cAMP for mutant
MlotiK1).
*Indicates that the average height is not signiﬁcantly different (Student t test) from the average height shown
at the top of the row. Adsorption buffer: 200 mM KCl, 20 mM Tris-HCl (pH 7.5), and cAMP concentrations as
indicated. Imaging buffer: 50 mM KCl, 20 mM Tris-HCl (pH 7.5), and cAMP concentrations as indicated.
†Indicates that the average height is signiﬁcantly different (Student t test) from the average height shown at
the top of the row (+cAMP/+cAMP/+cAMP).
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